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Obesity has become a worldwide epidemic. Impaired appetite control is associated 
with weight gain. People who have difficulties in recognising their appetite sensations 
before and after a meal and who do not eat in response to their appetite sensations 
seem to be more susceptible to weight gain. These individuals may represent the ‘low 
satiety phenotype.’  
The objective of the present study was to extend and test the work identified in the 
literature regarding the identification of a satiety phenotype. To identify, at baseline, 
individuals who struggle to lose weight on weight management programmes, due to 
reduced satiety, to help clinical professionals to identify those people at baseline so 
that they can use personalised weight loss strategies to help them.  
The work included studies in an acute laboratory setting and clinical studies. The first 
laboratory setting study was a pilot study to allow the researcher to gain expertise in 
the methods used to assess satiety phenotypes in people with obesity by analysing 
blood samples for gut hormone levels, subjective ratings of appetite response to a test 
meal, Three Factor Eating Questionnaire (TFEQ) subscales, food diaries and food 
craving. A second laboratory based study identified a satiety phenotype in individuals 
with normal weight by measuring energy intake in an ad libitum test meal, as well as 
energy intake from a 3 day food diary. Subjective ratings of appetite response, gut 
hormones, TFEQ and food cravings were also assessed. This study developed methods 
to subsequently use in a clinical community by designing a heat map, which is a visual 
presentation tool including independent variables, scores to help clinical professionals 
working in clinical settings to follow this scoring system to identify individuals who 
have low or high satiety prior to participation in weight management programmes. 
Clinical studies were carried out on individuals with obesity by determining at baseline, 
variables prior to participation in a weight management programme to identify those 
who struggle to lose weight. In the study carried out in a Tier 3 setting, fasting samples 
of plasma gut hormones, subjective ratings of appetite response and TFEQ subscales 
were used to predict subsequent weight loss and reduced satiety. In a Tier 2 setting 
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study, food diaries, food craving and TFEQ subscales were used to identify those who 
may struggle to lose weight. 
In the acute laboratory setting, subjective ratings of appetite response were found to 
be the best measure to identify satiety phenotypes and this was combined with other 
predictive measures to build the heat maps. 
 In the clinical studies, subjective ratings of appetite response were the best baseline 
measures to predict weight loss. In the Tier 3 study, subjective ratings of appetite 
response predicted weight loss and people with reduced satiety, as determined using 
the heat map tool, on average lost more body mass, BMI and waist circumference 
although the difference was not significant. In the Tier 2 study, carbohydrate food 
craving predicted subsequent weight loss. 
In conclusion, the novel findings in this study are the further development of protocols 
to identify high hunger and low satiety phenotypes. These will inform researchers and 
staff in clinical community settings to identify people who have a low satiety 
phenotype and may inform personalised treatments. However, further studies are 
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POMC Pro-opiomelanocortin 
PP Pancreatic polypeptide 
PVN Paraventricular nucleus 
PYY Peptide YY 
RIA Radioimmunoassay 
SD Standard deviation 
SE Satiety efficiency 
SI Satiety index 
SNP Single-nucleotide polymorphism 
SPSS Statistical Package for the Social Science 
SQ Satiety quotient 
T2DM Type 2 Diabetes mellitus 
TEI Total energy intake 
TFEQ Three-Factor Eating Questionnaire 
VAS Visual analogue scales 
VLCD Very low-calorie diet 
VMN Ventromedial hypothalamic nucleus 
WC Waist circumference 
WHO The World Health Organization 


























List of Figures ……….…………………………………………………………………………….17 





















Table of Contents 
 
1 Chapter 1  General introduction ........................................................................... 23 
 Obesity overview .................................................................................................. 23 
 Definition of obesity ............................................................................................. 23 
 Classification and anthropometric measurement of obesity ............................... 23 
 Prevalence of obesity ............................................................................................ 25 
 The aetiology of obesity........................................................................................ 26 
 Obesity management strategies ........................................................................... 28 
 Appetite terminology: satiety and satiation ......................................................... 29 
 Energy Homeostasis and appetite regulation ....................................................... 31 
 Role of the CNS in energy homeostasis and appetite regulation ............................ 32 
 Role of peripheral adiposity signals in energy homeostasis and appetite 
regulation (long-term signal or tonic) ................................................................... 34 
 Role of gut hormonal signals in energy homeostasis and appetite regulation 
(short-term signal or episodic) ............................................................................. 35 
 Ghrelin ..................................................................................................................... 37 
 Peptide tyrosine tyrosine (PYY) ............................................................................... 39 
 Pancreatic polypeptide (PP) .................................................................................... 40 
 Glucagon-like peptide 1 (GLP-1) .............................................................................. 42 
 Food macronutrients and satiety ......................................................................... 43 
 Protein (PRO) ........................................................................................................... 43 
 Carbohydrate (CHO) ................................................................................................ 44 
 Fat ............................................................................................................................ 44 
 Methods to measure appetite .............................................................................. 44 
 Measuring satiation ................................................................................................. 44 
 Measuring satiety .................................................................................................... 45 
 Quantification of satiety ....................................................................................... 47 
 Satiety quotient (SQ) ............................................................................................... 47 
 Factors affecting satiety ........................................................................................ 48 
 Body mass ................................................................................................................ 48 
 Gender ..................................................................................................................... 49 
 Age ........................................................................................................................... 50 
 Sleep ........................................................................................................................ 50 
 Social situations ....................................................................................................... 50 
11 
 
 Identification of a satiety phenotype ................................................................... 51 
 Predicting weight loss ........................................................................................... 52 
 Eating behaviour ................................................................................................... 52 
 Food Craving ......................................................................................................... 54 
 Food craving and obesity ......................................................................................... 55 
 Food diaries and dietary assessment .................................................................... 55 
 Food preferences .................................................................................................. 56 
 Types of diet used to reduce weight .................................................................... 57 
 High protein and gut hormones .............................................................................. 57 
 High protein diet and weight loss ............................................................................ 58 
 Aims of thesis ........................................................................................................ 59 
2 Chapter 2 Materials and methods ........................................................................ 62 
 General Methods .................................................................................................. 62 
 Participants, recruitment and timings .................................................................. 62 
 Pilot study (study 1) ................................................................................................. 62 
 Identification of a satiety phenotype in people with normal weight (Study 2) ...... 64 
 Tier 3 study (Study 3) ............................................................................................... 66 
 Tier 2 study (Study 4) ............................................................................................... 66 
 Anthropometry ..................................................................................................... 67 
 Height ...................................................................................................................... 67 
 Weight ..................................................................................................................... 67 
 Circumference Measurements ................................................................................ 68 
 Questionnaires ...................................................................................................... 68 
 Three factors eating questionnaire (TFEQ).............................................................. 68 
 Food craving inventory questionnaire (FCI) ............................................................ 69 
 Food diaries ............................................................................................................. 69 
 Assessment of appetite ........................................................................................ 70 
 Visual analogue Scale .............................................................................................. 70 
 Satiety Quotient (SQ) ............................................................................................... 71 
 Blood sample collection ........................................................................................ 72 
 Laboratory methods ............................................................................................. 73 
Prior to commencing experimental trial days, all reagents were prepared. .......................... 73 
 Preparation of reagents for the multiplex assay ..................................................... 73 
 Plate washing procedure ......................................................................................... 74 
 Immunoassay procedure ......................................................................................... 74 
 Gut hormone analysis ........................................................................................... 75 
 Statistical analysis ................................................................................................. 75 
3 Chapter 3  Introduction ........................................................................................ 78 
12 
 
 Low satiety phenotype and high protein diet....................................................... 78 
 Rationale for the methods used to measure satiety and hunger in laboratory 
settings .................................................................................................................... 79 
 Aims ......................................................................................................................... 83 
 Materials and methods ......................................................................................... 84 
 Participant recruitment ........................................................................................... 84 
 Statistical analysis .................................................................................................... 86 
 Results ................................................................................................................... 87 
 Baseline characteristics of the study participants ................................................... 87 
 Scores of total energy intake, macronutrient intake based on food diaries and food 
craving questionnaires of participants .................................................................... 87 
 Fasting and AUC appetite, total energy and macronutrient intake ........................ 88 
 Satiety quotient (SQ), satiety quotient composite appetite score, total energy 
intake and macronutrient intake ............................................................................. 89 
 Three factor eating questionnaire subscales, total energy and macronutrient 
intake ....................................................................................................................... 89 
 Fasting sample and AUC of gut hormone, total energy and macronutrient intake 
based on food diaries .............................................................................................. 90 
 Food cravings, total energy and macronutrient intake ........................................... 91 
 Food cravings, fasting and AUC appetite ................................................................. 91 
 Food cravings and satiety quotient (SQ) ................................................................. 92 
 Food cravings and three factor eating questionnaire subscales. ............................ 92 
 Food cravings and gut hormones ............................................................................ 93 
 Food preferences of participants ............................................................................ 94 
 Examples of food recipes in the diets provided ...................................................... 96 
 Diet allocation .......................................................................................................... 96 
 Follow up ................................................................................................................. 97 
 Discussion ............................................................................................................. 98 
 Baseline characteristics and scores of total energy intake, macronutrient   intake 
based on food diaries and food craving questionnaires of participants. ................ 98 
 Fasting sample and AUC appetite, total energy and macronutrient intake ............ 98 
 Satiety quotient (SQ), SQ composite score, total energy and macronutrient intake99 
 Three factor eating questionnaire subscales, total energy and macronutrient 
intake ....................................................................................................................... 99 
 Fasting and AUC of gut hormone, total energy and macronutrient intake ........... 100 
 Food cravings and total energy and macronutrient intake based on food diary 
records ................................................................................................................... 101 
 Food cravings, fasting and AUC of appetite .......................................................... 102 
 Food cravings and fasting and AUC hormone ....................................................... 102 
 Food cravings, satiety quotient and SQ composite score ..................................... 102 
13 
 
 Design and development of increased protein diet .............................................. 102 
 Follow up diet ........................................................................................................ 103 
 Summary ................................................................................................................ 103 
 Study strengths and limitations ............................................................................. 104 
4                  Chapter 4  ................................................................................................................ 105 
4 Introduction ........................................................................................................ 106 
 Factors affecting the food intake in laboratory settings .................................... 107 
 The ‘low satiety phenotype’ .................................................................................. 107 
 Aims ....................................................................................................................... 108 
 Materials and methods ....................................................................................... 109 
 Participants and recruitment ................................................................................. 109 
 Questionnaires....................................................................................................... 110 
 Statistical analysis .................................................................................................. 110 
 Results ................................................................................................................. 113 
 Baseline characteristics of the study participants ................................................. 113 
 Food diary and food craving questionnaires ......................................................... 113 
 Visual analogue scale measurements versus time during the test morning ......... 114 
 Plasma gut hormone concentrations versus time during the test morning ......... 114 
 Visual analogue scales, three factor eating questionnaire, gut hormones, food 
cravings and total energy and macronutrient intake. ........................................... 117 
 Visual analogue scale, three factors eating questionnaire, gut hormones and ad 
libitum lunch intake ............................................................................................... 127 
 Models for baseline of variables as predictors to identify individual satiety 
phenotypes. ........................................................................................................... 142 
 Total energy intake ad libitum lunch intake and of food diary and independent 
variables that identify individual satiety phenotypes. .......................................... 146 
 Participants averages of BMI of low, medium and high satiety participants based 
on total energy intake and Ad libitum lunch intake. ............................................. 156 
 Average TFEQ subscales in low, medium and higher satiety participants based on 
total energy intake and ad libitum lunch intake. ................................................... 162 
 Discussion ........................................................................................................... 168 
 Participants characteristics at baseline ................................................................. 168 
 Visual analogue scale, total energy, macronutrient intake and ad libitum lunch 
intake ..................................................................................................................... 169 
 Relationships of SQ, visual analogue scale and total energy................................. 170 
 Relationship between fasting visual analogue scale and macronutrient intake ... 171 
 Relationships SQ of visual analogue scale macronutrient intake of food diary .... 171 
 Visual analogue scale and ad libitum lunch intake ................................................ 171 
 SQ of visual analogue scale and ad libitum lunch intake ....................................... 172 
14 
 
 The correlation between subscales of TFEQ and food intake (ad libitum lunch and 
total energy and macronutrient intake). ............................................................... 173 
 The correlation of hormones and food intake (ad libitum lunch intake and total 
energy and macronutrient intake). ....................................................................... 175 
 Food craving, total energy and macronutrient intake and ad libitum lunch intake.177 
 Heat map ............................................................................................................... 177 
 Summary ................................................................................................................ 178 
 Study strengths and limitations ............................................................................. 179 
5             Chapter 5   ………… ........................................................................................................ 180 
5 Introduction ........................................................................................................ 181 
 Factors previously studied in predicting weight loss .......................................... 181 
 Visual analogue scales to measure subjective ratings of appetite ........................ 181 
 Eating behaviours .................................................................................................. 182 
 Rotherham Institute for Obesity ........................................................................... 184 
 Aims ....................................................................................................................... 184 
 Materials and methods ....................................................................................... 185 
 Participants and recruitment ................................................................................. 185 
 Blood sample and visual analogue scale ............................................................... 186 
 Statistical analysis .................................................................................................. 186 
 Results ................................................................................................................. 187 
 Baseline characteristics of the study participants ................................................. 187 
 Percentage weight loss after one month .............................................................. 187 
 Percentage weight loss after three months .......................................................... 188 
 Visual analogue scale scores versus time post breakfast during the test morning.189 
 Visual analogue scale appetite scores and subsequent weight loss ..................... 191 
 The correlation between three factors eating questionnaire subscales and 
subsequent weight loss ......................................................................................... 201 
 Fasting plasma gut hormones concentrations and subsequent weight loss. ........ 202 
 Identification of individual satiety phenotypes ..................................................... 206 
 Weight loss of participants by satiety phenotype ................................................. 208 
 Average three factors eating subscales and subsequent weight loss ................... 209 
 Discussion ........................................................................................................... 210 
 Baseline characteristics of participants ................................................................. 210 
 Visual analogue scale scores at different time points and percentage of weight loss 
after one month..................................................................................................... 210 
 Fasting plasma gut hormones and percentage weight loss after one month ....... 211 
 Three factors eating questionnaire subscales and subsequent weight loss ......... 214 
 Identification of satiety phenotype ....................................................................... 215 
 Summary ................................................................................................................ 215 
15 
 
 Study strengths and limitations ............................................................................. 216 
6                 Chapter 6   ................................................................................................................ 217 
6 Introduction ........................................................................................................ 218 
 Factors reported to predict successful weight loss ............................................... 218 
 Food cravings ......................................................................................................... 218 
 Eating behaviours .................................................................................................. 219 
 Food diaries ........................................................................................................... 220 
 Shape- Up .............................................................................................................. 221 
 Aims ....................................................................................................................... 221 
 Materials and methods ....................................................................................... 222 
 Participants and recruitment ................................................................................. 222 
 Questionnaires....................................................................................................... 222 
 Statistical analysis .................................................................................................. 223 
 Results ................................................................................................................. 224 
 Baseline characteristics of the study participants ................................................. 224 
 Food diary results and food craving scores of participants. .................................. 224 
 Weight loss of all participants after ten weeks ..................................................... 225 
 Total energy intake, macronutrient intake of food diary and baseline 
anthropometric measures ..................................................................................... 226 
 Food craving and baseline anthropometric measures .......................................... 226 
 The three factor eating questionnaire subscales and baseline anthropometric 
measures ............................................................................................................... 226 
 Total energy intake, macronutrient intake food diary, three factory eating 
questionnaire subscales and subsequent weight loss (all participants) ............... 229 
 Food craving and subsequent weight loss ............................................................. 229 
 Total energy intake, macronutrient intake based on food diaries, three factor 
eating questionnaire subscales and subsequent weight loss ................................ 230 
 Food craving and subsequent weight loss ............................................................. 230 
 Identification of satiety phenotype ....................................................................... 231 
 Average subsequent weight loss after 10 weeks on the programme ................... 233 
 Average three factor eating questionnaire subscales low and high satiety 
participants ............................................................................................................ 234 
 Average macronutrient in low and high satiety participants ................................ 235 
 Average food craving values in low and high satiety participants ........................ 236 
 Discussion ........................................................................................................... 237 
 Baseline of food craving scores, food diaries data and TFEQ subscales of 
participants ......................................................................................................... 237 
 Total energy intake, macronutrient intake based on food diaries and baseline 
anthropometric measure....................................................................................... 237 
16 
 
 Total energy intake and macronutrient intake and subsequent weight loss ........ 238 
 TFEQ subscales and subsequent weight loss of participants ................................ 240 
 Food craving and subsequent weight loss ............................................................. 241 
 Identifying a satiety phenotype ............................................................................. 242 
 Summary ................................................................................................................ 242 
 Study strengths and limitations ............................................................................. 242 
7 Chapter 7  General discussion ............................................................................ 244 
 Background to the investigations ....................................................................... 244 
 Key findings ......................................................................................................... 246 
The table below shows all measures and the key findings of this thesis. ............................ 246 
 Visual analogue scale measures in the laboratory reflect real life ..................... 247 
 Optimal measurements of VAS (fasting, SQ and AUC) in prediction of a satiety 
phenotype ........................................................................................................... 247 
 Plasma gut hormone levels as a measure to in predict a satiety phenotype ..... 248 
 TFEQ .................................................................................................................... 248 
 Food craving ........................................................................................................ 249 
 Gender ................................................................................................................ 249 
 Heat map............................................................................................................. 250 
 Future work......................................................................................................... 251 
 Limitations of the study ...................................................................................... 252 
 Final conclusion .................................................................................................. 252 
8 References .......................................................................................................... 253 












List of figures   
 
Chapter 1                                                                                                                            Page No      
Figure 1-1: The “satiety cascade” ............................................................................................... 31 
Figure 1-2 : Gut-brain axis: regulation of food intake. ............................................................... 34 
Figure 1-3 : Brain–gut mechanisms regulating food intake and the secretion of gut hormones . 36 
Figure 1-4: Example for visual analogy scale for hunger ........................................................... 46 
Figure 1-5: Feeling of a) hunger and b) fullness measured on a 100 mm VAS .......................... 46 
Figure 2-1:  An example of an AUC calculation of hunger scores for participant No 4 in 
response to a test meal. ............................................................................................................... 71 
Figure 2-2: Preparation of standards for the multiplex assay. .................................................... 74 
Figure 3-1: Flow chart of participants in the study ..................................................................... 85 
Figure 4-1 : Representation of the laboratory period of the trial days. VAS= visual analogue 
scale for all questions, BS=blood sample ................................................................................. 109 
Figure 4-2 VAS scores: hunger (A), fullness (B), desire to eat (C) and   prospective food intake 
(D) for participants versus time, during the test morning. ........................................................ 115 
Figure 4-3: Concentration of  plasma hormones (ghrelin (A), GLP-1(B), PP (C) and PYY (D)  
for participants versus time during the test morning. ................................................................ 116 
Figure 4-4 : VAS fasting and AUC fasting scores and ad libitum lunch intake (kcal) scores for 
females and males (A= VAS fasting hunger, ............................................................................ 129 
Figure 4-5: The relationship of VAS post-breakfast scores and Ad libitum lunch intake (kcal) 
scores for females and males .................................................................................................... 131 
Figure 4-6 : The relationship of 30 min scores  of  four questions of VAS and Ad libitum lunch 
intake  (kcal) scores for females and males .............................................................................. 133 
Figure 4-7: The relationship of AUC hunger, fullness, desire to eat and prospective food intake 
and ad libitum lunch intake ....................................................................................................... 135 
Figure 4-8: The relationship between TFEQ subscales and ad libitum lunch intake ................ 138 
Figure 4-9: The relationship between fasting gut hormones and ad libitum lunch intake scores 
for females and males ............................................................................................................... 139 
Figure 4-10: The relationship between food cravings and ad libitum lunch intake .................. 141 
Figure 4-11 : Average BMI female based on ad libitum lunch intake by using (A) method one 
and (B) method two. ................................................................................................................. 157 
Figure 4-12:  Average BMI male based on ad libitum lunch intake by using (A) method one (B) 
method two................................................................................................................................ 158 
Figure 4-13: Average BMI of female based on total energy by using (A) method one (B) 
method two................................................................................................................................ 160 
18 
 
Figure 4-14: Average BMI male based on TEI in males by using (A) method one (B) method 
two. ........................................................................................................................................... 161 
Figure 4-15: Average TFEQ subscales of female based on TEI using (A) method one (B) 
method two................................................................................................................................ 163 
Figure 4-16 : Average TFEQ subscales of male based on TEI  using (A) method one (B) method 
two. ........................................................................................................................................... 164 
Figure 4-17 : Average TFEQ subscales of females based on ad libitum lunch intake by using 
(A) method one (B) method two. .............................................................................................. 166 
Figure 4-18:  Average TFEQ subscales of males based on ad libitum lunch intake by using (A) 
method one (B) method two. .................................................................................................... 167 
Figure 5-1: Individual percentage weight loss and weight gained after one month on ............ 188 
Figure 5-2 : Percentage weight loss after three months on Advice diet and regular exercise. .. 188 
Figure 5-3 :  The VAS scores for hunger (A), fullness (B), desire to eat (C) and prospective food 
intake (D) versus time post breakfast, ....................................................................................... 190 
Figure 5-4: Relationship between VAS and percentage weight loss after one month.). ........... 199 
Figure 5-5 : Relationship between VAS scores and BMI and waist circumference change. .... 200 
Figure 5-6: Relationships between fasting plasma gut hormones and percentage weight loss 
after one month  ........................................................................................................................ 203 
Figure 5-7: Relationships between plasma gut hormones and BMI change (A= fasting ghrelin 
B= fasting PP C= fasting PYY and D= fasting GLP-1). ........................................................... 204 
Figure 5-8: Relationships between fasting plasma gut hormones and waist circumference change
 .................................................................................................................................................. 205 
Figure 5-9 : Average subsequent weight loss of all participants one month on a diet .............. 208 
Figure 5-10 : Average TFEQ subscales and satiety phenotype ................................................ 209 
Figure 6-1 : Weight loss of all participants after ten weeks on the Shape-up programme ....... 225 
Figure 6-2: Relationship between food craving and baseline of anthropometry measurements for 
all participants ........................................................................................................................... 228 
Figure 6-3 : Average subsequent weight loss of all participants  ............................................. 233 
Figure 6-4 : Average TFEQ subscale scores for low and high satiety participants .................. 234 
Figure 6-5: Average macronutrient intake in low and high satiety participants ....................... 235 







List of tables 
Chapter 1                                                                                                                            Page No 
Table 1-1:  Classification of overweight and obesity in adults according to BMI ...................... 24 
Table 1-2: Disease risk associated with visceral or abdominal obesity ...................................... 25 
Table 3-1: Baseline characteristics of the study participants ...................................................... 87 
Table 3-2 : The mean ± standard deviation of TEI, macronutrient intake based on food diaries 
and food craving questionnaires of participants ......................................................................... 88 
Table 3-3 : Correlation coefficients between fasting and AUC appetite, TEI and macronutrient 
intake ........................................................................................................................................... 89 
Table 3-4 : Correlation coefficients between TEI and macronutrient intake of food with SQ. .. 89 
Table 3-5 : Correlation coefficients between TFEQ subscales, TEI and macronutrient intake .. 90 
Table 3-6 : Correlation coefficients between fasting and AUC for gut hormones, TEI and 
macronutrient intake ................................................................................................................... 90 
Table 3-7 : Correlation coefficients between food cravings, TEI and macronutrient intake. ..... 91 
Table 3-8 : Correlation coefficients between food cravings, fasting and AUC appetite............. 92 
Table 3-9 : Food cravings and satiety quotient and SQ composite score. .................................. 92 
Table 3-10:  Correlation between food cravings and three factor eating questionnaire subscales
 .................................................................................................................................................... 93 
Table 3-11 : Correlation coefficient values between food cravings and gut hormone levels. .... 94 
Table 3-12 : Food preferences of participants ............................................................................ 95 
Table 3-13 : Allocation of diet based on diets tried previously which were unsuccessful. ........ 96 
Table 4-1  : Baseline characteristics of the study participants .................................................... 113 
Table 4-2:  Food diary scores, ad libitum lunch intake and food craving inventory for 
participants ................................................................................................................................ 114 
Table 4-3: The correlations of fasting and AUC fasting composite appetite score of VAS and 
TEI and macronutrient intake. .................................................................................................. 118 
Table 4-4: The correlations of fasting and AUC fasting composite appetite score of VAS ..... 118 
Table 4-5 : The correlations of VAS post-breakfast and TEI. .................................................. 119 
Table 4-6: The correlations of VAS post-breakfast and TEI and macronutrient intake ........... 120 
Table 4-7: The correlations of VAS 30 min and TEI. ............................................................... 121 
Table 4-8: The correlations of VAS 30 min visual analogue scale and TEI and macronutrient 
intake. ........................................................................................................................................ 121 
Table 4-9: Correlations between AUC hunger, AUC fullness, desire to eat, AUC prospective 
food intake, AUC composite of appetite score and TEI. .......................................................... 122 
Table 4-10: Correlations between AUC hunger, AUC fullness, desire to eat, AUC prospective 
food intake, AUC composite of appetite score and macronutrient intake. ............................... 122 
Table 4-11:  Correlation between SQ of VAS and TEI. ........................................................... 123 
20 
 
Table 4-12:  Correlation between SQ of VAS and macronutrient intake. ................................ 123 
Table 4-13: Relationship between subscales of TFEQ and TEI. .............................................. 124 
Table 4-14: Relationship between subscales of TFEQ and macronutrient intake of food diary.
 .................................................................................................................................................. 124 
Table 4-15:  Correlation between fasting hormones and AUC hormones and TEI .................. 125 
Table 4-16:  Correlation between fasting hormones and AUC hormones and total energy ..... 126 
Table 4-17: Correlation between food craving and TEI. .......................................................... 127 
Table 4-18:  Correlation between food craving and macronutrient intake. .............................. 127 
Table 4-19: Regression model identifying predictors (VAS appetite scores at different time 
points, gut hormones) of energy food diary intake in females .................................................. 142 
Table 4-20: Regression model identifying predictors (VAS appetite scores at different time 
points, gut hormones) of energy food diary intake in males ..................................................... 143 
Table 4-21: Regression model identifying predictors (VAS appetite scores at different time 
points, gut hormones) of ad libitum lunch intake in females .................................................... 144 
Table 4-22: Regression model identifying predictors (VAS appetite at different time points, gut   
hormones) of ad libitum lunch intake in males ......................................................................... 145 
Table 4-23: Heat map of satiety phenotype of females based on ad libitum pasta intake in female 
using method one ...................................................................................................................... 147 
Table 4-24: Heat map of satiety phenotype of males based on ad libitum pasta intake in                               
by using method one ................................................................................................................. 148 
Table 4-25: Heat map of satiety phenotype of females based on ad libitum pasta intake in 
females by using method two.................................................................................................... 149 
Table 4-26:  Heat map of satiety phenotype of males based on ad libitum pasta intake in males 
by using method two ................................................................................................................. 150 
Table 4-27: Heat map of satiety phenotype of females based on TEI and independent variables 
by using method one ................................................................................................................. 152 
Table 4-28: Heat map of satiety phenotype of males based on TEI and independent variables by 
using method one ...................................................................................................................... 153 
Table 4-29: Heat map of satiety phenotype of females based on TEI and independent variables 
by using method two ................................................................................................................. 154 
Table 4-30:  Heat map of satiety phenotype of males based on TEI and independent variables by 
using method two ...................................................................................................................... 155 
Table 5-1 : Baseline characteristics of the study participants ................................................... 187 
Table 5-2 : Relationship between VAS scores (different time points, AUC and SQ) and 
percentage weight loss after one month for all participants. (N=22) ........................................ 192 
Table 5-3 : Relationship between VAS scores (different time points, AUC and satiety quotient) 
and percentage weight loss after three months for all participants. (N=11) ............................. 194 
Table 5-4: Relationship between VAS scores (different time points, AUC and SQ) and BMI 
change for all participants. (N=22) ........................................................................................... 196 
21 
 
Table 5-5 : Relationship between VAS scores (different time points, AUC and SQ) and waist 
circumference change for all participants. (N=22) ................................................................... 198 
Table 5-6 : Correlation between TFEQ subscales and subsequent weight loss ........................ 201 
Table 5-7 : The correlation between fasting plasma gut hormone concentrations and weight   
loss subscales ............................................................................................................................ 202 
Table 5-8: Heat map of variables predicting satiety phenotype ................................................ 207 
Table 6-1: Baseline characteristics of the study participants .................................................... 224 
Table 6-2: The mean ± SD of TEI and macronutrient .............................................................. 225 
Table 6-3 : Relationships between food craving, macronutrient intake food diary, TFEQ 
subscales and baseline anthropometric measures ..................................................................... 227 
Table 6-4 : The relationship between TEI, macronutrient intake based on food diary, TFEQ 
subscales and subsequent weight change of all participants ..................................................... 229 
Table 6-5: The relationship between food craving and subsequent weight loss ....................... 229 
Table 6-6 : The relationship between TEI, macronutrient intake based on food diaries, TFEQ 
subscales and subsequent weight loss in females. .................................................................... 230 
Table 6-7 : The relationship between TEI, macronutrient intake based on food diaries, TFEQ 
subcategory and subsequent weight loss in males. ................................................................... 230 
Table 6-8: The correlation between food craving and subsequent weight loss in females. ...... 231 
Table 6-9 : The correlation of food craving scores and subsequent weight loss in males. ....... 231 
Table 6-10 : Heat map of TFEQ Hunger and satiety phenotype ............................................... 232 
Table 7-1 : Comparison of variables as predictors in the different studies undertaken in this 














































1   General introduction 
 Obesity overview 
Despite recent improvements in our knowledge of the physiological mechanisms that 
regulate energy intake (EI), energy expenditure and body mass, obesity continues to 
be a substantial worldwide health  issue with an array of metabolic, vascular and 
psychosocial co-morbidities (Suzuki, Jayasena and Bloom 2012). Obesity is the result of 
a long-term imbalance in energy, where EI exceeds energy expenditure (Crino et al., 
2015). Furthermore, obesity has been recognised as a worldwide epidemic and 
prevalence has increased rapidly in high-income countries since the 1970s; middle and 
low–income countries have an increased prevalence of obesity in both adults and 
children (Swinburn et al., 2011).  
 Definition of obesity 
Obesity is broadly defined as an abnormally high accumulation of fat in adipose tissue 
that associates with significant morbidity and mortality (Chan and Woo, 2010). The 
World Health Organization (WHO) has stated that overweight and obesity are the fifth 
leading cause of global deaths (Posovszky and Wabitsch, 2015). It is responsible for 
reducing life expectancy by 6 to 7 years; a body mass index (BMI) of 30–35 reduces life 
expectancy by 2–4 years while severe obesity (BMI > 40) reduces life expectancy by 10 
years (Fock and Khoo, 2013). 
Moreover, there is extensive evidence that obesity associates with increased risk of 
comorbidities such as cardiovascular disease (CVD),  hypertension (HTN), type 2 
diabetes mellitus (T2DM), non-alcoholic fatty liver disease (NAFLD) hyperlipidaemia, 
stroke, thromboembolic disease, certain cancers (e.g. colorectal and breast), asthma, 
gall bladder disease, sleep apnea, liver  and gastroesophageal reflux disease, 
gynaecological and osteoarthritis problems (Finelli et al., 2014). 
 Classification and anthropometric measurement of obesity 
Measurement of body composition is required for accurate classification to describe a 
person as normal weight, overweight or obese. However, measuring body fat can be 
an expensive and difficult method, with no precise method that is easily accessible for 
clinical practice. Therefore, BMI remains the most widely and simple indicator for 
24 
 
determining obesity. It is expressed as an individual's weight in kilograms (kg) divided 
by their height in meters squared (m2) )Buchholz and Bugaresti, 2005; James, 2004). 
 
WHO has categorized obesity and overweight in an individual based on different BMI 
cut-offs.  People who have a BMI ≤ 18.5 kg/m2 are underweight. 18.5-24.9 kg/m2 are 
normal weight. 25.0 kg/m2 or greater are considered to be overweight and those with 
BMI of 30.0 kg/m2 or greater are obese. A BMI of 40 kg/m2 or above is classified as 
morbid obesity. The BMI cut-offs are set depending on the associated comorbidities 
risk (table 1.1) (WHO, 2012). However, BMI does not differentiate between body mass 
in relation to either fat or muscle, and the relationship between the content of body 
fat and BMI differs depending on body build and proportion (Ho-Pham et al., 2015). 
Conversely, several studies indicate that central fat accumulation or intra-abdominal 
measurement is a better predictor than BMI  for reflecting the risk  factors of 
cardiovascular disease and other forms of chronic disease (Klein et al., 2007; Wang et 
al., 2009).  
 
Central fat accumulation  assessment can help in defining obesity  (Chan and Woo, 
2010). Waist circumference (WC), hip circumference and waist-to-hip ratio (WHR) are 
the anthropometric indices commonly used in assessing abdominal obesity and health 
risks related to obesity (Kitzinger and Karle, 2013). Visceral fat or excessive abdominal 
fat is defined as a waist circumference > 102 cm in men or > 88 cm in women, which 
can increase risks of morbidity and  mortality (Table 1.2). Additionally, there are 
metabolic symptoms that are connected to excessive visceral fat such as dyslipidaemia, 
insulin resistance and hypertension (Chan and Woo, 2010). 
 
Table 1-1:  Classification of overweight and obesity in adults according to BMI (Adapted from 
Chan and Woo, 2010). 
Classification BMI (kg/m2) Risk of co-morbidities 
Underweight <18.5 Low (but increase of risk other clinical problems) 






obese ≥ 30  
Obesity class I 30.0−34.9 Moderate 
Obesity class II 35.0−39.9 Severe 
Obesity class III   ≥40 Morbid  
 
 
Table 1-2: Disease risk associated with visceral or abdominal obesity (Adapted from Cheah and 
Kam, 2005). 
                    Disease risk relative to waist circumference 
Category Men < 102 cm 
Women < 88 cm 
Men ≥ 102 cm 
Women ≥ 88 cm 
Underweight - - 
Normal weight Minimal Slightly increased 
Overweight Increased High 
Obesity I High Very high 
Obesity II Very high Very high 
Obesity III 
(Extreme obesity) 
Extremely high Extremely high 
 
 Prevalence of obesity  
The rising prevalence of obesity poses a significant health threat to national and global 
public health in terms of prevalence, incidence and economic burden (Tremmel et al., 
2017). The WHO estimates that the global prevalence of obesity has nearly tripled 
between 1975 and 2016. In 2016, overweight adults who were aged 18 years and older 
accounted for more than 1.9 billion, of which over 650 million adults were deemed   
obese. Approximately 13% of the global adult population were classed as obese (11% 
of men and 15% of women). WHO has estimated that in 2016, about 41 million 
children who were  aged under 5 years were overweight or had obesity and more than 
340 million children and adolescents aged 5-19 years were considered to be 
overweight or obese (WHO, 2018). 
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Worldwide, it is projected that sixty percent of the world’s population (3.3 billion 
people) will be overweight (2.2 billion) or obese (1.1 billion) by the year 2030, if recent 
trends of obesity and overweight rates continue (Kelly et al., 2008). 
In the UK, 25% of adults are obese and if overweight adults are included this increases 
to two-thirds of the adult population (Booth, Prevost  and Gulliford, 2015). 
Furthermore, predictions from the UK Foresight report show that men will overtake 
women for obesity (47% and 36% respectively by 2025). Conversely, men with morbid 
obesity (BMI ≥ 40 kg/m2) are likely to be less common than women (Boyers et al., 
2015). 
In England, if the current trend continues it shows that by 2050, 60% of males and 50% 
of females could be obese. It has been estimated that on current trends around 8% of 
1–2-year-old children with obesity are predicted to be obese adults, and 80% of 10–14-
year olds are predicted to be adults with obesity. Moreover, it has been suggested that 
by 2050, among children aged 6–10 years, the number of obese boys will be more than 
girls with an estimate of 50% of boys will become obese by 2050 (Agha and Agha, 
2017). 
 The aetiology of obesity 
The aetiology of obesity is multifactorial and represents a complex interaction 
between genetics, hormones, environmental, physiological, psychological, economic, 
social and even political factors. These factors interact to enhance the risk of obesity 
development (Wright and Aronne, 2012; Aktar, Qureshi and Ferdous, 2017). Though 
several genetic markers have been implicated in the pathogenesis of obesity, these 
findings are inconsistent. These genes include the beta-3-adrenergic receptor gene, 
melanocortin-4 receptor gene, peroxisome-proliferator-activated receptor gamma 2 
genes, chromosome 10p and other genetic polymorphisms (Mutch and Clement, 2006). 
Genetic predisposition affects obesity risk and there is ample evidence that single gene 
mutations can cause rare forms of monogenic obesity e.g., in the genes coding for 
leptin (LEP), leptin receptor (LEPR), melanocortin-4 receptor (MC4R) and pro-
opiomelanocortin (POMC). However, common single-nucleotide polymorphisms (SNP) 
or genetic variants might also play a significant role in the obesity epidemic. These 
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SNPs have different impacts on an individual's vulnerability to common forms of 
obesity (Nguyen and EL-Serag, 2010). 
Several hormones are also included in the pathophysiology and regulation of obesity, 
involving gut-related hormones, adipokines and others. Ghrelin is an orexigenic 
hormone which is responsible for stimulating appetite, whereas anorectic gut 
hormones such as Peptide YY (PYY), Cholecystokinin (CCK), and Glucagon-like peptide-
1 (GLP-1) are responsible for limiting food intake (Aktar, Qureshi and Ferdous, 2017). 
These hormones are released, in response to ingested food, from several sites in the 
gut, including the stomach, proximal/distal small intestine, pancreas and colon 
(Schwartz, 2006; Konturek et al., 2004). Peripheral signals from adipose tissue and the 
gut integrate in the hypothalamus to control short-term food intake and achieve long-
term energy balance; centrally released hormones and neurotransmitters also 
contribute to appetite regulation (Chaudhri, Small and Bloom, 2006; Yu and Kim, 2012). 
Homeostatic and hedonic systems in the brain also impact on appetite and satiety. The 
physiologic need to eat during negative energy balance is a primitive survival function, 
mediated through the hindbrain and hypothalamus (Lean and Malkova, 2016).  
In contrast, a desire to consume attractive foods arises from mesolimbic reward 
circuits and regions in the orbitofrontal cortex that regulates hedonic food intake 
based on the sensations of taste, smell, texture and sight. The hedonic systems are in 
constant interaction with homeostatic mechanisms and sensory attractiveness of 
foods can become dominant to contribute to weight gain and obesity (Lean and 
Malkova, 2016). 
Low physical activity, adoption of a sedentary lifestyle, high energy density diet, 
increased portion size, as well as eating disorders have been considered as important 
risk factors for obesity (McKenney and Short, 2011). Moreover, drugs (steroids and 
antipsychotic) and neuroendocrine diseases (hypothalamic, pituitary, thyroid and 
adrenal) can lead to obesity (McKenney and Short, 2011). 
In addition, low socioeconomic groups tend to have BMIs that are higher than middle 
and high socio-economic groups; in migrants, obesity is common, perhaps because 
they live under new socio-economic and cultural conditions (Wright and Aronne, 2012; 
Ali and Crowther 2009). Reduced physical education in schools and increased time 
28 
 
undertaking sedentary behaviours such as computer use, watching television and 
playing video games have also been linked to the increasing prevalence of obesity 
(Wright and Aronne, 2012). Sleep debt also contributes to increasing body mass. 
Evidence of some studies has shown that hours of sleep per night are negatively 
associated with BMI and sleep restriction has been shown to contribute to increased 
hunger and appetite (Wright and Aronne, 2012). 
Mental wellbeing can impact on eating habits; some individuals eat in response to 
negative emotions. For instance, stress not only increases food consumption but also 
biases consumption toward higher caloric foods that are normally avoided (Ali and 
Crowther 2009).  
  Obesity management strategies 
The treatment of obesity is more than just weight loss alone and must also focus on 
health improvement and reduction of risk of comorbidities (Aktar, Qureshi and 
Ferdous, 2017). To achieve significant and enduring weight loss, numerous studies 
have focused on developing several interventions, including: 1) - life style modification 
using several diet restrictions, alone or in conjunction with physical activity, 2) - 
pharmacotherapy and 3) - bariatric surgery. 
1.6.1.1  Life style modification 
Lifestyle modification strategies (diet and exercise) are the initial intervention in 
mitigating obesity risk and encouraging weight loss. Diet is dependent on the principles 
of metabolism and work by decreasing the intake of calories (energy) to create a 
negative energy balance (i.e. more energy is used than is consumed). Diet programmes 
can produce meaningful weight loss over the short term (Zhang et al., 2014). In general, 
there are four types of dietary regimens suggested for weight loss which are Low-
Calorie Diet (LCD), low-fat diet, low-carbohydrate diet and Very Low-Calorie Diet 
(VLCD). All these diets provide 800–1500 kcal/day, while VLCD is < 800 kcal/day (Fock 
and Khoo, 2013). 
According to a systematic review of 34 randomised trials, LCD (55–60% carbohydrate) 
consumed during a 3–12-month period resulted in 8% body weight loss (Strychar, 
2006). Low-fat diet used over 2–12 months in 16 trials showed a 5% reduction in body 
mass and improved cardiovascular risk factors such as hypertension and high levels of 
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low- density lipoprotein (LDL)-cholesterol (Astrup et al., 2000). Low-carbohydrate diets 
reduced 5% of body weight in 2–12 months (Fock and Khoo, 2013). Whereas, VLCD 
should only be used under supervision by trained medical personnel, because they are 
associated with electrolyte imbalance, low blood pressure and increased risk of 
gallstones (Fock and Khoo, 2013). 
Obesity is associated with inactivity and increased sedentary behaviour. Therefore, 
physical activity (PA) is an essential part of a well-rounded treatment programme for 
obesity.  PA leads to lipolysis and as a result, free fatty acids are released from 
triglycerides stored as fat for use as an energy source by muscle, thus there is an 
increase in energy expenditure (Fujioka et al., 2000). Although some reports show that 
PA alone can produce a 2% to 3% decline in BMI, it is a more effective body mass loss 
strategy when combined with dietary modification. Most of the research advocates 
that exercise alone is ineffective in achieving initial weight loss or results in only 
modest weight loss of a few kilograms. However, it can help in long-term weight loss 
maintenance (Shaw et al., 2010). The consensus UK guideline recommendation for 
weekly physical activity has been prescribed as 150 minutes of moderate-intensity 
activity, or more per week.  On approach is to do 30 minutes on at least 5 days a week 
or 75 minutes of vigorous-intensity activity, or some combination of moderate and 
vigorous activity with resistance exercise on 2 days (Chief Medical Officer, 2011). 
 Appetite terminology: satiety and satiation 
Blundell, Rogers and Hill (1987) described the overlapping processes occurring after 
food intake until the next period of eating in their satiety cascade over 25 years ago. 
But later Mela (2006) developed a modified framework of the satiety cascade and 
added long-term regulation to it. Since then, numerous other papers e.g. Halford and 
Harrold (2012) and Van Kleef et al., (2012) have also described the satiety cascade. The 
satiety cascade combines the physiological events that control appetite with the 
simultaneous behaviours and psychological experiences that are integral to the eating 
process. Hunger is defined as a state that leads to the initiation of the eating process, 
particularly as it links to meals. The stomach is the most commonly perceived hunger 
signal where electrical (vagus nerve) signals relate the state of emptiness (or fullness), 
reinforced by the release of the hormone ghrelin and by metabolic signals such as 




The satiety cascade expresses two distinct processes: satiation and satiety. Satiation 
(intra-meal satiety) is defined as the processes that develop during eating and tends to 
bring the period of eating to an end; therefore, it inhibits hunger (Gibbons, 2014; 
Blundell et al., 2010b; Gerstein et al., 2004). Whereas, satiety (inter-meal satiety) 
refers to the post-ingestive processes that occur following a meal and inhibit further 
eating, and includes the suppression of hunger and a feeling of fullness during the 
inter-meal period, and is usually associated with measures of time until the next meal 
and/or later meal or snack intake. The satiety cascade describes how cognitive, 
sensory, post-ingestive and post-absorptive factors stimulate and suppress appetite 
(Blundell et al., 2010b). 
 
Sensory and cognitive processes also guide meal expectation and learned relations to 
anticipate reward and pleasure.  Early pre-ingestive signals from sensory and cognitive 
signals play a vital role in food choice, meal initiation, satiation and the early stages of 
satiety (Blundell et al, 2010b). After food enters the gastrointestinal system post-
ingestive information is provided by the stomach and intestines via the physical signals 
of stretch/distension, as well as osmotic load, providing feedback related to meal 
quantity. Medium-term satiety is controlled by gut peptide hormones including GLP-1, 
CCK and PYY. These hormones are considered to have meal-processing roles in 
addition to their inhibitory effects on food intake. Cognitive, sensory, post-ingestive 
and post-absorptive signals are integrated to determine the experience of satiety 
(Amin and Mercer, 2016; Blundell et al., 2010b). The combination of these satiety 
signals occurs in the hypothalamus and cortico-limbic structures in the brain that are 
involved in the control of food intake (Chambers, 2016). The post-absorptive phase 
contributes to long-term satiety. It is controlled by insulin, glucose and amino acid 









Figure 1-1: The “satiety cascade”, first constructed by Blundell, Rogers and Hill (1987) (Taken 
from Blundell et al., 2010a). CCK = Cholecystokinin, GLP-1= Glucagon-like peptide-1 and   PYY = 
Peptide YY 
 Energy Homeostasis and appetite regulation 
The role of the gut/brain axis and peripheral hormones in appetite regulation has 
received widespread attention in the literature owing to the increasing worldwide 
obesity crisis. Of particular interest has been the potential of these peripheral signals 
for providing novel targets for developing anti-obesity therapies (Bewick, 2012).  
Energy balance and appetite are regulated by neural signals that are released from 
adipose tissue and endocrine, neurological and GI systems and are integrated by the 
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central nervous system (CNS). The CNS relays signals to multiple organs in the 
periphery in order to control EI and expenditure and maintain energy homeostasis 
over long periods of time (Chaptini and Peikin, 2016; MacLean et al., 2017). 
 Role of the CNS in energy homeostasis and appetite regulation 
1.8.1.1  Hypothalamus 
The hypothalamus and brainstem are the two areas in the CNS which are responsible 
for the metabolic aspects of appetite control and energy homeostasis (Sam et al., 
2012). Based on early hypothalamus lesioning experiments in rats, it was believed that 
the lateral hypothalamic area (LHA) acted as the ‘hunger centre’ while the 
ventromedial hypothalamic nucleus (VMN) was a ‘satiety centre'. However, it is now 
clear that several hypothalamic nuclei and neuronal circuits interact with the 
brainstem and higher cortical centres in appetite regulation. In addition,  peripheral 
signals relay through the brainstem and vagus nerve, with some researchers 
suggesting the presence of an incomplete blood-brain barrier (BBB) at the median 
eminence of the hypothalamus and area postrema of the brainstem, permitting 
peripheral circulating factors direct access to the CNS (Suzuki et al., 2010). 
The arcuate nucleus (ARC) of the hypothalamus is a group of neurons which has a 
significant role in the integration of signals regulating appetite (Wójcik-Gładysz and 
Szlis, 2016).  The ARC contains two populations of neurons with opposing effects on 
food intake. Orexigenic neurons have the overall effect of increasing appetite by 
expressing neuropeptide Y (NPY) and Agouti-related protein (AgRP).  
These neuropeptides are inhibited by leptin and insulin and stimulated by ghrelin 
(Bewick, 2012; Sorrentino and Ragozzino, 2017). Whilst anorexigenic neurons inhibit 
appetite by expressing alpha-melanocyte-stimulating hormone (alpha-MSH) derived 
from pro-opiomelanocortin (POMC), and cocaine and amphetamine-regulated 
transcript (CART). Both populations project to the hypothalamic areas, which are 
involved in appetite control including dorsomedial hypothalamic nucleus (DMN), 
paraventricular nucleus (PVN) and LHA (Bewick, 2012). 
Alpha-MSH produced within POMC neurons binds to melanocortin-4 receptor (MC4R) 
and melanocortin-3 receptors (MC3R) in the PVN to inhibit food intake (Schwartz et al., 
2000; Marić, 2014). Hyperphagia and obesity have also been noticed in MC4R knock-
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out mice (Huszar et al., 1997). It is similar in humans, MC4R mutations which associate 
with 6% of severe early-onset obesity and more than 70 different mutations have been 
related to obesity (Tao, 2005).  
Neuronal expression of CART in the ARC co-localises with POMC and animal studies 
have proved that intracerebroventricular (ICV) administration of CART suppresses 
feeding, whereas ICV injection of antibodies to CART can increase food intake (Suzuki 
et al., 2010).  
NPY/AgRP neurons have extensive projections within the hypothalamus, including the 
PVN, DMN and LHA. ICV administration of NPY has been found to stimulate food intake 
in rats and repeated daily injections of NPY can result in chronic hyperphagia and 
increased weight gain (Suzuki et al., 2010). The orexigenic effect of NPY can be 
mediated by stimulation of hypothalamic NPY receptors (Y1R) and (Y5R) (Wójcik-
Gładysz and Szlis, 2016) in addition to local inhibition of POMC neurons in the ARC 
(Suzuki et al., 2010). Furthermore, AgRP serves as a selective antagonist at MC3R and 
MC4R in the PVN.  The PVN also contains corticotrophin-releasing hormone and 
anorectic thyrotropin-releasing hormone. Destruction of the PVN leads to hyperphagia 
and obesity (Suzuki et al., 2010). Other nuclei within the hypothalamus are also 
involved in the control of food intake. The LHA has the orexigenic hormones, melanin-
concentrating hormone and orexin, and the DMN receives NPY/AgRP projections from 
the ARC (Wynne et al., 2006). In the VMN, brain-derived neurotrophic factor (BDNF) is 
highly expressed and suppresses food intake through MC4R signalling (Xu et al., 2003). 
1.8.1.2 The brainstem 
The dorsal vagal complex (DVC) is located within the brainstem and consists of three 
major areas which are the dorsal motor nucleus of vagus (DVN), area postrema (AP), 
and the nucleus of the tractus solitarius (NTS). The DVC is thought to be a crucial 
communication link between peripheral signals from the gut to the hypothalamus 
(Schwartz, 2010). 
Vagal afferent, within the brainstem express receptors for a variety of  hormones that 
have a role in controlling food intake including cholecystokinin (CCK) 1R and CCK 2R at 
which both CCK and gastrin act (Moriarty et al., 1997), insulin receptors, GLP-1 
(Nakagawa et al., 2004) and GLP-2R (Nelson et al., 2007), growth hormone 
34 
 
secretagogue receptor (GHS)-R1 at which ghrelin acts (Date et al., 2002), the orexin 




Figure 1-2 : Gut-brain axis: regulation of food intake. (Taken from (Sam et al., 2012) 
PVN = paraventricular nucleus, ARC= arcuate nucleus, NPY = neuropeptide Y, AgRP= Agouti-
related protein and POMC = pro-opiomelanocortin, PYY = Peptide tyrosine tyrosine and GLP-1= 
Glucagon-like peptide 1. 
 
 Role of peripheral adiposity signals in energy homeostasis and 
appetite regulation (long-term signal or tonic) 
 Adiposity signals modulate energy balance via the regulation of food intake and 
energy expenditure. They are peripheral signals that circulate in proportion to body fat 
and inform the brain about the stored energy state (Roh, Song and Kim, 2016). It is 
widely accepted that insulin and leptin are adiposity signals (Schwartz et al., 1992 and 
Zhang et al., 1994). Adiposity signals are implicated in the long-term regulation of 
energy balance (Perry and Wang, 2012). 
Insulin is produced by the β cells of the islets of Langerhans in the pancreas and is 
secreted rapidly following a meal to exert hypoglycaemic effects. As it penetrates the 
BBB, insulin also exerts an anorexigenic effect by inhibiting the NPY/AgRP pathways 
and stimulating the POMC pathways (Wynne et al., 2006). The circulating 
concentrations of insulin are proportional to fat mass (Suzuki et al., 2010). Central 
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administration of insulin can reduce food intake and body weight in rodents (Perry and 
Wang, 2012).  
Leptin is exclusively secreted and expressed by white adipose tissue adipocytes.  It 
circulates at levels proportional to fat mass (Perry and Wang, 2012). Increasing leptin 
concentration produces an anorexigenic action by inhibiting the NPY/AgRP neurons 
and stimulating the POMC neurons (Cowley et al., 2001). Peripheral or central 
administration of leptin resulted in reduction of food intake and body mass and 
increased energy expenditure in rodents (Friedman and Halaas, 1998). Paz-Filho et al., 
(2009) reported an inverse correlation between circulating leptin concentrations 
adjusted for body fat and body weight in men with obesity, suggestive of a leptin 
deficient state linked to with obesity. 
  Role of gut hormonal signals in energy homeostasis and appetite 
regulation (short-term signal or episodic) 
The GI tract can be defined as the largest endocrine organ in the body and it plays an 
important role in appetite-regulation because it is the source of various regulatory 
peptide hormones (Perry and Wang, 2012).  The GI tract secretes more than 20 
different hormones. These hormones perform several roles, which include digestion 
and absorption along with the prime role of nutrient uptake (Mishra, Dubey and Ghosh, 
2016). 
It is widely accepted that gut peptides are part of the energy homeostasis system that 
contributes to the regulation of body weight, and malfunctions in these peptides can 
lead to obesity (Blundell et al., 2008). In this system these peptides are hypothesised 
to play a vital role in the translation of energy requirements into an orexigenic drive, or 
inhibit this drive via mediating in processes that produce satiety. Consequently gut 
peptides are envisaged to either stimulate or inhibit episodes of eating in accordance 
with the principles of energy homeostasis. This usually implies the modulation of the 
state of hunger, which is a marker of the orexigenic drive and a measure of the 
operation of satiety. Numerous peptides have been identified as biomarkers of 
satiation or satiety. Some of these peptides are considered as promoting obesity by 
weakening the operation of satiety  )Blundell  et al., 2008). Figure 1.3 shows how 
central and peripheral signals communicate information about the current state of 
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energy balance to key brain regions (hypothalamus and hindbrain) and how hormones 
act on specific centres in the brain to affect the sensations of hunger and satiety 
(Mendieta-Zeron, Lopez and  Diéguez, 2008).  
 
  
Figure 1-3 : Brain–gut mechanisms regulating food intake and the secretion of gut hormones 
(Taken from Mendieta-Zeron, Lopez and Diéguez,  2008). Red-labelled peptides are 
anorexigenic and ghrelin, the unique orexigenic hormone is green-labelled. PP= Pancreatic 
polypeptide CCK= Cholecystokinin GLP-1= Glucagon-like peptide 1 OXM= oxyntomodulin PYY= 




Whilst the GI tract secretes multiple gut hormones, this chapter will now focus on the 
four hormones which were measured as part of the programme of research i.e. Ghrelin, 
PYY, PP and GLP-1. 
  Ghrelin 
Ghrelin is an orexigenic gut hormone that consist of 28 amino acids derived from pre-
proghrelin and is produced predominantly in the stomach by the X/A cells of the 
gastric oxyntic gland, but it is also secreted in the small intestine. Ghrelin circulates in 
two forms being acylated and deacylated. Acylated ghrelin binds to the G protein-
coupled receptor 1a (GHS-R1a) to cross the BBB (Wójcik-Gładysz and Szlis, 2016). 
The NPY/AgRP neurons situated in the ARC nucleus are the primary targets for ghrelin 
and this population of neurons plays an essential role in the mediation of the 
orexigenic effects of ghrelin. GHS-R1a is expressed at high levels in the whole 
hypothalamus area and studies conducted on rats have shown the presence of the 
GHS-R1a receptor in the ARC nucleus. Within the ARC, ghrelin stimulates NPY and 
AgRP transcription, as well as encourages secretion of both these orexigenic peptides 
in the PVN. Therefore, the central actions of ghrelin give rise to increased food intake 
and body weight gain (Wójcik-Gładysz and Szlis, 2016). 
Ghrelin is called the ‘hunger hormone’ and since its discovery in 1999 it has been 
suggested to function as a meal initiator (Kojima et al., 1999). It is the only known gut 
hormone to increase appetite and food intake. Ghrelin promotes gastric motility, acid 
secretion and pancreatic exocrine secretion in anticipation of meals, as a result 
preparing the GI tract to process food (Cummings, 2006). 
It is worth emphasizing that ghrelin induces appetite in both lean people and people 
with obesity and is suppressed by feeding (Troke, Tan and Bloom, 2014). Circulating 
ghrelin levels rise before the start of a meal and fall again rapidly after the initiation of 
the meal in humans (Cummings et al., 2004; Cummings et al., 2001) and rodents 
(Tschop, Smiley and Heiman, 2000; Wren et al., 2000). 
Fasting ghrelin concentrations have been shown to be lower in people with obesity 
when compared with normal weight controls, which suggests ghrelin is not a cause of 
obesity; although there is a suggestion that obese people are actually more sensitive to 
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the hormone. However, more research is needed to confirm this (Cummings et al., 
2002).  
The typically expected post-prandial fall in circulating ghrelin concentration is also 
attenuated, or even absent in people with obesity (English et al., 2002) suggestive of a 
role of ghrelin in the pathophysiology of obesity (Perry and Wang (2012). Moreover, 
the circulating ghrelin concentration is reduced after gastric bypass surgery. This fall in 
plasma ghrelin levels may contribute to reduced appetite and weight loss following 
this procedure (Cummings et al., 2002). In contrast, there is evidence demonstrating 
that plasma ghrelin levels are elevated in people with weight loss resulting from 
anorexia nervosa and bulimia nervosa or caloric restriction as well as from chronic 
exercise without hypophagia (Cummings, 2006).  
Cummings et al., (2004) have reported that there is a close overlap between ghrelin 
temporal profiles and subjective hunger scores, with ghrelin peaks preceding hunger. 
As a result, ghrelin has a critical role in meal initiation (Karra and Batterham, 2010). 
Many studies have commonly described ghrelin as a short-term signal, however, it has 
been argued that ghrelin can also be considered a long-term signal, since it relates 
inversely to adiposity and is important for body weight regulation (Karra and 
Batterham, 2010; Klok, Jakobsdottir and Drent, 2007). 
Various studies have shown that intravenous administration of ghrelin in both lean and 
humans with obesity can increase feelings of hunger and EI from buffet meals (Druce 
and Bloom, 2006; Druce et al., 2005; Wren et al., 2001).  In addition to this, chronic 
central ghrelin administration in rats elevates the release of enzymes that stimulate fat 
storage in adipose tissue (Theander-Carrillo et al., 2006). Additionally, both central and 
peripheral infusions of ghrelin have been shown to enhance body weight gain 
(Nakazato, 2001).  In rats, Wren et al., (2000) have reported that central and 
peripheral administration of ghrelin resulted in stimulation of food intake. Daily 
administration of GHS-R 1a antagonists in diet-induced obese mice has been shown to 
decrease EI and result in ~ 15% weight loss compared with pair-fed controls. GHS-R 
antagonists reduced EI and decreased gastric emptying in lean mice and in ob/ob 
obese mice and decreased body weight gain and improved glycaemic control in ob/ob 
obese mice (Asakawa et al., 2003). 
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How fast ghrelin levels decline after a meal, as well as the extent and the duration of 
the inhibition is determined by the caloric load, the size, the frequency and the 
composition of the meals (Klok, Jakobsdottir and Drent, 2007; Cummings, 2004). 
Dietary carbohydrates and protein suppress ghrelin release greater than dietary lipids 
(Cummings, 2006) and glucose-sweetened beverages are better at suppressing ghrelin 
concentrations compared to isocaloric fructose-sweetened beverages. Ghrelin levels 
are also influenced by age, gender, BMI, growth hormone, glucose and insulin 
(Cummings, 2006). 
   Peptide tyrosine tyrosine (PYY)    
The PP-fold family includes NPY, PYY, and PP. PYY and PP are secreted from the GI tract, 
whereas NPY is distributed within the CNS (Suzuki, Jayasena and Bloom, 2011). 
PYY is a 36 amino acid peptide synthesized and released from the L-cells in the GI tract. 
The first isolation of PYY was from porcine upper small intestine. There are two 
circulating forms of PYY being PYY (1-36) and PYY (3-36). PYY (1-36) is the major 
circulating form that is released by cleavage of the N-terminal Tyrosine-Proline 
residues via the enzyme dipeptidyl-peptidase IV (DPPIV) to give the active form, PYY 
(3-36).  Recently, the DPP-IV inhibitors have been evaluated for their effects on obesity 
and metabolic traits (Abdalla, 2017). 
PYY (3-36) reduces food intake through binding with highest affinity to the 
hypothalamic Y2 receptor which has highest affinity for PYY (Troke, Tan and Bloom, 
2014). The secretion of PYY plays a pivotal role in satiety.  In the fasted state, 
circulating PYY concentrations are low and they quickly rise following a meal, peaking 
at 1-2 hours and stay high for several hours (Suzuki, Jayasena and Bloom, 2012). The 
level of circulating PYY can rise through stress and exercise and it acts mainly as a 
satiety factor rather than a food terminator (Mishra, Dubey and Ghosh, 2016).  
Many researchers highlight the effects of PYY on food intake in both lean and obese 
humans and rodents following peripheral administration. However, the findings of 
these studies are conflicting, peripheral administration of PYY (3-36) has been reported 
to reduce food intake. A previous study has reported an acute inhibition of feeding by 
peripheral administration of PYY (3–36) in rats or mice (Chelikani, Haver and 
Reidelberger, 2005).  
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Furthermore, peripheral PYY (3-36) administration to rodents resulted in reduction in 
food intake and body weight gain (Pittner et al., 2004). A further study in the same 
year was conducted by Adams et al., (2004) confirmed that intraperitoneal PYY (3–36) 
injection inhibited short-term food intake by up to 50% in overnight-fasted mice. 
Conversely, central administration of PYY has been reported to be associated with 
stimulating feeding in rats (Hagan, 2002).  
IV administration of PYY (3-36) has also been demonstrated to lead to a reduction in 
appetite and an almost 30% restriction in caloric intake in lean and obese humans 
(Batterham et al., 2003a). Moreover, peripheral infusion of PYY (3–36) leads to 
reduced appetite and 24 hour caloric intake in normal-weight humans. PYY 3-36 
physiologically inhibits food intake (Batterham et al., 2002). This is in contrast with 
Sloth et al., (2007) who examined the effect of PYY (1-36) and PYY (3-36) on food 
intake reporting it had no inhibitory effect on food intake, although, PYY (3-36) showed 
increased perceptions of satiety and decreased perceptions of hunger. 
Numerous reports have shown that PYY (3-36) may prompt weight loss in part by its 
effect on energy expenditure and fuel partitioning (defined as a steady supply of 
energy-yielding substrates to meet the needs of various tissues). However, there is a 
negative link between markers of obesity in adults, children and infants and fasting 
PYY (Mishra, Dubey and Ghosh, 2016). 
A decrease in total fasting PYY, or no changes in fasting, or impaired postprandial PYY 
have been reported in overweight people (Moran et al., 2007).  Several studies have 
shown the retention of sensitivity to PYY (3-36) among people with obesity which is in 
contrast to leptin. As a result, it is a matter of debate as to whether PYY has a critical 
role in the pathogenesis of obesity (Mishra, Dubey and Ghosh, 2016).  
In rodents, dietary protein results in a greater stimulus of PYY secretion (Batterham et 
al., 2006), whereas, ingestion of a high carbohydrate, low fat diet appear to give the 
greatest rise in PYY levels in obese humans (Essah et al., 2007). 
  Pancreatic polypeptide (PP) 
PP is also a member of the PP-fold family. It is secreted as a 36 amino-acid peptide 
from the PP cells of the islets of Langerhans in the pancreas after eating (Troke, Tan 
and Bloom, 2014). PP is known to decrease food intake directly via the Y4 receptor in 
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the hypothalamus and brainstem (Suzuki Jayasena and Bloom, 2011). Circulating PP 
concentrations increase after meals and remain elevated for up to 6 hours post-
prandially (Chaudhri, Small and Bloom, 2006). The vagus nerve has a significant role to 
play in stimulating PP release, along with some other stimulators like gastric distension, 
exercise and gut hormones such as gastrin, CCK, secretin and motilin, whereas 
somatostatin prevents its release. PP has the highest affinity for the Y4 receptor, which 
is widely expressed in the brain areas involved in the hypothalamus and brainstem, 
which have a key role in the central control of appetite (Chaudhri, Small and Bloom, 
2006). Concentrations of PP are reduced in people with obesity and increase following 
a meal. The action of PP causes a reduction in food intake and gastric emptying (Troke, 
Tan and Bloom, 2014). There is growing evidence proposing that PP plays a vital role in 
the regulation of body weight (Karra and Batterham, 2010). 
A number of studies have focused on the effect of PP on food intake in humans and 
rodents. According to a previous study in normal weight volunteers conducted by 
Batterham et al., (2003b), there was a 22% decrease in hunger scores and food intake 
persisting for 24 hours following infusion of PP at 10 pmol/kg min. Further previous 
studies have observed that the infusion of PP at 5 pmol/kg min following a buffet meal, 
reduced EI by 11% compared with saline control, together with a decrease in hunger as 
analysed by visual analogue scales (VAS) (Jesudason et al., 2007). Moreover, it has 
been reported that a reduction in PP release in obese patients with Prader-Willi 
syndrome (PWS) (Suzuki, Jayasena, and Bloom, 2012) and twice-daily infusion of PP in 
volunteers with PWS has been reported to reduce food intake by 12% (Berntson et al., 
1993). 
Other studies were carried out in normal weight and genetically obese (ob/ob) rodents. 
These studies have confirmed that the peripheral administration of PP decreased food 
intake in rodents (Neary et al., 2008; Liu et al., 2008; Asakawa et al., 2006). Moreover, 
Asakawa et al., (2003) reported that acute intraperitoneal injection of PP in fasted 
mice reduced food intake up to 24 hours after injection. Chronic infusion of PP to 
ob/ob mice over 6 days significantly decreased body weight gain. Ueno et al., (1999) 
have reported that PP over-expressing mice have a decreased daily food intake and 
exhibit a lean phenotype. 
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  Glucagon-like peptide 1 (GLP-1) 
GLP-1 is cleaved from the product of the pre-proglucagon gene.  It is continuously 
expressed in the α-cells of the pancreas, the L-cells of the small intestine and neurons 
located in the caudal brainstem and hypothalamus (Shah and Vella 2014). GLP-1 has 
several forms, but the major circulating form is GLP-1 (7–36) amide (Murphy and 
Bloom, 2006). GLP-1 receptors are found in the gut, pancreas and brain, specifically the 
hypothalamus and AP, all areas closely associated with appetite regulation (Suzuki et 
al., 2010). GLP-1 is of relevance to appetite and weight maintenance because it has 
actions on the GI tract as well as the direct regulation of appetite. It is responsible for 
delaying gastric emptying, gut motility in humans and suppression of appetite (Troke, 
Tan and Bloom, 2014; Shah and Vella 2014). 
Circulating concentrations of GLP-1 are low during the fasting state and increase 
rapidly post-prandially, especially after ingestion of carbohydrates and fat (Ronveaux, 
Tomé and Raybould, 2015).  After meals, GLP-1 releases into the circulation and it acts 
as an incretin hormone that stimulates pancreatic insulin release and suppresses 
glucagon secretion (Holst, 2004; De Silva and Bloom, 2012). 
GLP-1 receptor agonists have been used in chronic weight management programmes. 
The first GLP-1 receptor agonist was approved by the Food and Drug Administration 
(FDA) for   this   indication.  GLP-1 agonists offer a novel treatment option that may be 
safer and better tolerated than the available alternatives. Other GLP-1 agonists have 
also been studied for their effects on weight loss in patients with or without diabetes 
(Isaacs, Prasad-Reddy and Srivastava, 2016). Numerous studies have confirmed that 
systemic administration of GLP-1 or GLP-1 receptor agonists decrease food intake, 
slows gastric emptying (a test that measures the time it takes for food to empty from 
the stomach and enter the small intestine) and reduces body weight (Marathe et al., 
2011; Van Bloemendaal et al., 2014). It has consistently been found that peripheral 
and central administration of GLP-1 to rodents acutely decreases food intake and 
chronic administration of GLP-1 reduces weight gain in rats (Meeran et al., 1999; 
Turton et al., 1996). 
However, GLP-1 receptor knockout mice showed no alteration in food intake or body 
weight. This may be because GLP-1 has a more significant physiological role in 
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controlling blood glucose than in regulating food intake or it may be that 
developmental changes compensate for the lack of GLP-1 signalling (Drucker, 2006). 
In humans, the IV administration of GLP-1 to normoglycemic and people with diabetes 
prompts satiety and decreases food intake in short term studies. Chronic continuous 
infusion of GLP-1 to human with diabetes showed no association with modest weight 
loss (Verdich et al., 2001). Moreover, it is well established that the IV administration of 
GLP-1 at doses up to 1.2 pmol /kg/min inhibits food intake in humans (Näslund et al., 
1999; Gutzwiller et al., 1999). GLP-1 has been proposed for use in the treatment of 
obesity. However, it has a short circulating half-life and is rapidly broken down in the 
circulation by the enzyme DPP-IV to an inactive form, rendering native GLP-1 being 
excluded from therapeutic use (Bewick, 2012). 
Dietary protein is more of a stimulator of GLP-1 release than carbohdrates (CHO) 
(Lejeune et al., 2006). When comparing meals rich in protein, fat, carbohydrate or 
alcohol, GLP-1 secretion was the highest after a protein rich meal (Karhunen et al., 
2008). 
   Food macronutrients and satiety 
Blundell and Macdiarmid (1997) suggested a hierarchy of satiating effects of 
macronutrients in the order of protein > carbohydrate > fat. 
  Protein (PRO) 
Diets high in protein lead to greater satiety and reduced hunger scores (Lobley et al., 
2015).  Acute studies have shown protein as the most satiating of the macronutrients 
in both people with obesity and those who are normal weight, rather than other 
macronutrients (Batterham et al., 2006). The mechanism for the satiating action of 
protein remains unresolved, but a range of hypotheses include increased postprandial 
thermogenesis, decreased rate of gastric emptying, reduced digestion and absorption 
rates, supply of specific amino acids (AA) that serve as a precursor for brain 
metabolites and release of gut peptides involved in appetite regulation such as ghrelin 
and GLP-1 (Lobley et al., 2015). 
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  Carbohydrate (CHO) 
The satiating effect of CHO results from changes in blood glucose, liver metabolism, 
end products of CHO metabolism and secretion of satiety hormones including insulin, 
GLP-1 and amylin (Feinle, O'Donovan and Horowitz, 2002). It has been established that 
low glycaemic index foods induce satiety and suppress voluntary food intake (Ludwig, 
2000). Conversely, high glycaemic index CHO tends to suppress short-term (1 hour) 
intake more effectively than low glycaemic index CHO, but the reverse occurs in long-
term intake (Anderson and Woodend, 2003).  
  Fat  
Fat can affect satiety by slowing gastric emptying, inhibiting the release of ghrelin and 
promoting the release of satiating gut hormones (Little et al., 2007). However, it has 
been suggested that fat has a lesser effect on satiety than either protein or CHO 
(Blundell and MacDiarmid, 1997; Robinson, Yeomans and French, 2005). When people 
are provided with a range of foods with higher fat in free feeding experiments they 
consumed more energy than when they are provided with high CHO foods (Blundell, 
Green and Burley, 1994). Thus, offering high fat foods stimulated passive over-
consumption (Blundell and Tremblay, 1995). Importantly, it seems to be that fat-
related increased EI does not cause increased sensations of satiety (Blundell and 
Macdiarmid, 1997). 
 
  Methods to measure appetite 
  Measuring satiation  
1.12.1.1    Food intake 
Satiation can be measured by serving an ad libitum test meal to participants under 
standardised conditions at predetermined time points. Participants are requested to 
eat until comfortably full and satisfied and then the amount of food consumed is 
recorded. It has also been used to quantify the effect of dietary manipulations 
(Blundell et al., 2010a). It has been shown that there is no difference in the frequency 
of eating between normal-weight and individuals who are obese, yet people with 
obesity tend to consume more calories, therefore indicating the importance of meal 
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size as a contributor to over-consumption and obesity development (Gibbons et al., 
2014). 
Reproducibility of ad libitum energy intake during single meals has been shown to be 
high in both people with obesity and normal weight. A study was carried out on 
overweight and obese men and women, which demonstrated that ad libitum EI was 
highly reproducible (Lara, Taylor and Macdonald, 2010). Moreover, Horner, Byrne and 
King (2014) have assessed the reproducibility of subjective appetite ratings and ad 
libitum test meal EI after a standardised pre-load in men who were overweight or had 
obesity. Their findings showed the reproducibility of subjective appetite ratings and ad 
libitum energy intake is similar to that reported in lean adults (Gregersen et al., 2008).  
  Measuring satiety 
 There are numerous approaches to measure satiety as follows. 
1.12.2.1  Self-report scales 
Subjective appetite ratings (as a measure of the motivation to eat) can be measured 
through VAS, which are the standard tools used to assess subjective appetite 
sensations (hunger, fullness, satiety and desire to eat). They have also been used to 
monitor depression and pain in clinical and research settings (Gibbons et al., 2014).  
Initial questionnaires have considered measurement of hunger through asking the 
question “how hungry are you right now” which ignored the fact that appetite is 
multidimensional (Hill and Blundell, 1982). This weakness was recognised and 
consequently, an additional seven questions were proposed covering various facets of 
appetitive sensations, involving fullness, satisfaction and prospective food 
consumption. These questions are ‘How hungry are you right now? How strong is your 
desire to eat right now? How much could you eat right now? How full are you right 
now? How strong is your desire to consume something sweet right now? How strong is 
your desire to consume something savoury right now? How thirsty are you right now? 
(Drapeau et al., 2007). 
VAS comprise of a 100–150 mm line with extreme subjective feelings anchored at 
either end, for example ‘How hungry are you?’, ‘Not at all hungry’ at one end versus 
‘As hungry as I have ever felt’ at the other end (Stubbs et al., 2000). Participants are 
requested to place a vertical mark on the scale at a point between the two extreme 
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ratings to rate their feeling in response to the questions that include appetite 
sensations (Chaput et al., 2010).  
        
 
Figure 1-4: Example for visual analogy scale for hunger (Stubbs et al., 2000). Calculation of VAS 
measurement can be done by measuring the distance from the left end of the line to the mark 




Figure 1-5: Feeling of a) hunger and b) fullness measured on a 100 mm VAS 
 (Flint et al., 2000). 0 min = fullness/hunger before eating the test food, other times after 
eating the test food. 
 
VAS are applied using pen and paper, which are convenient and quick to complete 
(Rumbold, Dodd-Reynolds and Stevenson, 2013). However, data collection using this 
method is time consuming and susceptible to human error, because each line needs 
manual measurements and needs to be individually inputted into a spreadsheet. 
Electronic Appetite Ratings System (EARS) have been developed to reduce the 
measurement error.  The benefits of using EARS are inexpensive cost and its practical 
benefits. Moreover, EARS include the use of an audio alarm as a reminder of when the 
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VAS needs to be completed, leading to compliance rates of 90% or better (Whybrow, 
Stephen and Stubbs, 2006; Hufford and Shields, 2002).  
Numerous studies have used VAS in appetite research. Flint et al., (2000) has reported 
the validity and reliability of VAS. Additionally, previous studies that have used VAS for 
measuring appetite reported that these scales have a high degree of reproducibility 
(Delargy et al., 1996, Stratton et al., 1998, Stubbs et al., 2001, Whybrow et al., 2006, 
Stubbs et al., 2000). VAS are predictive of EI in experimental conditions (laboratory and 
free-living) (Flint et al., 2000; Stubbs et al., 2000). 
1.12.2.2 Biomarkers 
The power of satiety can be inferred by levels of circulating appetite-related peptides, 
such as ghrelin, CCK, GLP1, PP and PYY, which have a vital role in the short-term 
control of appetite. These peptides are often measured as biomarkers of satiety 
(Gibbons et al., 2014) and have been discussed in detail earlier in this chapter. 
The degradation of the peptides and sample storage are also of importance and 
precautions must be taken to avoid this. As a result, it is important to treat blood 
samples with protease inhibitors immediately after blood collection. However, 
biomarkers cannot be used on their own to quantify hunger or satiety, but when 
combined with other measurements they are indicators of appetite and food intake 
(Delzenne et al., 2010). 
There are a number of analysis techniques that are used for measuring peptides – for 
example, radioimmunoassay (RIA) and enzyme-linked immunosorbent assay (ELISA). 
ELISA technology is one of the methods most applied for measurement of specific 
peptides and proteins. The conceptual idea of an ELISA evolved to include multiplexing 
methods that permit simultaneous detection of multiple analytes (Albrechtsen, 2017). 
These are more cost effective, therefore these are useful in large-scale studies also 
multiplex allows for measuring many analytes with only a small amount of sample 
(Gibbons et al., 2014) 
  Quantification of satiety 
 Satiety quotient (SQ)  
The SQ was first introduced by Green et al., (1997) to evaluate the satiating effect of 
an eating episode. SQ is calculated from the difference in hunger ratings pre- and post-
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consumption of a food, divided by the weight or energy content of the food or drink 
being tested (Tremblay and Bellisle, 2015). When the motivation to eat is assessed on 
VAS and scored in mm, the result is expressed in mm/g or in mm/kJ. A higher SQ 
means a higher satiety level because there is a higher suppressive effect on the 
motivation to eat. The SQ has been applied in a wide range of research, a low SQ in 
response to a fixed-energy meal has been shown to be related to higher subsequent 
ad libitum energy intake measured under both laboratory and free-living conditions 
(Drapeau et al., 2005; Drapeau et al., 2007). This quotient uses a mean value for the 
post-meal assessed by hunger, fullness, desire to eat and prospective consumption 
scales rated every 10 min during a 60 min period, and multiplying the result by 100 
(Drapeau et al., 2005). 
 
 Factors affecting satiety 
 Body mass 
People with obesity and lean people have different responses to tests of appetite and 
EI, as their energy requirements are different. People with obesity have higher energy 
requirements than lean participants. There are differences in some aspects of 
physiological appetite control between people with obesity and those with normal 
weight (Benelam, 2009). Gastric mechanisms of satiation, nerves communicate an 
increase in gastric volume to the brain when food or drink reaches the stomach. It is 
clear that gastric distension stimulates satiation, independently of nutrient content 
(Benelam, 2009). 
When a food or drink is consumed and enters the GI tract it is digested and absorbed. 
Signals as a result of the ingestion of energy feed into specific areas of the brain that 
are involved in the regulation of EI, in response to the sensory and cognitive 
perceptions of the food or drink consumed and the distension of the stomach. These 
signals are integrated by the brain and satiation is stimulated. When nutrients reach 
the intestine and are absorbed, a number of hormonal signals that are again integrated 
in the brain to induce satiety are released. In addition to these episodic signals, satiety 
is also affected by fluctuations in hormones, such as leptin and insulin, which indicate 
the level of fat storage in the body (Benelam, 2009). 
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Furthermore, there is evidence that when food is removed from the stomach after 
ingestion, satiation does not occur. In experiments where cannulas are fitted that 
permit food to drain from the stomach, animals eat continuously, but quickly reach 
satiation when the cannula closes allowing food to fill the stomach normally (Davis and 
Smith, 1990). There is the possibility that gastric distension could be used as a 
biomarker of satiation. Kim et al., (2001) have reported that people with obesity have 
greater gastric capacities, which could result in a greater EI before gastric distension-
stimulated satiation occurs. However, this may be associated with binge eating and not 
strictly linked to obesity itself, and, although the likelihood of binge eating can increase 
with the degree of obesity, it has been reported that the gastric capacity of normal 
weight bulimic patients is larger than that of some people with obesity (Geliebter and 
Hashim 2001).  
The gastric capacity of people with obesity is reduced after weight loss and it is 
possible that this could help restore a stronger satiation response (Geliebter et al., 
1996). Differences in satiety signalling in people with obesity are another physiological 
aspect that can affect satiety. Ghrelin hormone concentrations are found to be lower 
in people with obesity compared with lean people (English et al., 2002). The inhibition 
of ghrelin in response to a meal may indicate some form of dysregulation of appetite 
hormones in obese individuals. In addition, ghrelin levels increase with subsequent 
weight loss, which has a role long-term role in weight regulation. It has also been 
suggested that a lowering in fasting ghrelin could be a consequence of downregulation 
caused by overeating. Two anorexigenic hormones, Peptide YY and GLP-1, have been 
reported to be lower in individuals with obesity, suggesting differences in these 
hormones could be contributing to a higher EI  in the population with obesity )Brown 
et al., 2014). 
  Gender 
Another factor that has an effect on appetite and EI is gender. Men are likely to 
consume more food than women due to their higher resting metabolic rate and higher 
body mass (Rolls, Fedoroff and Guthrie 1991b). It has been reported that appetite 
ratings differed according to gender (Gregersen et al., 2011).  Food intake of women 
has been observed to fluctuate during the menstrual cycle. Food intake decreases in 
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the periovulatory phase and elevates in the luteal phase, compared to the follicular 
phase (Buffenstein et al., 1995).   
  Age 
Age can affect satiety responsiveness, in particular sensory specific satiety and changes 
in taste receptors. Sensitivity to sensory specific satiety seems to decrease with age 
and this is important if the test meal presented in research studies is in the form of a 
buffet, where subjects are provided with a variety of foods (Rolls and McDermott, 
1991a). Many people experience a decrease in appetite with ageing. This condition is 
called anorexia of aging and is defined as age-related reduction in appetite and food 
intake (Wysokinski et al., 2015). It has been estimated that between 15 and 30% of 
older people have anorexia of ageing, with higher rates in women, hospitalised people 
and nursing home residents (Malafarina et al., 2013). 
  Sleep 
It has been suggested that reduced sleep duration is associated with an increased risk 
of obesity and weight gain (Broussard et al., 2016). The main mechanism is that short 
sleep duration may predispose individuals to weight gain through changes in appetite-
regulating hormones, leading to increased food intake. Indeed, experimental studies 
have consistently presented that sleep restriction increases caloric intake when free 
access to food is allowed (St-Onge et al., 2011; Bosy-Westphal et al., 2008). However, 
findings regarding the direct effects of sleep restriction on appetite-regulating 
hormones have been inconsistent; some studies have reported that increased levels of 
the appetite-stimulating hormone ghrelin and decreased levels of the satiety hormone 
leptin during controlled caloric intake (Spiegel et al., 2004).   
  Social situations 
It has been shown from decades of research that other people can influence our 
choices and food intake in a variety of ways (Higgs and Thomas, 2016). When eating in 
groups, people tend to consume significantly more energy than when alone. De Castro 
et al., (1997) reported that people ate more than 50 per cent more food when they ate 
in groups than when eating alone. This may be due to a number of factors, such as a 
relaxation of dietary restraint and longer duration of eating (Benelam, 2009). However, 
this was not consistent for all people and all types of groups, Brindal et al., (2015) 
51 
 
found that in a fast-food restaurants, women ate more when they were with other 
women when compared to mixed gender groups, similarly, men ate more when they 
were with other men compared to mixed gender pairs.  
   Identification of a satiety phenotype 
Appetite is controlled by psychological, behavioural and physiological aspects (Blundell 
and Gillett, 2001). Some of these aspects promote food intake (excitatory processes) 
and are reflected by the subjective sensation of hunger, whereas others (inhibitory 
processes) are responsible for satiation and satiety signals and are reflected by the 
subjective sensation of fullness (suppression of the feeling of hunger) (Blundell and 
Gillett, 2001). The balance between hunger, satiation and satiety is complex but can 
have important implications for body weight gain and the development of obesity. It 
has been reported that a weaker satiety response to a test meal in certain individuals 
who were obese, who claimed their eating was unrelated to their appetite sensations 
(comparison of obese or normal weight controls) (Barkeling et al., 2007). The people 
with obesity who expressed a weaker satiety response showed similar diurnal 
oscillations in hunger (and fullness) to the other two groups (obese or normal weight 
controls), indicating a weakened satiety response can occur despite normal daily 
satiety signalling mechanisms.  
Moreover, higher disinhibition and hunger scores have been observed in people with 
obesity claiming problems with appetite sensations compared to lean or people with 
obesity (Barkeling et al., 2007), which are eating behaviour traits that are related to 
overconsumption and higher body weights (Bryant et al., 2008). Based on these 
experimental observations, it can be hypothesised that impaired satiety signals could 
favour overconsumption and increase the risk of weight gain in certain individuals, but 
not limited to people with obesity. 
Numerous studies have attempted to predict satiety. Drapeau et al., (2007) used 
appetite sensations and the satiety quotient of VAS to predict EI of people with obesity. 
They found that higher scores of baseline SQ for fullness were associated with low ad 
libitum test lunch energy intake in women. These findings indicate that individuals with 
low SQ have weaker appetite sensation responses after a meal. Drapeau et al., (2005) 
also found a negative correlation between SQ and lunch energy intake. A further 
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previous study investigated the response of appetite sensations to fasting in obese and 
non-obese people.  The study reported that during fasting, desire to eat, hunger and 
prospective consumption was reduced for the non-obese, whereas these appetite 
sensations were increased slightly for people with obesity (Oh, Kim and Choue, 2002). 
Lindroos et al., (1997) and Provencher et al., (2003) used the three factor eating 
questionnaire (TFEQ) to predict satiety phenotype. They found TFEQ-H (hunger) was 
positively associated with EI. 
   Predicting weight loss 
Drapeau et al., (2007) found that higher baseline fasting desire to eat, hunger and 
prospective food consumption VAS scores were associated with reduced weight loss. 
Other researchers measured gut hormones to predict weight loss. Hainer et al., (2008) 
and Koska et al., (2004) used fasting PP to predict weight loss, they reported that 
baseline PP values were inversely associated with body weight. Moreover, Williams et 
al., (2016) found that a higher baseline level of ghrelin predicted greater weight loss at 
six months in males and females. Macronutrients in a food diary have been studied to 
predict weight loss. Buscemi et al., (2017) using 3 day food records found that low 
initial levels of caloric intake were positively associated with changes in BMI. Moreover, 
Linde et al., (2006) showed eating high fibre cereal, fruit and overall fibre intake at 
baseline were related to lower BMI in females.  
Eating behaviour traits have been measured and are thought to be useful in predicting 
weight loss in clinical patients, to monitor progress during weight loss treatment and  
is considered to be one of the most widely used indicators to study eating behaviour in 
individuals with obesity (Beechy et al., 2012). Food craving has also been used in 
predicting weight loss. Buscemi et al., (2017) showed that there was a relationship 
between higher initial food cravings and more gradual and less steep reductions in BMI. 
Both findings warrant further consideration. 
 Eating behaviour 
Eating behaviour can be described as a complex phenomenon encompassing the size 
and frequency of eating episodes and everyday food choices, which together can 
determine total energy and macronutrient intake (Martins, Robertson and Morgan, 
2008). It is the result of constant physiological and environmental inputs. The latter are 
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especially important and it has been accepted that the physiological mechanisms that 
control food intake can be easily overridden by strong social and environmental factors. 
Appetite can be explained as the control of food intake and defined as a range of 
variables related to food consumption that predict normal eating behaviour (Martins, 
Robertson and Morgan, 2008).  Moreover, eating behaviour is one of the most 
important factors contributing to body weight status (Dietrich et al., 2014). 
Many questionnaires have been developed to measure eating behaviours, especially 
dietary restraint. TFEQ was developed by Stunkard and Messick (1985) and consists of 
51 items. It is designed to assess 3 aspects of eating behaviour—cognitive restraint 
(TFEQ-R) (21items), disinhibition (TFEQ-D) (16 items) and hunger (TFEQ-H) (14 items) 
(Keskitalo et al., 2008).  The TFEQ has been validated and shows good test-retest 
reliability (reliability coefficients for internal consistency (Cronbach’s alpha) were 0.80 
for the restraint factor of the TFEQ-R (Laessle et al., 1989)). It is commonly used in 
appetite research to describe study populations (Harden et al., 2009).  
Cognitive restraint is generally accepted to be a tendency to consciously restrict one’s 
food intake instead of using physiological cues (i.e. hunger and satiety) as regulators of 
intake (Cornelis et al., 2014). Restrained eaters attempt to inhibit impulses to eat in 
order to pursue long-term weight goals. They avoid fattening foods and eat small 
portions (Hays et al., 2006). 
Disinhibition is a term that is defined as a tendency to overeat in the presence of 
palatable foods or other stimuli, such as boredom or sadness and hunger could be 
defined as the susceptibility to perceive body symptoms that signal the need for food 
(Hays et al., 2006). Disinhibited eaters consume food because of external 
environmental cues, such as palatable food. They find it difficult to resist food 
stimulation and/or eat under emotional distress (Dietrich et al., 2014). 
Hunger is defined as the susceptibility to perceived body symptoms that signal the 
need for food (Hays et al., 2006). TFEQ-H has been studied to predict the satiety 
phenotype of individuals.  Provencher et al., (2003) observed positive associations with 
EI and hunger. In theory, those who report chronically high levels of hunger are likely 
to be more susceptible to overeating compared with those who do not report being 
often hungry. Furthermore, Lindroos et al., (1997) reported that hunger was positively 
associated with daily EI in individuals with obesity. Moreover, high scores on TFEQ-H 
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have been associated with higher body weight (Dykes et al.,  2004; French, et al., 2014), 
which runs counter to the original idea that high scores on TFEQ-H might relate to 
greater interoceptive awareness (homeostatic information to consciousness) and 
consequently lower susceptibility to overeating. TFEQ-H has been used to predict 
weight change. Previous studies have shown that baseline hunger was negatively 
correlated with weight change (Batra et al., 2013; Bas and Donmez, 2009).  
 Food Craving  
Food craving is referred to as frequent, intense desires to consume a specific type of 
food (Kahathuduwa et al., 2018). It is believed to be a multidimensional experience as 
it involves cognitive e.g. thinking about food, emotional e.g. desire to eat or changes in 
mood, behavioural e.g. seeking and consuming food and physiological e.g. salivation 
aspects (Rodríguez-Martín and Meule, 2015). 
Psychometric self-report scales for the experience of food cravings have been 
developed by a number of researchers. The Food Craving Inventory (FCI) consists of 28 
items measuring the frequency of cravings for specific foods comprising of 4 factors or 
subscales measuring cravings for high fats, CHO/starches, sweets and fast food and 
generates a total score (White and Grilo, 2005). FCI places the question about craving 
in the test rubric, ‘‘Over the past month, how often have you experienced a craving for 
the food?’’ and then assesses the participant on a number of specific foods. It has been 
consistently demonstrated that there are gender differences in food cravings: women 
tend to experience higher food cravings than men (Weingarten and Elston, 1991). 
These differences may be linked to hormonal differences between women and men, 
particularly as many women experience rises in food cravings perimenstrually and 
prenatally (Hormes, 2014). Additionally, White et al., (2002), using the FCI found that 
people with obesity report more frequent cravings for high fats than their normal-
weight counterparts. It has been reported that the FCI is a reliable and valid measure 
of general and specific food cravings (White et al., 2002). It can be used in research 
related to overeating and binge eating. Moreover, FCI may be useful and valuable in 
treatment studies that target obesity and/or food cravings (White et al., 2002). 
55 
 
  Food craving and obesity 
Food craving has been found to associate with calorie overconsumption (Hill, Weaver 
and Blundell, 1991; Lafay et al., 2001; White and Grilo, 2005). A cross-sectional study 
of 646 adults, conducted by Chao et al., (2014) showed that there was a significant 
positive relation between food craving and BMI. They also reported significant positive 
associations between cravings for specific calorie dense foods e.g. sweets, high fat 
foods, CHO and fast foods and actual consumption of those respective foods. It has 
also been reported from longitudinal evidence that there are relationships between 
food cravings, EI and BMI, with suggestions from experimental evidence that caloric 
restriction is associated with decreased food cravings and weight loss decreased food 
cravings (Anton et al., 2012; Martin et al., 2011). 
Recently a study used the FCI and a three day dietary recall to explore relationships 
between food craving, caloric intake and BMI changes over the course of an 18 month 
weight loss trial. The finding of the study showed that from baseline to 6 months, 
there was a relationship between higher initial food cravings and more gradual and 
less steep reductions in BMI. Additionally, the relationship between changes in food 
craving and BMI changes were noted to vary by levels of change in caloric intake, such 
that there was a positive correlation between BMI change and change in food cravings 
and change in caloric intake at low levels, but at average and high levels the changes in 
caloric intake were unrelated. Similarly, from baseline to 6 months and from 6 to 18 
months, the relationship between changes in food craving and BMI changes were also 
found to vary by initial levels of caloric intake (Buscemi et al., 2017). 
 
 Food diaries and dietary assessment  
Dietary records (also known as food diaries) are typically obtained for 3 to 7 days. They 
are considered a prospective, open-ended survey method where the subjects are given 
a recording form to collect data about their foods and beverages consumed over a 
previously specified period of time. Food diaries are often requested to record detailed 
information about food preparation methods, ingredients of mixed dishes and recipes, 
and even the brand name of commercial products, depending on the aim/hypothesis 
of the study. Food diaries can be applied to estimate the current diet of individuals and 
population groups, as well as to identify groups at risk of diet inadequacy. They have 
been used in epidemiological and clinical studies (Ortega, Pérez-Rodrigo and López-
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Sobaler, 2015). It has been reported that 3 days of food diaries have high validity and 
precision (Yang et al., 2010; Schlundt, 1998). 
Food diaries with weighed portion size are known as one of the best instruments 
among dietary assessment methods. Nevertheless, when using food diaries concerns 
have been raised about the possibility that food behaviour may be influenced or 
changed by the recording process (Cantwell et al., 2006). Biro´ et al., (2002) highlighted 
the main concerns related to food diaries. For example, participants may forget to 
record items immediately following eating, the likelihood of omitting foods may 
increase when they later record their intake. Participants may experience difficulties in 
writing down the foods and beverages consumed or in describing the portion sizes. 
Increasing the number of days observed reduces the quality of completed diet records 
(Biro´ et al., 2002). It should also be considered the high cost of coding and processing 
information collected in diet records (Ortega, Pérez-Rodrigo and López-Sobaler, 2015). 
Finally, the reliability of food diaries can be decreased over time due to respondent 
fatigue because they have a high degree of participation burden (Biro´ et al., 2002). 
Food diaries can also be used to measure the contribution of macronutrients to total 
energy intake (TEI) and BMI.  In a study, subjects were classified into three BMI groups 
(underweight, normal and overweight). There was no difference in the TEI in all three 
BMI groups. However, when stratified by age, a positive correlation was observed 
between polyunsaturated fatty acid intake in younger women and animal protein 
intake in older women and BMI (Shin et al., 2007). 
 Food preferences 
Food preferences are influenced by a wide range of behavioural, social and economic 
variables, including food availability. However, the desire to select one food over 
another is more closely associated with taste and other sensory properties of foods 
(Mela, 2001). Food preferences can be measured by preference checklists or actual 
taste tests and are often considered to predict food consumption in everyday life 
(Drewnowski, 1997). Their use allows investigators to dispense with the less reliable 
food diaries. Again, attitudinal responses collected in the laboratory often fail to 
predict real-life behaviour, because many people do not overeat the foods they like. 
Potential reasons for dissociation between taste preferences and actual intake may 
include weight-related attitudes and behaviours and general concern with nutrition 
and health (Drewnowski, 1997).  Previous studies have examined the relationship 
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between food preferences and obesity. Davis et al., (2007) found that preference for 
sweet and fatty foods were positively correlated with BMI. Moreover, it has been 
reported that there was a positive correlation between BMI and consumption of a diet 
characterized by higher intakes of meat, eggs, fats and oils (Maskarinec, Novotny and 
Tasaki, 2000). Whereas, preference for vegetables, beans, fruit and grains had a 
negative association with BMI (Maskarinec, Novotny and Tasaki, 2000). Drewnowski et 
al., (1992) reported that women preferred high-fat, high-sugar foods, men appeared to 
prefer high-fat, high-protein foods. 
 Types of diet used to reduce weight  
There are four types of diet that are recommended for weight loss which are Low-
Calorie Diet (LCD), Low-fat diet, Low-carbohydrate diet and Very Low-Calorie Diet 
(VLCD). All these diets provide 800–1500 kcal/day while VLCD is< 800 kcal/day (Fock  
and Khoo,  2013). 
One of the common diets that is used for weight loss is a high protein (HP) diet. 
Increased protein intake during calorie deficit is beneficial for appetite control and it is 
defined as a diet with around 30% protein, 30% fat and 40% CHO from energy 
(Johnstone, 2012). Thus, designing a diet with HP can help people with low satiety and 
those who struggle to lose weight. The guidelines from the Institute of Medicine 
permit the inclusion of higher amounts of protein than previously recommended in a 
healthy diet and it reported that there is no clear evidence that HP intake increases the 
risk of renal stones, osteoporosis, cancer or CVD (Johnstone, 2012). It has been shown 
that diets containing 30% protein are well-tolerated and may have a health benefit, 
providing that the increase in protein is not made up of red meat and provided CHO is 
not excluded (Halton and Hu 2004).  
  High protein and gut hormones  
It has been hypothesised that there are relationships between protein -induced satiety 
and a larger increase in concentrations of anorexigenic hormones (GLP-1, 
cholecystokinin, PYY) or large reduction in ‘orexigenic’ (ghrelin) hormones (Veldhorst 
et al., 2008). Previous studies have shown that HP increases GLP- 1 and decreases the 




Veldhorst et al., (2009) reported that HP (25%) increased GLP-1 and decreased the 
concentration of ghrelin in twenty five subjects fed breakfast containing whey or whey 
without glycomacropeptide (GMP) as a type of protein. Several amino acids were 
increased more after the breakfast with whey than after the breakfast with whey 
without GMP, regardless of the protein concentration, namely serine, threonine, 
alanine, alpha-aminobutyric acid and isoleucine. It may be hypothesized that these 
amino acids play a role in the reduction of food intake 
 A further study carried out by Blom et al., (2006) assessed blood samples and 
subjective measures of satiety in fifteen healthy men. The study aimed to investigate 
whether a HP breakfast is more satiating than a high-CHO breakfast (HC) due to 
suppression of postprandial ghrelin concentrations. At the end of the study the HP 
breakfast decreased postprandial ghrelin secretion more than the HC breakfast. The 
HP breakfast also decreased gastric emptying, probably through increased secretion of 
cholecystokinin and GLP-1. 
   High protein diet and weight loss 
1.21.2.1 Short-term effects of a high-protein weight-loss diet 
 A study included twenty people with obesity with a mean BMI 34.8 kg/m2 conducted 
by Neacsu et al., (2014) in a crossover design with either a meat-based HP weight-loss 
(Meat- HPWL) or a vegetarian HPWL (Soy-HPWL) diet for 2 weeks. Both diets 
comprised 30% protein, 30% fat and 40% CHO. Over 2 weeks there was a significant 
decrease in participant’s weight on both diets, approximately 2.41 kg for (Soy-HPWL) 
and 2.27 kg for Meat- HPWL. Gut hormone profiles indicated diet effects for ghrelin 
and PYY but not for GLP-1 plasma concentrations. The diet effect on plasma 
concentrations of amino acids was not related to a change in appetite. Since appetite 
control and weight loss were similar in both the Soy-HPWL and Meat-HPWL diet 
groups, a vegetarian HP diet could be a healthier alternative to a meat-based HPWL 
diet, achieving desired results without any negative health effects (e.g. risk of colon 
disease). 
 A short term study was conducted by Johnstone et al., (2011) on 16 people with 
obesity. They did a randomised, cross-over design for 4 weeks with two HP diets (30%) 
with Low CHO (LC, 4 % CHO) and a moderate CHO (MC, 35 % CHO). The result of study 
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showed that participants lost about 6.75 kg of their weight on HP and LC and 4.32 kg 
on HP and MC diet. A study was carried out by Johnstone et al., (2008) on seventeen 
obese men. They were offered two types of HP for 4 weeks with LC and MC. The 
finding of this study reported that there was significant reduction in subject’s weight 
with LC diet compared with the MC diet. 
1.21.2.2 Long-term effects of a high-protein weight-loss diet 
Due et al., (2004) reported that at 12 months there was greater abdominal fat loss in 
subjects that followed a HP diet of about 25% protein from total energy rather than 
those following a medium protein diet. Two further clinical intervention studies were 
carried out by Brinkworth et al., (2004) on different groups of individuals with obesity; 
one group had T2DM and the other had hyperinsulinemia. Participants were randomly 
assigned to either a HP diet (30%) or a standard protein (SP) diet (15%). The duration 
of the study carried out on T2DM subjects was 15 months and the duration of the 
study on the hyperinsulinemia group was 17 months. The results of both studies 
reported that a HP diet reduced body weight of T2DM and hyperinsulinemia 
participants by 3.7 kg and 4.1 kg respectively, whereas weight loss for SP diet subjects 
was 2.2 kg and 2.9 kg respectively. 
 Aims of thesis  
The aim for this thesis is to extend and test the work identified in the literature 
regarding the identification of a satiety phenotype. To identify at baseline individuals 
who struggle to lose weight on a weight management programme due to reduced 
satiety, in order to help clinical professionals to identify those people to develop 
strategies to help them lose weight. This was achieved by the following objectives. 
In a pilot study  
1- To investigate the relationship between VAS appetite/hunger and total energy and 
macronutrient intake.      
2- To investigate the relationship between TFEQ subscales and total energy and 
macronutrient intake.      
3- To investigate the relationship between plasma gut hormone levels and total energy 
and macronutrient intake.      
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4- To investigate the relationship between food craving and total energy and 
macronutrient intake.      
5- Design a diet for people with low satiety.      
6- To investigate whether a high-protein diet is an effective weight-loss strategy for 
individuals with reduced satiety compared to other diet strategies. 
 In a laboratory setting, study individuals with normal weight  
1- To investigate the relationship between VAS, ad libitum lunch and food diary energy 
intake.  
2- To investigate the relationship between plasma gut hormone concentrations and ad 
libitum lunch and food diary energy intake. 
3- To investigate the relationship between the TFEQ-H subscale and ad libitum lunch 
and food diary energy intake. 
4- To investigate the relationship between food craving and ad libitum lunch and food 
diary energy intake. 
5- Use this data to develop a method to identify an individual's satiety phenotype. 
 
In a clinical Tier 3 setting 
1- To investigate the relationship between VAS, appetite rating scores and subsequent 
weight loss. 
2- To investigate the relationship between fasting concentrations of plasma gut 
hormone levels and subsequent weight loss. 
3- To investigate the relationship between the TFEQ subscales and subsequent weight 
loss. 
 
In a clinical Tier 2 setting 
1- To investigate the relationship between a 3 day food diary and weight loss. 
2- To investigate the relationship between the food craving scores and weight loss. 
3- To investigate the relationship between the TFEQ subscales and subsequent weight 




























2 Materials and methods  
 General Methods 
The purpose of this chapter is to give an overview and description of all the general 
methods used as part of the programme of research in this thesis. The laboratory work 
of this thesis was carried out at the Biomolecular Sciences Research Centre and 
Sheffield Business School Specialist Facilities (Food and Nutrition laboratories) at the 
City Campus of Sheffield Hallam University (SHU). 
 Participants, recruitment and timings 
 Pilot study (study 1)    
Healthy, overweight and people with obesity aged between 18-60 years with BMI ≥ 25 
kg/m2 participated voluntarily. They were recruited from staff and students at SHU 
through advertisement posters asking for people who would be interested in taking 
part in the studies. The participant's characteristics are described in chapter 3. Prior to 
the main trials, each eligible participant was interviewed at the first visit for 
preliminary screening using a Pre-Test Medical Questionnaire (Appendix 1). Volunteers 
were excluded from participation in the study if they were over 60 years, pregnant, 
those had a BMI 25 kg/m2 or they had a history of chronic disease such as diabetes, 
hypertension or heart disease. The ethical approval for the study was granted by the 
Faculty of Health and Wellbeing Research Ethics Committee, SHU (Appendix 2). 
All volunteers were provided with a participant information sheet 1 (Appendix 3) 
explaining the purpose and giving a brief description of the procedures of the study. 
They completed and signed an informed consent form (Appendix 4). They were given 
an explanation of the experimental protocol and any questions were answered by the 
investigator (HE). After enrolment, participants completed a number of questionnaires. 
These included questionnaires about dieting and weight history (Appendix 5), food and 
beverage preferences (Appendix 6), a food diary (Appendix 7), food craving inventory 
(FCI) (Appendix 8) and the three factor eating questionnaire (TFEQ-51) (Appendix 9) 
(Stunkard and Messick, 1985).  
Anthropometric measurements were taken by the investigator for the participants at 
the first visit including height, weight, waist and hip measurements. 
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Participants were asked to fast for 12 hours overnight prior to a second visit for the 
main trial, which included blood sample collection and VAS questionnaires (Appendix 
10 Appetite scale 1). This visit lasted approximately 3 hours 30 minutes. Finger prick 
blood samples were taken for hormone analysis five times from participants during 
this period and the VAS questionnaires were used at the same time points to evaluate 
sensations of appetite (hunger, satiety, desire to eat and fullness). Volunteers were 
instructed to fill out the first VAS questionnaire before the breakfast and another VAS 
questionnaire was filled out again directly after they consumed their breakfast, at 30 
minutes after breakfast and then at 1, 2 and 3 hours post breakfast. A test breakfast 
was served to volunteers after taking the first blood sample for monitoring metabolic 
and hormonal responses. It consisted of standard breakfast products, which were all 
commercially available. It comprised of 200 ml of Tesco Smooth orange juice (Tesco’s 
own brand, Tesco, UK), 100 ml of Tesco British Semi Skimmed Long life UHT Milk 
(Tesco’s own brand, Tesco, UK) and 50 g of Tesco Corn Flakes Cereal (Tesco’s own 
brand, Tesco, UK). Total calories provided by the breakfast test meal were 327 kcal 
(83.3% CHO, 10.7% protein, 6% fats). Participants were allowed to read or work during 
the trial and were not exposed to food cues. 
2.2.1.1 Personalised diets  
Three types of diet were tested to investigate which diets would be the most effective 
in terms of weight loss in the current study. The diets were personalised by giving 
participants suggested food plans based on their stated food preferences.  These were 
1) an increased or high protein diet (HP), 2) NHS Choices 12 week guide and 3) the 
intermittent fasting diet (5 days normal food consumption and 2 days fasting).  
2.2.1.2   Diet allocation of participants 
Volunteers were allocated to a diet, taking into account which types of diet they had 
tried before. After the second visit, participants were allocated to meal plans based on 
the diet and information to help them follow the diet day to day. In the HP diet, the 
number of calories per day was restricted, for most men, this meant consuming no 
more than 1,900 kcal a day, and for most women, 1,400 kcal. Men were instructed to 
consume 142.5 g of protein per day, this amount comes from dividing 1,900 kcal by 
30% of total protein and after that divide this number by 4, which is calories of protein 
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per gram. Women were instructed to consume 105 g of protein per day using the same 
calculation based on 1,400 kcal.  
Participants on the intermittent fasting 5:2 diet were required to limit calorie intake 
for two days, consecutively or otherwise each week. The calorie limit for fasting days 
was approximately 600 kcal for men and 500 kcal for women. On non-fasting days 
subjects were able to eat a normal calorie level (approximately 2500 kcal for men and 
2000 kcal for women). 
The NHS Choices guide helps individuals to work towards losing weight using an online 
programme.  For most men, this meant consuming no more than 1,900 kcal a day, and 
for most women, 1,400 kcal. 
2.2.1.3   Follow up diet of participants 
Participants were met after 6 weeks for repetition of the anthropometric 
measurements and to discuss how their diet was going and to give them advice, then 
another meeting after 12 weeks for repeating hormone analysis, questionnaires 
(Dieting and weight history, food and beverages preferences, a food diary, FCI and the 
TFEQ-51 and taking measurements.  
 Identification of a satiety phenotype in people with normal weight (Study 2) 
Students were recruited from Sheffield Business School Specialist Facilities at SHU, UK. 
They were aged between 18-45 years. Participant characteristics included in this study 
are described in chapter 4. This study was approved by the Faculty of Health and 
Wellbeing Research Ethics Committee, SHU.  
Before the main trial, student classes were visited to describe the study protocol and 
procedures and the students were given a pack with participant information sheet and 
informed consent form to consider prior to participation in the study, the pack also 
included questionnaires. Volunteers were instructed to attend one practical session in 
the laboratory over a one week period. Participants arrived at the laboratory first thing 
in the morning after 12 hours fasting.  
The finger prick blood samples were collected five times from participants, details are 
given in section 2.6. The first samples were collected in the morning when participants 
first arrived, then a further 4 samples were taken over the next 3 hours. 
Anthropometry measurements were also taken. Participants were instructed to fill out 
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the first VAS before breakfast and another VAS was completed directly after they 
consumed their breakfast and at 30, 90 and 150 minutes after the end of breakfast  
the VAS was completed. The exact time they finished their breakfast was noted. After 
the participants gave the first blood sample and completed the VAS questionnaire they 
were asked to not look at earlier pages during the time they completed the remaining 
pages. For the standardised breakfast test meal, cornflakes were weighed and 
recorded then put in bowls. This breakfast test meal was served to them. An Ad libitum 
test lunch of fusilli Tesco pasta (Tesco’s own brand, Tesco, UK) and tomato sauce 
(Sacla, Tesco, UK) were weighed out for participants.  
The protocol for cooking pasta was undertaken in the following steps: first of all, a 
large mixing bowl was weighed and the exact weight recorded. Then 400g fusilli pasta 
was weighed out. After that, unsalted water was boiled in a kettle and 2 litres of 
boiling water added to the pasta in the bowl. The bowl was put in to a 900W 
microwave and heated for 7 minutes. Pasta was stirred gently and a further 400ml of 
boiling water was added and then the bowl then was placed in the microwave at 900W 
for 7 minutes. Pasta was stirred gently again and then the drained in a colander for 2 
min (total). After that the bowl was transferred from the colander three times with 
shaking each time, to remove the water. The pasta was left in the colander for the 
remaining time. It was dried and returned to the bowl and 500g in the pasta bowl was 
placed on a balance and 400g of sauce was added to the bowl and the exact weight of 
sauce was recorded on the sheet, the sauce was then mixed into the pasta until the 
pasta was evenly coated. Finally, the bowl was covered with cling film and placed in 
the fridge overnight. 32 g of extra-virgin olive oil was added to the pre-prepared pasta 
and mixed until homogenous and then it warmed up and served to participants.  
Participants were instructed to consume the pasta lunch after the 150 minute VAS and 
blood sample were taken. Pasta was consumed in the sensory suite where participants 
ate in isolation and were devoid of other food cues.    
The plate with 500g mixed pasta and sauce was served with 1 glass of water and 
participants were instructed to eat until they felt comfortably full and satisfied. 
Participants were not allowed to read or to access their phones during this part of the 
trial. The plates were monitored at intervals, as soon as the bottom of the plate was 
visible the plate was topped up with additional pasta and sauce. The amount of mixed 
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pasta and sauce participants ate was recorded. The EI provided by the ad libitum lunch 
was calculated using the information provided by the food manufacturer.  
 Tier 3 study (Study 3) 
People with obesity and overweight people aged between 25-80 years were recruited 
from Rotherham Institute for Obesity (RIO, Rotherham, UK) prior to starting a weight 
loss programme by letter of invitation. Participants' characteristics included in this 
study are described in chapter 5. The inclusion criteria for this study were the same as 
the inclusion criteria for acceptance of participants on to the RIO weight management 
programme.  This is:  BMI>40 kg/m2, BMI>30 kg/m2 with comorbidities such as 
diabetes, hypertension, heart disease and arthritis, waist circumference over 102 cm 
(males) or 88 cm (females).  Exclusion criteria for the study was anyone unwilling or 
unable to provide informed consent to undertake the study.  After patients agreed to 
take part in the study two appointments were arranged. The first 30min appointment 
was immediately after the participant's initial consultation with the clinicians and 
dieticians. During this appointment, volunteers were interviewed and were provided 
with a participant information sheet 2 (Appendix 11). They were asked to sign the 
consent form and then questionnaires were provided for them to complete. These 
included TFEQ-51.  
A second appointment was arranged during this meeting and participants chose the 
best day to come back to RIO a few days after meeting 1 or during the following week. 
The second appointment was for 2 hours. In this appointment one finger prick blood 
sample was collected in the morning between 8:00 -10:00 AM at the RIO meeting 
room, after the participant had fasted for 12 hours overnight. Then, they were asked 
to complete a VAS questionnaire (Appendix 12 Appetite Scale 2) after which a 
breakfast test meal was served to them. Participants completed multiple VAS 
questionnaires for the next 1 hour and 45 minutes.  During this time participants 
needed to stay at RIO but were free to read or use their phones.  
 Tier 2 study (Study 4) 
People with obesity and overweight people were recruited from Rotherham Leisure 
Complex (Rotherham, UK) prior to starting a community group-based weight loss 
programme. Participants were aged between 25-80 years and their characteristics are 
described in chapter 6. 
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Volunteers were recruited via two visits by the researcher, during two weeks.  At the 
first visit, a presentation was made about the study for participants during their first 
group session. They were provided with information and a description of the study 
protocol. They were given the opportunity to ask questions regarding the study. 
Researchers (Hameida Elfarssi and Caroline Dalton) gave out packs with questionnaires 
including the FCI and the TFEQ-51. They took the information sheet including 
information on food diaries and the questionnaires home for a week so that they could 
consider about taking part.  After the session in week 1, questionnaires were collected 
the following week. Participants completed and signed an informed consent form. 
Data from food diaries from for the participants were collected including breakfast, 
lunch, dinner and snacks for seven days. Three consecutive following days from the 
diary were analysed from these forms. 
 Anthropometry 
  Height 
Height was measured to the nearest 0.1 cm. Participants were asked to remove their 
shoes and stand with their back to the height rule. They were told that the back of the 
head, back, buttocks, calves and heels should be against the wall, with feet and knees 
together. Participants were asked to look straight ahead, with their head in the 
Frankfort horizontal plane (It is referred to the as lower orbits of the eyes and the 
external auditory meatus).  
In study 1 (chapter 3), the height of participants was taken by using a wall-mounted 
stadiometer (Seca, Hamburg, Germany). In the nutrition study (study 2, chapter 4), a 
213 Height Measure (Leicester) (Seca, Germany) was using for measuring participants 
height. 
In studies 3 and 4 (chapters 5 and 6 respectively), the height of participants was taken 
by trained RIO and Rotherham Leisure Complex staff and the data was then provided 
to the researcher. 
 Weight 
Body weight was measured to an accuracy of  0.1 kg. Participants were asked to 
remove their heavy outer garments (jacket and coat) and shoes. They were told to 
remove personal belongings in their pockets prior to measurement. They were also 
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asked to stand in the centre of the platform with head erect and eyes looking straight 
ahead. 
In study 1 (chapter 3), the weight of participants was measured by using a balance 
beam scale (Seca, Williams Medical Supplies, Germany). In the nutrition study (study 2, 
chapter 4), 899 portable electronic scale (Seca, Germany) was used for measuring 
participant's weight. 
In studies 3 and 4 (chapters 5 and 6 respectively), weight of participants was measured 
using 899 portable electronic scale (Seca, Germany) by trained RIO and Rotherham 
Leisure Complex staff and then staff provided the measurements on a spreadsheet 
containing participant data. In all studies, BMI was then calculated by dividing the 
participant's weight in kilograms by the square of their height in metres. 
 Circumference Measurements 
Waist and hip circumferences were measured using a tape measure (Seca 201 Fitness 
Body Waist to Hip Ratio Ergonomic Body Fat Measuring, Germany). Waist 
circumference was measured at the narrowest diameter between the xiphoid process 
and iliac crest. Hip circumference was measured as the maximal circumference over 
the buttocks. 
In study 1 (chapter 3), waist and hip circumference of participants was measured using 
a tape measure. In studies 3 and 4 (chapters 5 and 6 respectively) the circumferences 
of participants were measured by trained RIO and Rotherham Leisure Complex staff 
and then staff provided the data. These staff were trained for reliability in undertaking 
these measurements. 
    Questionnaires 
A number of questionnaires were given to participants to complete after enrolment, 
including the following. 
 Three factor eating questionnaire (TFEQ) 
The TFEQ-51 developed by Stunkard and Messick, (1985) was used to measure eating 
behaviour subscales of volunteers, including hunger. The 51-item questionnaire 
assesses eating attitudes and behaviour across three scales: dietary restraint (21 items), 
disinhibition (16 items) and hunger (14 items). The 51 items are measured on a 4-point 
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response scale (definitely true for me: 1, quite true for me: 2, occasionally true for me: 
3 definitely not true for me: 4 and scores were summated into subscale scores for: 
cognitive restraint, disinhibited eating and hunger.  
 Food craving inventory questionnaire (FCI) 
The FCI was used to assess frequency of desire to eat specific foods. It includes 28 
items classified into four subscales: 1) high fat foods (fried chicken, sausages, gravy, 
fried fish, bacon, steak, sausage rolls), (2) sweets (brownies, cookies, chocolate, 
doughnuts, cakes ice-cream, sweets, sponge cake), (3) CHO  (breads, pancakes, biscuits, 
sandwich bread, rice, baked potato, pasta, cereal, Danish pastry, crisps) and (4) fast 
food (hamburgers, French fries, pizza). Each subscale had multiple choices and the 
summation score of these multiple choices represented the frequency of desire for 
each food. The questionnaire measured the frequency of cravings for a specific food 
item on a scale of 0 -never, to 4- almost every day. 
 Food diaries 
Food diaries were used to measure nutrient intake and participants were asked to 
record their food. They were provided with instructions for recording their food in 
food diary sheets and were instructed to fill out their food for 3 days, noting down 
what they had eaten as close as possible to the time when they ate it (to help them to 
remember accurately). They were told that they should be as specific as possible about 
the amount of each item, what time they ate it and any brand names. For example: 
Breakfast 8am - 1 piece of Warburton's white bread with Olivio spread, 2 scrambled 
eggs, I large cup of coffee with 1 level teaspoon sugar. 
Lunch 12.30pm - 1 small plate of lettuce and tomatoes, half a large tin (160g) of 
Princes tuna in brine, 2 small new potatoes, boiled, small portion of full fat salad 
dressing, 1 can Coke. 
Evening meal 7pm - Beef chilli con carne with white rice (average portion).  Cup of 
black coffee with 1 level teaspoon sugar, 1 medium slice Tesco own brand blackcurrant 
cheesecake. They were asked to include all drinks and any between meal snacks and 




Nutritics software (Libro, Dublin, UK) (version 1.8) was used to calculate TEI and 
macronutrient intake. This provides users with a report that contained all micro and 
macro nutrient information from the food diaries. 
 Assessment of appetite 
   Visual Analogue Scale 
VASs were used in chapters 3, 4 and 5 to assess subjective appetite sensations (hunger, 
fullness, satiety and desire to eat). It is the most commonly used method to assess 
appetite sensations. VAS are comprised of a 100-mm horizontal line with words 
anchored at each end expressing the extreme of each rating, e.g. ‘I am not hungry at 
all’ (0 mm) / ‘I have never been more hungry’ (100 mm).  Pen and paper were used to 
administer the VAS, which were easy and quick to use. Participants were instructed to 
mark a vertical line on the scale at a point between the two extreme ratings, which 
they considered to reflect their current feeling. The VAS scores were quantified by 
measuring the distance in millimetres from the 0 mm point to the position of the mark. 
The questionnaire that was used consisted of four scales adapted from Flint et al., 
(2000). The VAS booklet included four questions and they were presented in the 
format (“How hungry do you feel”, “How satisfied do you feel” “How full do you feel” 
and “How much more do you think you can eat”. 
The area under curve (AUC) was calculated by using the trapezoidal method which 
draws four triangles and 4 squares on the graphs (Yeh, 2002). The summation of the 
area of the 4 squares and 4 triangles for each graph determined the AUC for the 
participants for those questions over the time of the experiment. AUC composite of 
appetite score were  summated  using the AUC for hunger, full, desire to eat and can 
eat more,  by using this equation  hunger score+ desire score + prospective food intake 
score + (100-fullness score) (Hill and Blundell, 1982). The figure below shows an 
example of the calculation of an AUC from a participant's hunger scores. 
AUC= Square 1 = score 30 x 0.5, Square 2= score 30, Square3= score 1hr, Square 4= 
score 2hr, triangle 1=score 0- score 30/2 x 0.5, triangle 2=score 1hr-30/2x0.5, triangle 




Figure 2-1:  An example of an AUC calculation of hunger scores for participant No 4 in 
response to a test meal. 
 Satiety Quotient (SQ) 
The SQ was used in chapters 3, 4 and 5. It is a formula to measure the satiating effect 
of foods relative to energy content. VAS scores were used to calculate SQ, in response 
to a fixed-calorie meal. Hunger VAS ratings were used to calculate the average SQ. SQ 
composite appetite scores were the summation of  SQ hunger, fullness, desire to eat 
and can eat more, by using this equation  hunger score+ desire score + prospective 
food intake score + (100-fullness score) (Hill and Blundell, 1982). 
A higher SQ is representative of a stronger appetite response to the ingested food, 
whereas a lower SQ represented a weaker response (Drapeau et al., 2005; Dalton et al., 
2015). 
In chapters 3 and 4 this equation below was used to calculate the SQ. 
𝑆𝑄 =
(Fasting AS −  mean 60 min post meal AS)
Energy content of the test meal ( kCAL)
   𝑋 100 
In chapter 5 this equation below was used to calculate the SQ following that reported 
in Dalton et al., 2015). 
𝑆𝑄 =
(Fasting AS −  mean 75min post meal AS)
Energy content of the test meal ( kCAL)
   𝑋 100 

























Hunger scores for participant No 4 in response to a test meal 
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   Blood sample collection 
Blood samples were taken by using mechanical finger-prick devices, Accuchek Safe-T-
Pro Plus Single Use Lancets (Mannheim, Germany). These samples were collected into 
ice-chilled microvette tubes containing 500 µl potassium ethylenediaminetetra-acetic 
acid (EDTA)-coated as an anti-coagulant (Sarstedt, Nümbrecht, Germany). Blood 
samples were dispensed into EDTA tubes for the determination of plasma gut hormone 
concentrations. 
Each microvette tube contained EDTA plus 2.5µL each of the 3 protease inhibitors (3.p-
hydroxymercuribenzoic acid (PHMB), DPPIV inhibitor and Pefabloc) to prevent the 
degradation of gut hormones. 
To prepare the PHMB solution, 30 µL of NaOH was added to 2.5 mL of phosphate 
buffered saline (PBS). 500 µL of PHMB was added to 500 µL of the NaOH/PBS solution 
before being frozen in aliquots. On the morning of the study, 5 microvette blood tubes 
were prepared per participant. Each tube contained 2.5 µL of the PHMB/NaOH/PBS 
solution, 2.5 µL of Pefabloc and 2.5 µL of DPPIV inhibitor. 
All blood samples were kept in an ice bath until centrifugation. The microvettes were 
spun at 1000xg for 10 min at 4°C and plasma supernatants were then aliquoted into 
plastic Eppendorf tubes for storage. 100 μL of 1 M HCl was added per mL of plasma to 
neutralise proteases and allow for acylated ghrelin and GLP-1 determination. 
After HCl was added to each plasma sample the sample was spun at 1000xg for 5 
minutes in a refrigerated centrifuge (Eppendorf® Minispin® and MiniSpin Plus personal 
microcentrifuge, Germany) at 4°C. All prepared plasma samples were labelled with a 
numerical code and stored at – 80°C in BMRC laboratory until the time of the assay. 
During blood collection, the subjects were allowed to sit in a room (at university for 
the pilot and nutrition studies and in a meeting room at RIO centre for the RIO study). 
They could bring their computer or iPad to work or listen to the radio, toilet visits were 






 Laboratory methods  
Prior to commencing experimental trial days, all reagents were prepared in advance.  
 Preparation of reagents for the multiplex assay 
Preparation of reagents, controls and working standards were carried out using the 
reagents and assay protocol provided by the manufacturer (EMD Millipore, Darmstadt, 
Germany). Hormone quantification used the human metabolic hormone magnetic 
bead panel, 96 well plate assays.  
2.7.1.1   Preparation of Antibody-Immobilized Beads 
Each antibody-bead vial was vortexed for 1 minute and 150 μL from each vial was 
added to the mixing bottle and the final volume made up to 3.0 mL with Bead Diluent. 
The mixed beads were vortexed well again.  
Example 2: When using 3 antibody-immobilized beads, 150 μL from each of the 3 bead 
vials was added to the Mixing Bottle. Then 2.55 mL Bead Diluent was added. 
2.7.1.2  Preparation of Quality Controls 
Before use, Quality Control 1 and Quality Control 2, supplied with the kit, were 
reconstituted with 250 μL deionized water. The vial was inverted several times to mix 
and vortexed. 
2.7.1.3   Preparation of Wash Buffer 
60 mL of 10X Wash Buffer was diluted with 540 mL deionized water. 
2.7.1.4  Preparation of Serum Matrix 
1 mL of deionized water was added to the bottle containing lyophilized Serum Matrix 
and it was mixed well and then allowed to stand for at least 10 minutes for complete 
reconstitution.  
Prior to use, the Human Metabolic Hormone Standard was reconstituted with 250 μL 
deionized water and then the vial was inverted several times to mix and then vortexed 







      Figure 2-2: Preparation of standards for the multiplex assay. 
  Plate washing procedure 
The plate was rested on a handheld magnet (EMD Millipore, Darmstadt, Germany) for 
60 seconds to allow the complete attraction of the antibody coated magnetic beads. 
The well contents were removed by gently decanting the plate into an appropriate 
waste receptacle and gently tapping on absorbent pads to remove residual liquid, after 
that the plate was washed with Wash buffer by removing the plate from the magnet 
and then adding Wash buffer (200 μL) to each well again and the plate was shaken for 
30 seconds and then reattached to the magnet and beads were left to settle for 60 
seconds and then well contents were removed as described above.  
 Immunoassay procedure 
Controls 1 and 2 and test samples were recorded on a 'Well Map Worksheet' in a 
vertical configuration to ensure accurate placement in the wells. First of all 200 μL of 
assay buffer was added to each well of the plate and then it was sealed and mixed and 
after that it was shaken for 10 minutes on a plate shaker at room temperature (20-
25°C). Assay Buffer was decanted and the residual amount was removed from all wells 
by inverting the plate and tapping it smartly onto absorbent towels several times. After 
that, 25 μL of each standard or control were added into the appropriate wells in 
duplicate and Assay Buffer was used as the 0 pg/mL standard (background) then 25 μL 
of Assay Buffer was added to the sample wells and 25 μL of appropriate matrix 
solution was added to the background, standards and control wells, then 25 μL of each 
sample was placed into the appropriate wells and the bottle of Mixed Beads were 
vortexed and mixed. Thereafter, 25 μL of Mixed Beads was taken and added to each 
well and the plate was sealed with a plate sealer, wrapped in foil and incubated with 
agitation on a plate shaker overnight (16-18 hours) at 4°C. After overnight incubation 
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well contents were gently removed and the plate washed 3 times. After that 50 μL of 
Detection Antibody was added to each well and the plate sealed and covered with foil 
and incubated with agitation on a plate shaker for 1 hour at room temperature (20-
25°C). 50 μL Streptavidin-Phycoerythrin was added to each well and the plate was 
sealed and covered as before and incubated with agitation on a plate shaker for 30 
minutes at room temperature (20-25°C). After that, well contents were gently 
removed and the plate washed 3 times. Then 100 μL of Drive Fluid was added to all 
wells and the beads were resuspended on a plate shaker for 5 minutes. Finally the 
plate was run on a Luminex® 200™, HTS, FLEXMAP 3D® or MAGPIX® with xPONENT® 
software and data was saved on a USB. 
 Gut hormone analysis 
All hormone assays were performed at the laboratory in the Biomolecular Sciences 
Research Centre at SHU. Samples for each participant were run in duplicate. 
Plasma acylated ghrelin, PYY, PP and GLP-1 concentrations were measured by enzyme-
linked immunosorbent assay using a commercially available kit (Human Metabolic 
Hormone Magnetic Bead Panel (HMHMAG-34K) following the manufacturers' 
instructions and it was assayed by Luminex MAGPIX instrument with xPONENT 
software version 4.2 (Austin, Texas, USA). 
 Statistical analysis 
 All data were analysed using the Statistical Package for the Social Science (SPSS) 
software version 24.0 (IBM) for Windows (SPSS Inc., Chicago, IL, U.S.A.) and Prism 
version 7.03 (GraphPad Software Inc., La Jolla, CA, U.S.A.). All data was normally 
distributed within the software and tests used were non parametric.  All AUC values for 
appetite perception and appetite hormone levels in chapters 3, 4, 5 were calculated 
using the trapezoidal rule. T-tests were used to assess differences in gender, age, 
height, body mass, BMI and other dependant variables between groups.  T-tests were 
also used to assess differences in mean values of BMI, body weight, waist change, 
TFEQ subscales, macronutrient and food cravings in high satiety participants (chapter 
6). 
Correlation coefficients were used to assess relationships between variables. Linear 
regression analysis was used to establish a relationship between dependent variables 
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(Ad libitum pasta and TEI measured by food diary) and independent variables (the 
predictors such as VAS (fasting time, hunger, fullness, desire to eat and prospective 
food intake), 30 min fullness, post breakfast desire to eat, AUC of 4 questions and SQ 
of 4 questions, gut hormones and TFEQ-H of the heat map. One way ANOVA was used 
to determine whether there were any statistically significant differences between the 
average BMI and TFEQ subscales of low, medium and high hunger groups (chapter4). 
One way ANOVA was used in chapter 5 to determine whether there were any 
statistically significant differences between the average BMI, weight, waist and TFEQ 
subscales in low, medium and high hunger participants. 
Data are represented as mean ± SD, unless otherwise indicated. A p value < 0.05 was 
considered to be statistically significant. Cohen d=0.2 was considered a 'small' effect 
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3  Introduction 
The use of pilot and feasibility studies to develop interventions is an important step in 
scientific research (Lancaster, 2015). Until recently, much of this preliminary work, 
including decision-making processes, methods optimisation and formal testing prior to 
a full-scale study, has gone unreported (Hoddinott, 2015). However, data generated 
from such studies is of interest to the scientific community, most notably for those 
individuals undertaking similar research. Pilot studies supply data to encourage 
scientific rigour and ensure that future study protocols are optimised to best 
investigate their aims and objectives )Van Teijlingen and Hundley, 2002).  
 Low satiety phenotype and high protein diet 
Impaired appetite control is one factor implicated in weight gain. Individuals who have 
difficulties in recognising their appetite sensations, before and after a meal, and who 
do not eat in response to their appetite sensations seem to be more susceptible to 
weight gain. These individuals represent the ‘low satiety phenotype’. This phenotype is 
associated with specific behavioural and metabolic profiles that could explain their 
susceptibility to overeating. Drapeau and colleagues (2005) reported individual 
variability in satiety responsiveness among both people with obesity and normal 
weight and have identified a 'low satiety phenotype' by using the satiety quotient (SQ) 
(Dalton et al., 2015).  The SQ is calculated from the difference in hunger ratings before 
and post-consumption of a food, then divided by the weight or energy content of the 
food or drink being tested (Tremblay and Bellisle, 2015). 
With an increasing prevalence rate of obesity in western countries, authorities 
emphasise the importance of averting weight gain, improving weight loss and 
sustaining weight-loss status. However, this requires a great effort from people who 
live in the modern obesogenic environment that encourages food intake and limits 
energy expenditure to maintain their healthy body weight. Several dietary strategies 
have been suggested to reduce body weight and prevent weight gain )Gilbert et al., 
2011). 
Previous studies have demonstrated that prescribing a diet with 30% of the calories 
obtained from protein reduces feelings of hunger, as protein has a greater effect on 
satiety than fats or CHO (Astrup, Raben and Geiker 2015).  Therefore this study 
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hypothesised that people with low levels of satiety hormones may find that a high 
protein diet is easier to adhere to than other types of diet.  Studies have shown that 
diets containing 30% protein are well-tolerated and may have some health benefits, 
providing that the increase in protein is not made up of red meat, and that CHOs are 
not excluded.  Higher protein diets also enhance weight loss due to increased dietary 
thermogenesis (Halton and Hu, 2004) and protein-induced alterations in 
gluconeogenesis to improve glucose homeostasis (Pesta and Samuel, 2014). 
Over the past two decades, high protein diets have proven to be a successful strategy 
that can prevent or treat obesity through improvements in the management of body 
weight. This is thought to be due, in part, to modulations in appetite, energy 
metabolism and EI (Leidy et al., 2015). Diets with high protein have a long history 
(Denke, 2001). Many people have also been encouraged to try higher protein diets due 
to their poor experiences in failing to achieve and maintain clinically relevant weight 
loss, which is typically stated as 5% (NICE, 2006(. 
 The rationale for the use of this type of diet is that it offers a more accentuated satiety 
response for a longer period of time, when compared with other macronutrients such 
as CHO and fat (Lepe, Bacardi and Jimenez, 2011). Moreover, it affects both sides of 
the energy balance, i.e. EI and energy expenditure, thereby providing a strategy for 
weight loss and weight maintenance after weight loss (Veldhorst, Westerterp and 
Westerterp-Plantenga, 2012). 
Identifying food preferences at the beginning of a weight loss programme would help 
to design diets that stick to the required protein content but reflect individual 
preferences.  
 Rationale for the methods used to measure satiety and hunger in 
laboratory settings  
3.1.1.1 Visual analogue scales 
VAS have been described previously and the reproducibility, validity and power of this 
tool has been well established (Parker et al., 2004). Appetite sensations reflect 
objective and subjective components of appetite control (Stubbs et al., 2000).  The 
Satiety Quotient in response to a standardised meal gives a numerical measure of 
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satiety, and is expressed per unit of intake (e.g. kcal) when calculated (Dalton et al., 
2015). 
3.1.1.2 Test meal  
The single-course test meal is used to measure both satiation (energy consumed to 
fullness) and later EI following a period of satiety.  It is the most widely utilised 
approach to quantifying the food consumed to fullness, in response to the variable 
being tested. This approach has advantages and limitations. The benefit of the single-
course meal is that it is easy to implement and interpret and enables a clear measure 
of quantitative intake to fullness. The limitation of this approach is that when 
restricting eating to a single meal item, the focus is only on quantity consumed and not 
on food choice, therefore poorly reflecting a real life meal, where several food items 
are available and can be freely consumed (Chapelot, Blundell and Bellisle, 2013; Hill, 
Rogers and Blundell, 1995). Participants can also become bored of the homogenous 
food and therefore are not eating until comfortably full and satisfied. 
3.1.1.3  Three factor eating questionnaire (TFEQ) 
Completing the TFEQ is an empirical approach to identifying eating behaviours 
(Stunkard and Messick, 1985). The TFEQ was originally developed to investigate the 
theory that people with obesity were thought to have different eating behaviours and 
different behavioural and emotional responses to situations involving food choices, 
compared to people who are normal weight. The TFEQ measures three distinct 
constructs of eating behavior: 1) Restraint, 2) Disinhibition and 3) Hunger. Restraint is 
described as the degree to which a person exerts behavioral control over their own 
eating behavior. Disinhibition refers to a person’s stable underlying readiness to eat in 
response to environmental triggers, such as the sight and smell of palatable food, 
social or emotional eating. Hunger represents a person’s stable underlying sensitivity 
to hunger feelings and predisposition to eat (French et al., 2014). The TFEQ has been 
validated and shown good test-retest reliability (Laessle et al., 1989).  
There are fewer studies that have shown associations between TFEQ hunger scores 
and outcome, compared to studies considering restraint and disinhibition. Provencher 
et al., (2003) have observed positive associations with EI. In theory, those who report 
chronically high levels of hunger should be more susceptible to overeating, compared 
with those who do not report being hungry. French et al., (2014) reported that there 
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was a significant correlation between each of the eating behavior measures and EI, and 
they found a strong correlation between TFEQ Hunger and food intake. Fundamental 
for the studies in this thesis it is vital that restrained eaters are excluded, otherwise 
they would not eat to fullness. 
3.1.1.4   Gut hormones 
Appetite-related peptides are known to play a physiological role in the regulation of 
hunger and satiety (Delzenne et al., 2010). This study measured four gut hormones:  
ghrelin, GLP-1, PP and PYY. These four hormones were selected as they represent the 
key group of hormones that have been shown to influence hunger and satiety. Ghrelin 
is the only known orexigenic hormone and fasting ghrelin concentrations have been 
shown to be lower in people with obesity when compared with normal weight controls 
(Cummings et al., 2002). Moreover, GLP-1, PP and PYY have been shown to lead to 
reduced food intake and body weight (Suzuki et al., 2010). 
Ghrelin increases with subsequent weight loss and so may have a role in long-term 
weight regulation. It has also been suggested that decreases in fasting ghrelin could be 
a consequence of downregulation caused by overeating (Geliebter, Hashim and Gluck, 
2008). GLP-1 acts as a satiety stimulator, which decreases hunger and promotes meal 
cessation (Figlewicz, 2003, Woods et al., 1998). It has been reported to be lower in 
people with obesity, suggesting differences in GLP-1 could contribute to higher EI in 
people with obesity (Brown et al., 2014).  
PP increases following a meal, and acts as a satiety stimulator. The action of PP 
involves a reduction in food intake and it is reduced in people with obesity (Troke, Tan 
and Bloom, 2014). It has a role in the central control of appetite because it has high 
affinity for the Y4 receptor, which is widely expressed in brain areas (the area 
postrema) (Chaudhri, Small and Bloom, 2006). 
PYY also acts as a satiety stimulator.  It inhibits food intake through binding with, the 
highest affinity to the hypothalamic Y2 receptor (Troke, Tan and Bloom, 2014). People 
with obesity have low plasma concentrations of total fasting PYY, or no changes in 
fasting, or impaired postprandial PYY, as a result it has a role in the pathogenesis of 
obesity (Moran et al., 2007). 
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3.1.1.5  Food diaries  
EI can be determined by meal frequency, portion size and specific macronutrient 
contents of food consumed. Food diaries request participants to record all foods and 
beverages that have been consumed over a specific period of time, usually 3 to 7 days 
with at least one weekend day. However, week-day food records need highly 
motivated participants, and they are expensive to administer in large samples, thus 3-
day food records are commonly used in free living studies (Yang et al., 2010).  The 
validity and reliability of 3-day food diaries for recording food intake has been reported 
in several studies (Schlundt, 1988; Yang et al., 2010).  
Food diaries can provide details about the macronutrient content of each participant's 
diet and their overall daily calorific intake. Using a 3-day food diary can identify a 
relationship between average daily EI and ab libitum food intake on the study date. For 
example, it could be predicted that participants who record a high carbohydrate diet 
across the 3-day food diary may consume more of a high carbohydrate meal in ad 
libitum conditions and participants who record a sustained high caloric intake would 
also consume a larger quantity of food in ad libitum conditions (Yang et al., 2010). The 
main limitation is the potential under reporting that has been described previously in 
chapter 1. 
3.1.1.6   Food cravings 
Food cravings have been suggested as a conditioned expression of hunger, where food 
cravings develop from pairing consumption of certain foods with hunger (Gibson and 
Desmond, 1999). It has been suggested that food cravings play a role in maintaining 
the excessive eating patterns observed in binge eating, bulimia and obesity. Numerous 
studies have examined the role of cravings for specific food classes (e.g. CHOs, sweets, 
and fats) (White et al., 2002) and have confirmed differences in the types of foods 
craved according to age, gender, time of day, hunger state and phase of the menstrual 
cycle (White et al., 2002). CHO craving has been most frequently studied (White et al., 
2002). Martin et al., (2008) tested the association between food cravings and 
consumption of specific foods in a laboratory taste test. The results indicated that food 
cravings are significantly related to food intake, with specific food cravings correlating 






The main aim of the present study was to pilot methods to assess satiety phenotypes. 
Aims of the present study are: 
1- To investigate the relationship between the VAS rating and total energy and 
macronutrient intake.      
2- To investigate the relationship between TFEQ subscales and total energy and 
macronutrient intake.      
3- To investigate the relationship between gut hormones and total energy and 
macronutrient intake.      
4- To investigate the relationship between food craving and total energy and 
macronutrient intake.      
5- Design a diet for people with low satiety.      
6- To investigate whether a HP diet is an effective weight-loss strategy for individuals 














 Materials and methods  
 Participant recruitment 
Twenty-seven healthy overweight participants and people with obesity were recruited 
from SHU. Of those, data is presented for twenty-two participants (n= 20 females and 
n= 2 males) as 5 people either did not give blood samples (n=2) or did not return the 
questionnaires (n=3). Participants were aged between 18-55 years (Mean ± SD 42.09 ± 
10.98 years). Participants were interviewed at the first visit for preliminary screening 
using a Pre-Test Medical Questionnaire (Appendix 1). Exclusion criteria were people 
aged over 60 years, pregnant, breast feeding, those with BMI≤ 25 kg/m2 or had a 
history of chronic diseases such as diabetes, hypertension or heart disease. 
Participants were excluded if they disliked or were allergic to the foods used in the 
study, or if they took medication that may affect their appetite and / or metabolism 
(more details are provided in Chapter 2). 
Intra assay % CV (The Average Coefficient of Variation) for ghrelin, PP, PYY and GLP-1 




































                        
Figure 3-1: Flow chart of participants in the study 
 
27 Participants recruited  
2 do not agree to 
blood sampling 
25 completed 





3 did not return 
questionnaires 
Allocated diet for 22 
participants  
3 participants 
followed up  
 
19 participants were 




 Statistical analysis 
All data were analysed using (SPSS) and Prism version 7.03 (GraphPad Soft-ware Inc., 
La Jolla, CA, U.S.A.). Nutritics software (Libro, Dublin, UK) was used to calculate the 
percentage of macronutrients as well as EI from the completed food diaries. 
Normal correlation was used to assess relationships between variables and total 
energy and macronutrients. Independent t-tests were used to assess for any 
differences in gender, age, height, body mass, BMI, TFEQ scores, macronutrient intake 
and food craving scores. A p value < 0.05 was considered to be statistically significant. 
Cohen d=0.2 be considered a 'small' effect size, 0.5 represents a 'medium' effect size 


















 Baseline characteristics of the study participants 
The baseline characteristics of all participants is shown in table 3.1, from where it is 
observed there are no statistical differences in measures between males and females 
apart from height and body mass, which were significantly different. 
 
Table 3-1: Baseline characteristics of the study participants 
Variables All (n=22)   
Mean ± SD 
Female (n=20) 
Mean ± SD 
Male (n=2) 
Mean ± SD 
t p d 
Age (y) 42.1±11 41.8±11.0 44.5±14.8 -0.318 0.754 0.202 
Height (cm) 164±7.7 163 ±5.8 177.6±13.6 -3. 038 0.007 1.397 
Body mass (kg) 93.3±30 82.3±10.2 132.5±38.9 -3.400 0.003 1.766 
BMI (kg/m2) 32 ±5.2 30.2±4 41.5±5.9 -1.819 0.317 2.239 
Waist (cm) 117.9±21.9 111.6±9.1 129.5±26.2 -.0.963 0. 509 0.915 
TFEQ Hunger  6.9±3.8 6.9±3.8 9.5±2.1 -0.940 0.359 0.850 
TFEQ Restraint 8 ±3.6 8.7±3.5 5.00±2.8 1.412 0.174 1.149 
TFEQ 
Disinhibition 
8.8±3.2 8.7±3.4 9.5±0.7 -0.313 0.758 0.317 
Values are mean ± standard deviation, n= number of participants, t = t-test and Cohen's d.  BMI: body 
mass index. SD: standard deviation. p < 0.05 significant differences between males and females. 
 
   Scores of TEI, macronutrient intake, based on food diaries and 
food craving questionnaires of participants 
Table 3.2 presents the data of TEI and macronutrient intake using food diaries and 
food craving questionnaires for all participants. As can be seen in the table there was 
no significant difference in TEI and macronutrient intake based on the food diaries 
between genders. There was a significant difference in fat cravings between women 
and men with men having stronger fat cravings. No significant difference was found 






Table 3-2 : The mean ± standard deviation of TEI, macronutrient intake based on food 
diaries and food craving questionnaires of participants 
Values are mean± standard deviation, n=number of participants, t= t-test and Cohen's d.  BMI: body 
mass index. SD: standard deviation.  p< 0.05 significant the differences between males and females. 
 
 Fasting and AUC appetite, TEI and macronutrient intake  
Table 3.3 displays the relationship between fasting and AUC appetite scores, measured 
using VAS and TEI and macronutrient intake from the food diary. As can be shown in 
the table, there was a positive correlation between fasting prospective food intake 
(r=0.441*) (p=0.040) and TEI. AUC prospective food intake (the amount of food that is 
expected to be eaten) was also positively correlated (r=0.497*) (p=0.019) with TEI. 
However, for the rest of the AUC and fasting scores for the 4 questions of the VAS 
there was no significant correlation with TEI. Fasting prospective food intake was 
significantly negatively correlated with percentage of CHO intake (r=-0.485*, p=0.019). 
However, for the rest of the fasting and AUC VAS measures there was no significant 
correlation with percentage CHO intake, AUC satisfaction was negatively correlated 







Females (n= 20) 
Mean ± SD 
Males (n= 2) 
Mean ± SD 
t p d 
Food diary-TEI 
(kcal) 
1747.7±499.4 1728.5±517.4 1939.5±262.3 -0.560 0.581 0.514 
Food diary-CHO 
(% of  TEI ) 
45.7± 7.9 45.6±±8.0 46.5±8.8 -0.161 0.874 0.114 
Food diary-
Protein (%  TEI ) 
19.3± 5.5 19.6±5.6 16.3±0.8 0.816 0.424 0.827 
Fat  -Food diary 
(% of  TEI ) 
32.5± 7 32.4±7.2 34.3±5.5 -0.372 0.714 0.306 
Food diary-Fibre 
(g) 
14.8±5.0 15.1±5.1 11.6±1.9 0.929 0.364 0.893 
Fast food craving 13.4± 4.3 13.3±4.5 14.5±2.1 -.0370 0.715 0.344 
Sweet craving 27.4±7.1 26.8±6.6 33.5±12.0 -1.297 0.209 0.691 
Fat craving 9.4±2.7 9.1±2.4 13.0±2.82 -2.184 0.041 1.506 
CHO craving 15.4±5.1 15.2±5.0 17.0±7.1 -1.907 0.643 0.293 
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 Table 3-3 : Correlation coefficients between fasting and AUC appetite, TEI and 
macronutrient intake  
Correlation TEI % CHO % Fat % Protein Fibre 
Fasting hunger 0.230 -0.180 0.265 -0.165 -0.003 
AUC hunger 0.045 0.048 0.358 - 0.246 -0.118 
Fasting satisfied -0.036 -0.032 -0.030 - 0.038 -0.198 
AUC satisfied 0.239 - 0.255 -0.184 0.326 0.394 
Fasting fullness VAS  -0.022 0.086 0.100 0.068 -0.032 
AUC fullness 0.155 0.155 -0.064 -0.088 0.318 
Fasting prospective food 
intake   
0.441* -0.485* 0.339 0.119 0.132 
AUC Prospective food intake 
0.497* 0.218 0.090 -0.024 0.261 
AUC composite appetite score 0.269 0.023 0.331 -0.376 0.017 
All significance tests were two-tailed (*p < 0.05) and values in table are r values.   
 SQ, SQ composite appetite score, TEI and macronutrient intake 
Table 3.4 presents the relationships between SQ of VASs for 4 questions and the SQ 
composite appetite score from the VAS and TEI and macronutrient intake taken from 
the food diary. There was a positive correlation between SQ composite appetite score 
and percentage CHO of food diary (r=0.504*, p=0.017).  SQ fullness was negatively 
correlated with percentage protein intake (r=-0.431*, p=0.045). Remaining SQs were 
not significantly correlated with TEI and macronutrient intake. 
 
Table 3-4 : Correlation coefficients between TEI and macronutrient intake of food with 
SQ.  
Correlation          TEI % CHO % Fat % Protein Fibre  
SQ hunger -0.055 -0.195 0.182 -0.195 0.182 
SQ satisfied -0.049 0.025 -0.245 -0.050 -0.111 
SQ fullness -0.041 0.088 0.011 -0.431* 0.093 
SQ prospective food intake 0.352 -0.289 0.134 0.037 0.323 
SQ composite appetite score -0.069 0.504* -0.366 -0.111 0.154 
All significance tests were two-tailed (*p <0 .05) and values in table are r values. 
 
 TFEQ subscales, TEI and macronutrient intake 
Table 3.5 shows the relationships between TFEQ subscales, TEI and macronutrient 
intake based on the food diary. No correlation was found between the TFEQ and to TEI. 
TFEQ Hunger and TFEQ Disinhibition were negatively correlated with percentage 
protein consumed, but this finding did not reach significance. 
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Values in table are r value 
 Fasting sample and AUC of gut hormone, TEI and macronutrient 
intake based on food diaries 
Table 3.6 shows the relationships between fasting and AUC of gut hormone levels and 
TEI and macronutrient intake based on food diaries. There was a positive correlation 
between fasting PYY and protein (r= 0.812**, p= 0.008). There was a negative 
correlation between the AUC for PYY, PP and GLP-1 and TEI. AUC for ghrelin was 
positively correlated with the TEI but this did not reach significance. Correlation 
between fasting samples of all hormones and TEI also did not reach significance. It was 
observed that there was some sample degradation on storage; repeat testing of 
samples, after being frozen for 2-3 weeks, gave much lower or undetectable values, 
indicating that samples had degraded. This affected analysis of 14 ghrelin samples, 10 
GLP-1 samples, 6 PP samples and 12 PYY samples.  Data from these samples was 
excluded from the analysis.   
Table 3-6 : Correlation coefficients between fasting and AUC for gut hormones, TEI and 






All significance tests were two-tailed (* p<0.01) and values in table are r value 
         
Correlation TFEQ Hunger TFEQ Restraint TFEQ Disinhibition  
TEI 0.122 0.041 0.068 
% CHO 0.052 -0.128 0.020 
% Fat 0.182 0.091 0.208 
% Protein -0.313 -0.111 -0.310 
Fibre -0.170 0.013 -0.025 
Correlation TEI % CHO % Fat % Protein Fibre 
Fasting ghrelin -0.178 -0.403 0.316 0.225 0.092 
AUC ghrelin 0.423 -0.626 0.590 0.002 0.597 
Fasting GLP-1 -0.101 -0.085 0.494 -0.104 -0.306 
AUC GLP-1 -0.205 -0.202 0.508 0.408 -0.275 
Fasting PP -0.081 -0.262 0.288 0.023 -0.068 
AUC PP -0.248 0.336 0.040 -0.302 0.064 
Fasting PYY 0.119 -0.432 0.088    0.812** 0.344 
AUC PYY -0.661 0.034 0.282 -0.208 -0.531 
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 Food cravings, TEI and macronutrient intake  
Table 3.7 represents the relationships between food cravings and TEI and 
macronutrient intake from the recorded food diaries. As can be observed in the table 
there was a correlation between food cravings and TEI and macronutrient intake. CHO 
craving was inversely correlated with TEI, percentage of fat and protein intake but 
these did not reach significance. CHO craving was positively correlated with 
percentage CHO intake, but this did not reach significance. Sweet craving was 
positively correlated with percentage of fat intake but this did not reach significance. 
All food cravings were negatively correlated with percentage of protein intake, but 
these did not reach significance. 
 
Table 3-7 : Correlation coefficients between food cravings, TEI and macronutrient 
intake. 
Correlation TEI % CHO % Fat % Protein Fibre 
Fast food craving  0.113 0.132 -0.056 -0.101 0.022 
Sweet craving 0.081 0.060 0.266 -0.334 -0.100 
 Fat craving -0.188 0.138 0.034 -0.241 -0.412 
 Carbohydrate craving -0.286 -0.138 -0.223 -0.205 -0.091 
Values in table are r values 
 
 Food cravings, fasting and AUC appetite 
Table 3.8 shows the relationships between food cravings and appetite scores from the 
VAS. There was an inverse correlation between AUC for satisfied (r=-0.541**, p= 0.009) 
and fat craving. There was a negative correlation between fasting prospective food 
intake (r=-0.494*, p=0.019) and CHO craving. The AUC satisfied values and fasting 
prospective food intakes were negatively correlated with fasting food craving but 
these did not reach significance. Fasting fullness rating was positively correlated with 
fat craving but this did not reach significance. There was an inverse correlation 
between fasting satisfied and AUC fullness and sweet and CHO craving but these did 
not reach significance. Fasting hunger, fasting satisfied, AUC fullness were inversely 







Table 3-8 : Correlation coefficients between food cravings, fasting and AUC appetite 






Fat craving Carbohydrate 
craving 
Fasting hunger  -0.300 0.021 -0.138 -0.268 
AUC hunger -0.155 0.039 -0.033 0.078 
Fasting satisfied  -0.024 -0.341 -0.077 -0.398 
AUC satisfied -0.283 -0.213 -0.541** -0.204 
Fasting fullness  0.217 0.077 0.235 0.147 
AUC fullness -0.212 -0.274 -0.117 -0.268 
Fasting prospective food 
intake  
-0.303 -0.187 -0.251 -0.494* 
AUC prospective food intake -0.131 0.086 0.093 -0.049 
AUC composite appetite 
score 
-0.077 0.066 0.199 0.183 
All significance tests were two-tailed (*p < 0.05; ** p<0.01) and values in table are r value 
 
 Food cravings and satiety quotient (SQ) 
Table 3.9 presents the relationships between food cravings and SQ from the VAS and 
SQ composite score. As can be seen in the table no significant correlations were found 
between food cravings and SQ scores. 
 
 Table 3-9 : Food cravings and satiety quotient and SQ composite score. 







SQ hunger -0.129 -0.004 0.040 -0.148 
SQ satisfied 0.309 0.351 -0.008 0.245 
SQ fullness -0.066 0.068 -0.113 0.105 
SQ prospective food intake -0.122 -0.260 -0.305 -0.198 
SQ composite appetite score 0.071 0.189 0.112 -0.085 
Values in table are r value 
 
  Food cravings and three factor eating questionnaire subscales 
Table 3.10 represents the correlation between food cravings and TFEQ. There was a 
positive correlation between TFEQ Hunger (r= 0.547*, p=0.010) and fast food cravings. 
TFEQ Disinhibition and TFEQ Restraint were also positively correlated with fast food 
cravings, but these did not reach significance. Moreover, TFEQ Disinhibition and TFEQ 
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Hunger were positively correlated (r=0.470*, p=0.032) and (r=0.628**, p=0.002) 
respectively with sweet cravings. However, TFEQ Restraint did not correlate with 
sweet cravings. TFEQ Hunger was positively correlated with fat cravings but this did 
not reach significance. TFEQ Restraint and TFEQ Disinhibition did not correlate with fat 
craving. TFEQ subscales were positively correlated with CHO craving but these did not 
reach significance. 
 
Table 3-10:  Correlation between food cravings and three factor eating questionnaire 
subscales 
 
 All significance tests were two-tailed (*p < 0.05; **p <0 .01) and values in table are r values 
 
   Food cravings and gut hormones  
Table 3.11 shows the correlation between food cravings and gut hormone 
concentrations. Fasting ghrelin and PYY levels were negatively correlated with all food 
cravings but these did not reach significance. AUC PYY was negatively correlated with 
fat, fast and carbohydrate food craving and positively with sweet cravings but these 
did not reach significance. There was a positive correlation between AUC for GLP-1 and 
fast food, sweet and fat food cravings but these did not reach significance. AUC GLP-1 
did not correlate with CHO craving.  AUC for ghrelin was negatively correlated with fat 
and fasting PP was positively correlated with fat craving but these did not correlate 
with fast food, sweet food and CHO food cravings. AUC for PP was positively correlated 
with fast food and negatively with fat food cravings and did not correlate with sweet 





Correlation TFEQ Hunger TFEQ Restraint TFEQ Disinhibition 
Fast food craving  0.547* 0.375 0.358 
sweet craving 0.628** 0.083 0.470* 
Fat craving 0.267 -0.070 0.182 
CHO craving  0.328 0.429 0.242 
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  Food preferences of participants  
3.3.12.1 Dairy, meat, fish and bread preferences of participants 
Table 3.12 displays the food preferences of participants. As can be seen in the table 
the percentage of participants that dislike dairy was 9% for milk, 4.5% cheese and 23% 
for yoghurt. Moreover, percentages of participants that dislike meat were 14% for beef, 
18% for lamb, 9% for chicken and 28% for bacon. The percentages of participants who 
disliked fish was 14% for tuna fish, 9% for salmon and 28% for cod. Furthermore, the 
percentages of participants who disliked bread was 9% for white bread, 14% for 














CHO craving  
Fasting ghrelin -0.529 -0.665 -0.707 -0.417 
AUC ghrelin 0.178 0.092 -0.203 -0.195 
Fasting GLP-1 0.278 0.256 0.267 -0.014 
AUC GLP-1 0.326 0.276 0.242 0.077 
Fasting PYY -0.361 -0.367 -0.508 -0.441 
AUC PYY -0.260 0.256 -0.272 -0.398 
Fasting PP -0.048 0.119 0.346 -0.010 
AUC PP 0.205 0.006 -0.309 0.160 
95 
 
Table 3-12 : Food preferences of participants 











   
Dairy 
preferences Meat preferences 
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3 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
4 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
5 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✕ ✓ ✓ ✓ ✓ ✓ ✓ 
6 ✓ ✓ ✓ ✓ ✕ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✕ ✓ 
7 ✕ ✕ ✕ ✓ ✓ ✓ ✓ ✓  ✕ ✓ ✕ ✕ ✓ 
8 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
9 ✓ ✓ ✓ ✓ ✓ ✓ ✕ ✕ ✓ ✓ ✓ ✓ ✓ ✕ 
10 ✓ ✓ ✓ ✓ ✓ ✓ ✕ ✓ ✓ ✕ ✓ ✓ ✓ ✕ 
12 ✓ ✓ ✓ ✕ ✕ ✕ ✕ ✓ ✓  ✓ ✓ ✓ ✓ 
13 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
15 ✓ ✓ ✓ ✕ ✕ ✕ ✕ ✕ ✕ ✕ ✓ ✓ ✓ ✓ 
18 ✓ ✓ ✕ ✓ ✓ ✓ ✕ ✓ ✓ ✕ ✓ ✕ ✕ ✓ 
20 ✓ ✓ ✕ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✕   ✓ 
21 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✕ ✕ ✓ 
25 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓  ✕ ✓ 
26 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✕ ✕ ✕ ✓ ✓ ✓ ✓ 
27 ✓ ✓ ✕ ✓ ✕ ✓ ✕ ✓ ✓ ✓ ✕ ✕ ✓ ✓ 
28 ✓ ✓ ✕ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
29 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
31 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✕ ✓ ✓ ✓ 
33 ✕ ✓ ✓ ✕ ✓ ✓ ✓ ✓ ✓ ✕ ✓ ✓ ✓ ✓ 





   Examples of food recipes in the diets provided 
(See appendix 13). 
 Diet allocation  
Table 3.14 presents the allocation of diets for the twenty-two participants based on 
diets they had attempted before. 
 
Table 3-13 : Allocation of diet based on diets tried previously which were unsuccessful. 
PN Type of diet tried before Diet Allocation 
3 low CHO, Low fat 5:2 
4 High protein diet, Atkins, caloric counting 5:2 
5 Caloric counting ,5:2, slimming word increased protein 
6 None increased protein 
7 5:2 NHS 
8 None NHS 
9 None NHS 
10 None 5:2 
12 Caloric counting, weight watch, slimming world increased protein 
13 None increased protein 
15 high protein diet 5:2 
18 None NHS 
21 All types except high protein Increased protein 
20 None 5:2 
25 None 5:2 
26 Caloric counting, weight watch, Slimming World NHS 
27 None 5:2 
28 Slimming World, other NHS 
29 Slimming World., weight watchers, 5,2 increased protein 
31 Slimming World, caloric counting increased protein 
33 Slimming World, Caloric counting NHS 






 Follow up  
Only three participants out of twenty-two adhered to the diet and completed sent 
food diaries after 6 weeks of starting the diet. Of these participants, one followed the 
5:2 diet and one followed the NHS diet. Due to the low sample size, statistical analysis 























The main aim of this study was to familiarise the researcher with the methods and test 
the suitability of the methods to assess satiety phenotypes and design diets for people 
with low satiety for future studies. The aim was also to investigate the relationship 
between subjective appetite sensations, TFEQ subscales, plasma gut hormone levels 
and food cravings and total energy and macronutrient intake. An additional aim was to 
investigate whether a HP diet is an effective weight-loss strategy for individuals with 
reduced satiety compared to other diet strategies.  However, too many participants 
were lost to follow up and therefore the sample size was inadequately powered to 
undertake statistical analysis for the diet part of the study. 
 Baseline characteristics and scores of TEI and macronutrient   
intake based on food diaries and food craving questionnaires of 
participants. 
Recruitment of males was difficult within this study. This is typical of weight loss 
studies; there is previous evidence to show that females predominantly participate in 
weight loss trials. Ahern et al., (2017) recruited 1,267 participants, about 90% of whom 
were females and another study carried out in the UK by Crane, Jeffery and Sherwood 
(2017) included only 18.4% males. This compares reasonably well with the present 
study in which the proportion of males was only 9.09%. 
 Fasting sample and AUC appetite, TEI and macronutrient intake 
3.4.2.1 Fasting sample and AUC of VAS and TEI 
Two previous studies by Doucet et al., (2003) and Drapeau et al., (2007) agree with the 
findings of the present study. Doucet et al., (2003) showed that AUC prospective food 
consumption was significantly correlated with reported 24 hour EI in males. Drapeau et 
al., (2007) reported a strong correlation between AUC desire to eat, and AUC for 
prospective food and TEI, as measured using the food diary. 
3.4.2.2 Fasting and AUC of VAS and macronutrient intake of food diary 
Johnstone et al., (2008) reported that people who had a lower percentage of CHO in 
their diet had higher scores for hunger and prospective food intake using the VAS. This 
finding agrees with the present study that found that people who had higher VAS 
99 
 
scores for fasting prospective food intake consumed a lower percentage of CHO and a 
higher percentage of fat in their diet. Furthermore, people who had higher satisfaction 
scores and fullness scores consumed a higher percentage of protein and fibre in their 
diet.  
 SQ, SQ composite score, TEI and macronutrient intake  
3.4.3.1  SQ and TEI 
The previous finding by Drapeau et al., (2005) carried out with a cohort of 53 
individuals who were overweight and/or had obesity found that SQ fullness scores 
predicted daily EI. Although SQ fullness in the present study did not reach significance 
and the r value of SQ fullness in both studies showed an inverse relationship, indicating 
similar findings.  
3.4.3.2  SQ, composite appetite score and macronutrient intake 
Only one other study in the literature has focused on SQ and macronutrient intake. In 
agreement with the present study, McNeil et al., (2014) studied 102 women and found 
that the SQ predicted the percentage of CHO intake, when measured using food 
diaries.  
 TFEQ subscales, TEI and macronutrient intake  
3.4.4.1 TFEQ subscales and TEI 
In contrast to the results of the current study, where no correlation was found, French 
et al., (2014) reported a strong and significant correlation between TFEQ Hunger, TFEQ 
Disinhibition and TFEQ Restraint and TEI. The potential explanation for the contrasting 
findings could be the larger sample size in the French et al., (2014) study, with 233 
participants. Another explanation could be the statistical tests used to find 
relationships between TEI and TFEQ scales in French et al., (2014). They used multiple 
regression analysis and the present study used Spearman correlation. The Spearmen 
correlation analyses two variables but multiple regression analyses multiple variables, 
which could explain the differences in findings between the studies. Moreover, 
another previous study has observed positive associations between hunger and EI 
(Provencher et al., 2003) in a large study of 244 men and 352 women. They report 
people with chronically high levels of hunger are more susceptible to overeating 
compared with those who do not report being hungry.  
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3.4.4.2  TFEQ subscales and macronutrient intake  
In contrast with the findings of the current study, De Lauzon et al., (2004) observed 
that females with a high cognitive restraint score had a higher proportion of EI derived 
from protein. The possible interpretation of this different finding could be linked to age. 
Lauzon et al., (2004) included teenagers and older adults. Teenagers have different 
eating behaviours and people eat less and make different food choices as they get 
older (Drewnowski and Shultz, 2001) which could explain the differences in findings 
with the current study, where age range was 18-60 years only with two teenagers. 
The findings of the present study are also in contrast with Lindroos et al., (1997) who 
showed no correlation between TFEQ Hunger and daily EI recorded using a food diary 
and the percentage of macronutrients (protein, CHO and fat) in a non-obese group. 
The possible explanation is that Lindroos et al., (1997) included people of all weight 
statuses. It has been suggested that high BMI associates with lower restraint and 
higher disinhibition scores (Stunkard and Messick, 1985). With regards to gender, 
Lindroos et al., (1997) included women and men. Restraint and disinhibition scores 
were higher in women compared to men (Provencher et al., 2003).  
 Fasting and AUC of gut hormone, TEI and macronutrient intake  
3.4.5.1  Fasting and AUC of gut hormone and TEI 
The present study indicated that the fasting sample and AUC of gut hormones were 
not significantly correlated with TEI. This was also observed by Ratliff et al., (2010) in a 
study which included only 21 men with an age range from 20 to 70 years. They also 
found that there was no correlation between macronutrient intake and PYY and GLP-1 
levels in serum.   
3.4.5.2  Fasting and AUC of gut hormone and macronutrient intake based on food 
diaries 
In a study by Kong et al., (2009), plasma ghrelin levels did not correlate with habitual 
macronutrient intake in postmenopausal women. However, they found higher habitual 
intake of dietary fat associated with ghrelin levels. They found a statistically significant 
positive association between percentage intake of saturated fat and ghrelin 
concentrations. The interpretation for this may be the method for measurement of 
macronutrient intake assessment. Kong et al., (2009) used food frequency 
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questionnaires (FFQs) and the present study used 3 day food diary. A possible 
interpretation may be food diary records have revealed relationships not observed in 
the FFQ (Freedman et al., 2006). However, most likely the difference in age of 
participants may account for the difference in findings with Kong et al. having post-
menopausal women in their study, compared to the current study where most women 
participants were premenopausal. 
People who had high scores of AUC PP consumed a higher percentage of CHO and 
lower percentage of protein in their diet and the remainder of fasting sample and AUC 
satiety hormones showed different findings. These samples had low values as a result 
of deterioration on storage and were excluded from the analysis. The researcher 
analysed these samples twice and found the sample had lower values after storage. So 
a higher level of protease inhibitors was added to samples for the remainder of the 
studies in this thesis to mitigate this issue. One of the purposes of the pilot study was 
to ensure robust procedures were in place for the larger studies.  
 Food cravings and TEI and macronutrient intake based on food 
diary records 
3.4.6.1  Food cravings and TEI 
The present study showed that food craving was not significantly correlated with TEI. 
3.4.6.2  Food cravings and macronutrient intake of food diary 
In agreement with the present study findings Chao et al., (2014) found significant 
positive relationships between specific categories of food cravings and habitual intake 
of those foods. Fast food craving was associated with increased CHO in the diet. The 
present study reported that people who crave all food types had a lower percentage of 
protein in their diet.  Sweet cravings were significantly associated with intake of fat 
measured by food diary records in the findings of Chao et al., (2014). These findings 
partially agree with the present study where people who crave sweet food had a 
higher percentage of fat in their diet reported by their food diary. The potential 
explanation for the current study may be age, as participants in Chao et al., (2014) 
were aged between 18-50 years where, average age of the current study was 18-60 
years with only two teenagers. It has confirmed differences in the types of foods 
craved according to age (White et al., 2002).  
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This finding agrees with Martin et al., (2008) who reported that specific food cravings 
were significantly correlated with consumption of corresponding types of foods.  
 Food cravings, fasting and AUC of appetite 
In the present study, people who had higher scores of fasting hunger and prospective 
to eat, crave less CHO and fast food based on food craving questionnaires. People who 
had higher scores of VAS 'satisfied' had less fat craving. This finding agrees with 
Hopkins et al., (2016) who found alterations in the physiological signals arising from 
the fat and CHO content of the meals may underlie the differences in satiety. 
 Food cravings and fasting and AUC hormone 
Only one previous study examined the effect of gut hormones on food cravings. Chao 
et al., (2017) reported that individuals with higher baseline total ghrelin had 
significantly higher food cravings at 6 months. This study, in contrast to the current 
study, indicates that people who had higher scores of fasting ghrelin had less food 
cravings for all subscales. A possible explanation for this difference may be to measure 
change in food craving during 6 months and their correlation with ghrelin. In Chao et 
al., (2017) and the present study only baseline of food craving was assessed. This 
would give different results because appetite at baseline could change with weight loss 
over a long duration. 
  Food cravings, satiety quotient and SQ composite score  
In the current study no significant correlation was found between food cravings and SQ 
and SQ composite appetite score.  
   Design and development of increased protein diet  
In the current study the 30% HP diet was designed for females and males based on 
their food preferences. The design of a HP diet was difficult. One reason for this was 
that it was designed for both sexes with different grams of protein intake. Another 
reason high protein diet from animal sources influences health, so there is a need to 
vary the diet by adding protein from plants. High protein diet was designed based on 
food preference and it would be easier to consider food preferences before the diet is 
designed in future studies. 
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  Follow up diet  
The current study did not follow up the diet with participants. In the present study, 
just three people continued with their diet and completed the food diary sheets. Two 
allocated with the 5:2 diet and one with the NHS diet. There were no participants who 
followed up the HP diet contacted after 6 weeks from starting the diet. Participants 
had less contact for the follow up diet, for this reason, the protocol developed for the 
following study focused on a food diary at baseline in the community to identify 
individuals prior to their participation in a weight management programme, who may 
struggle to lose weight due to impaired satiety. In the current study, some participants 
did not return questionnaires when they came for the trial day. In the present study 
participants did not communicate with the researchers in the follow up diet. 
Participants were contacted by email several times to arrange a meeting to discuss 
their diet but they did not reply. Low follow up made it impossible to undertake 
statistical analysis. To mitigate this effect, the protocol was changed for the remainder 
of the studies to a formal setting (Tier 2 and 3) to avoid this issue with regards to lack 
of follow up. 
  Summary  
The key findings of this chapter are that people who had higher scores on the VAS 
(fasting and AUC prospective food intake) ate more, according to their food diary TEI. 
They had a lower percentage of CHO and had a higher percentage of fat in their diet. 
People who had higher scores for satisfied and fullness had higher percentages of 
protein and fibre in their diet. In the current study, SQ did not correlate with TEI or 
food cravings. However, SQ composite appetite score was positively correlated with 
percentage CHO in food diaries and SQ full was negatively correlated with percentage 
protein intake. TFEQ subscale scores did not correlate with TEI in the present study but 
the results of macronutrient intake indicated that people who had high scores for 
eating behaviour, based on TFEQ subscales, had a lower percentage of protein in their 
diet and had more food cravings.  
 
Plasma gut hormone results showed that fasting samples and AUC of gut hormones 
were not significantly correlated with TEI and people who had higher scores on the 
fasting ghrelin sample and AUC ghrelin had a lower percentage of CHO and higher 
percentage of fat in their diet. Moreover, people who had higher scores of fasting 
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ghrelin had less food cravings for all subscales. The findings of the present study also 
indicated that food craving was not significantly correlated with TEI and people who 
had more food cravings, had a lower percentage of protein in their diet.  In the present 
study, people who had higher scores of fasting hunger and prospective to eat, craved 
less CHO and fast food. 
Based on this preliminary pilot study the protocols were changed for future studies. 
This included: 
• Changing the VAS sheets to a more relevant version  
• Adding a higher concentration of protease inhibitors (Pefabloc) (DPP IV 
inhibitor) to prevent sample degradation 
• Stopping the HP diet. 
• Using only baseline assessments, due to lack of follow up in the pilot study. 
 
  Study strengths and limitations 
This study had both strengths and limitations. The strength of the study was that it has 
developed a method to study the satiety phenotype of individuals to avoid any issue 
that may be faced in the remainder of the studies in this thesis.  The limitations of the 
study were: the small number of participants, lack of follow up on completion and the 
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4 Introduction  
Research surrounding appetite control and satiety in relation to energy balance has 
recently increased substantially, in an attempt to elucidate and aid the battle against 
obesity. Both hunger and satiety play major roles in excessive eating (Beaulieu et al., 
2016). Appetite refers to the desire to fulfil a bodily need and is divided into three 
components: hunger, satiation and satiety (Mattes et al., 2005).  The definition of 
satiety was discussed earlier in Chapter 1. Impairment in appetite control has been 
recognised as an essential contributor to over consumption and weight gain (Blundell 
and Finlayson, 2004; Dalton et al., 2013) with one potential marker of susceptibility to 
over eating and obesity being a weakened satiety response to food (Blundell and 
Gillett, 2001). 
Research examining individual differences in satiety responsiveness has shown that 
people with obesity who report no relationship between their eating behaviour and 
appetite sensations, exhibited a weaker satiety response during a test meal compared 
to people with obesity who reported that their eating behaviour was associated with 
their appetite sensations (Barkeling et al., 2007). Interestingly, people with obesity 
with weak satiety responsiveness had higher scores on the TFEQ subscales of 
disinhibition (TFEQ-D) and hunger (TFEQ-H) compared to controls (Barkeling et al., 
2007), which are eating behaviour traits linked to over consumption and a higher BMI 
(Bryant, King and Blundell, 2008). 
A weaker satiety response is not limited to people with obesity, indeed, Drapeau and 
colleagues identified a “low satiety phenotype” highlighting individual variability in 
satiety responsiveness among both individuals with obesity and normal weight 
individuals (Drapeau et al., 2005; Drapeau et al., 2013). These studies calculated the 
SQ to identify individuals as high or low in satiety responsiveness. A low SQ in response 
to a fixed-energy meal has been shown to be related to greater subsequent ad libitum 
EI, measured under both laboratory and free-living conditions (Dalton et al., 2015).  
When investigating appetite regulation, the most common study design employed is 
the single day preload study, where short-term postprandial effects of an intervention 
are assessed. These studies measure the effects of a fixed nutrient, food or meal 
(termed the ‘preload’) on postprandial appetite-related ratings, such as hunger and 
fullness, and also measure ad libitum food intake from one or more subsequent meals 
(termed the outcome ‘test meal’) from which the participant eats freely (Bertenshaw, 
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Lluch and Yeomans, 2008; Blundell et al., 2010). Several studies used appetite 
sensations and ad libitum test meals to measure EI (Horner, Byrne and King, 2014). 
There are several methods to assess satiety and hunger in laboratory settings such as 
VAS, gut hormones, eating behaviour, test meal, food diary and food craving. All these 
methods have been described in detail in earlier chapters. 
 
  Factors affecting the food intake in laboratory settings 
 Measuring food intake within laboratory settings is challenging, it is important to take 
into account a range of factors that may significantly influence or bias the amount of 
energy consumed until fullness. These include environmental cues within the test 
room such as plate size, choice of utensils, food label information, visual cues that 
could stimulate appetite,  including the smell or sight of food. Every effort should be 
made to keep these factors controlled and constant from one session to the next to 
ensure comparable experimental conditions across trials. Furthermore, it has been 
suggested that consumption within a laboratory environment may not reflect normal 
eating behaviour (Meiselman, 1992). One concern about laboratory based assessment 
of eating is that if participants understand that their intake is being observed this may 
affect how much food is consumed. It is suggested that when participants are directly 
monitored by an experimenter present in the same room, they eat less food than 
when a researcher is not present (Roth et al., 2001). This inhibitory effect of 
monitoring on eating can extend to situations when the experimenter is not in the 
same room, but participants feel as though the experimenter will know how much 
food they have eaten (Polivy et al.,  1986).  
  The ‘low satiety phenotype’ 
The low satiety phenotype reflects weaker appetite sensation responses after a caloric 
load (Dalton et al., 2015). Previous studies have studied the low satiety phenotype; 
Drapeau et al., (2005) demonstrated that appetite sensations measured in response to 
a standardised breakfast test meal represented markers of overall intake. They used 
1h post meal AUC and the SQ as predictors of EI.  
Drapeau et al., (2007) also used VAS (fasting, fullness, desire and prospective) to 
identify low satiety phenotype. In this case, the negative relationship between SQ for 
fullness and TEI was stronger for women. These results indicate that individuals 
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characterised with a low SQ have weaker appetite sensation responses after a meal 
and could be more vulnerable to overeating. These individuals represent the ‘low 
satiety' phenotype. Dalton et al., (2015) also examined SQ to identify low satiety 
phenotype. They found that a low SQ was associated with a greater implicit wanting 
for high fat foods and higher scores on the TFEQ Disinhibition subscale. 
 
 Aims  
The present study was designed to identify a satiety phenotype in individuals. The 
hypothesis was that by measuring VAS (fasting, fullness, desire and prospective), gut 
hormone levels in blood, TFEQ and food craving it is possible to identify people with 
low and high satiety phenotype who would eat low or high EI at an ad libitum test meal, 
as well as EI from a 3 day food diary.  
The aims of the present study were: 
1- To investigate the relationship between VAS, ad libitum lunch and food diary EI.  
2- To investigate the relationship between gut hormone concentrations and ad libitum 
lunch and food diary EI. 
3- To investigate the relationship between the TFEQ-H subscale and ad libitum lunch 
and food diary EI. 
4- To investigate the relationship between food craving and ad libitum lunch and food 
diary EI. 















   Materials and methods  
 Participants and recruitment 
Participants were aged between 18-45 years (mean ± SD 22.55 ± 5.93 years). All 
participants were recruited using posters and word of mouth at SHU, Sheffield, UK. 
Exclusion criteria were any chronic disease such as heart disease, diabetes, 
hypertension or conditions known to affect metabolism. Participants were excluded if 
they disliked or were allergic to the foods used in the study and they were also 
excluded if they took medication that may affect their appetite or if they were 
pregnant or breast feeding. The ethical approval for the study was granted by the 
Faculty of Health and Wellbeing Research Ethics Committee, SHU.  
Study design, study setting, experimental design of the study day, anthropometry, 
questionnaires, test meal, food intake and laboratory methods were performed as 
indicated in the relevant sections in chapter 2. 
Forty seven healthy students initially volunteered for the study. Of those, data is 
presented for forty-five participants (n=19 males, n= 26 females). Two participants 
were excluded from the study due to not providing blood samples (n= 1) and not 









   Figure 4-1 : Representation of the laboratory period of the trial days. VAS= visual analogue 



































Three questionnaires were given to participants to complete on a separate day from 
the day of the laboratory experiment. These were the TFEQ, the FCI and food diaries, 
over 3 days as described in Chapter 2. 
 Statistical analysis 
4.2.3.1  Software 
 All data were analysed using SPSS software version 24.0 (IBM) for Windows (SPSS Inc., 
Chicago, IL, U.S.A.) and Prism version 7.03 (GraphPad Soft-ware Inc.). Nutritics 
software (Libro, Dublin, UK) (version 1.8) was used to calculate percentage of 
macronutrients as well as EI from the completed food diaries. 
4.2.3.2  Data analysis  
Normal correlation was used to assess relationships between independent variables 
and ad libitum pasta and TEI. Independent t-tests were used to assess for any 
differences in sex, age, height, body mass, BMI, TFEQ scores, macronutrient intake and 
food craving scores. Linear regression analysis was used to establish a relationship 
between dependent variables, ad libitum pasta and total energy, measured by food 
diary and independent variables, the predictors such as VAS (fasting hunger, fullness, 
desire to eat and prospective food intake), 30 mins fullness, post breakfast desire to 
eat, AUC of 4 questions and SQ of 4 questions), gut hormone levels and TFEQ Hunger. 
AUC was calculated by using the trapezoidal method (chapter 2).  One way ANOVA was 
used to determine whether there were any statistically significant differences between 
the average BMI and TFEQ subscales of low, medium and high hunger groups. Data are 
represented as mean ± SD, unless otherwise indicated. A p value < 0.05 was considered 
to be statistically significant. Cohen d=0.2 was considered a 'small' effect size, 0.5 
represents a 'medium' effect size and 0.8 a 'large' effect size. 
4.2.3.3  AUC and SQ calculation 
A composite appetite score was calculated by summing AUC scores at individual time 
points. This equation was used to calculate composite appetite score (hunger score+ 
desire score + prospective food intake score + (100-fullness score) (Hill and Blundell, 
1982).  
The SQ was calculated for each appetite sensation at 60 min as described in chapter 2. 
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SQ composite appetite score were a summation of SQ scores at individual time points. 
This equation was also used to calculate SQ composite appetite score (hunger score+ 
desire score + prospective food intake score + (100-fullness score). AUC fasting 
composite appetite score, which was the summation of fasting time individual time 
points, (hunger score+ desire score + prospective food intake score + (100-fullness 
score) (Hill and Blundell, 1982) was used to calculate SQ composite appetite score. 
4.2.3.4  Heat map design 
A heat map was developed to model the satiety phenotype of participants. All 
independent variables (fasting appetite VAS, VAS 30 mins fullness, post breakfast 
prospective food intake, AUC (for 4 questions), AUC composite appetite score, AUC 
fasting  appetite composite score, SQ composite score, fasting ghrelin, PP and GLP-1 
levels, TFEQ-H and BMI. All these independent variables were analysed using linear 
regression and those that were significant and showed the most important predictors 
for ad libitum lunch and total energy of food diary were used to generate the heat 
maps. 
The heat maps were generated by two methods to assess the optimal method. 
 
Method one 
In this method participants were spilt by gender and analysed separately. For each 
variable, participants were ranked in order from low to high values of the variable.  The 
participants were then split into tertiles according to the value of the variable.  Each 
participant was allocated a colour for that variable: i.e. green cells for low scores, 
orange for medium and red for high scores for variables, where a low score was 
associated with satiety e.g. ghrelin, or hunger and a high score associated with hunger 
or low satiety.  For other measures e.g. fullness or PP hormones, high values were 
green and small values red. This process was repeated with each variable so that each 
participant was allocated a colour for each variable and this was used to build a heat 
map for each person. Participants were then determined as low, medium or high 
satiety phenotypes by using the equation = (R*2+O*1), R= red cells and O=orange cells.  
After that the heat map was reordered by ad libitum lunch intake and the same 






In this method, participants were again spilt by gender. In this method participants 
were spilt into three groups based on values of variables taken from the literature 
(Carlson et al., 2009; Chungchunlam et al., 2015; Cummings et al., 2004 Gibbons et al., 
2013; Lemmens et al., 2011). For hormones, ranges were taken from published work, 
split into tertiles and used to determine the 3 groups.  For VAS scores 0-33 mm were 
green, 34-66 mm - orange) and 67-100 mm - red for e.g. hunger. High scores for 
ghrelin (8.06-252 pg/ml) GLP-1 (2.36-141 pg/ml) and PP (5.46-477 pg/ml) cut off levels 
and VAS fullness were green and low scores red. Participants were again allocated a 
colour for each variable and a heat map was built.  After these steps the process was 























 Baseline characteristics of the study participants 
The baseline characteristics of all the subjects are shown in table 4.1. 
 
Table 4-1  : Baseline characteristics of the study participants 
Variables 
All  (n=45)   
Mean ± SD 
Female (n=26) 
Mean ± SD 
Male (n=19) 
Mean ± SD 
t p d 
Age (y) 22.5 ± 5.9 23.9 ±7.5 21± 1.1 2.190 0.037* 0.597 
Height (m) 
171.1 ±  9.3 165.1 ± 6.1 179.1 ± 6.4 -7.692 0.000* 2.262 
Body mass  (Kg) 
70 ± 13.4 65 ± 11.7 77± 12.7 -3.347 0.002* 0.982 
BMI (Kg/m2) 23.9 ± 4.1 23.8± 4.3 24± 3.8 -0.157 0.876 0.049 
TFEQ Hunger  
6 ± 3.4 6.3 ± 3.1 6.3 ± 3.9 -0.104 0.918 0.030 
TFEQ Restraint 
7.11±5.0 8.5 ±4.9 5.30±4.7 2.225 0.031* 0.663 
TFEQ Disinhibition 6.2 ±3.1 7.0±3.2 5.1±2.6 2.204 0.033* 0.664 
Values are mean± standard deviation, n=45, t= t-test and d= Cohen's d.  BMI: body mass index. 
 p < 0.05 for significant differences between males and females. 
 
 Food diary and food craving questionnaires  
Table 4.2, presents the data from the food diary and the food craving inventory for all 
participants, grouped into females and males. There was a significant difference in ad 
libitum lunch intake between males and females. There was a significant difference 
between males and females in total energy, protein (g) and fat (g) intake, measured by 
the food diary and also a difference in CHO craving. Females craved more CHO than 
males. However, no differences were found between the percentage of total energy of 
protein, CHO and fat for females and males. Moreover, there was no significant 
difference in fibre intake and there was no significant relationship between sweet, fast 









Table 4-2:  Food diary scores, ad libitum lunch intake and food craving inventory for 
participants 
Values are mean ± standard deviation, n=45, t= t-test and d= Cohen's d.  BMI: body mass index. p < 
0.05 for the differences between males and females. TEI= Total energy intake and nutrients estimated 
from 3-day food records. g= gram, kcal= kilocalories  
 
 VAS measurements versus time during the test morning 
Figure 4.2 shows VAS measurements versus time for female and male participants.  
There were significant differences in VAS hunger (p=0.047), fullness (p=0.017), and 
prospective food intake (p=0.006) scores between females and males. However, no 
significant difference was found between females and males in VAS desire to eat 
(p=0.251) during the test morning. 
 
 Plasma gut hormone concentrations versus time during the test 
morning 
Figure 4.3 shows there was no significant difference in ghrelin (p=0.608), GLP-1 






Females (n= 26) 
Mean ± SD 
Males (n= 19) 
Mean ± SD 
t p d 
TEI (kcal) 1738.8 ± 672 1532.3 ± 470.9 2007.3±802.2 -2.513 0.016* 0.722 
Food diary-CHO (g) 
(% of TEI) 
204.8 ± 89.6 
46±7.7 
192.5 ± 80.9 
47.1±7.4 








Food diary-Protein (g) 
(% of TEI) 
71.1 ± 30.6 
17.7±4.4 
59.6 ± 16.6 
16.7±3.4 








Fat (g) -Food diary 
(% of TEI) 
62.5 ± 26.5 
31.9±8.4 










Food diary-Fibre (g) 16.5± 8.8 14.91 ± 5.3 18.5 ± 11.8 -1.389 0.172 0.395 
Ad libitum lunch  
 intake (kcal) 
620.7 ± 245.1 551.6 ± 194.4 714.0±278.9 -2.355 0.023* 0.676 
Fast food craving 8.3 ± 3.7 8.2 ± 3 8.31 ± 4.2 -0.102 0.920 0.042 
Sweet craving 10.1 ± 4.6 11.6 ± 4.9 9.1 ± 4.2 1.468 0.154 0.554 
Fat craving 5.6 ± 4.2 5.2 ± 3.8 5.9 ± 4.5 -0.440 0.663 0.171 
Carbohydrate craving 7.4 ± 4.8 9.5 ± 4.2 5.9 ± 4.8 2.085 0.047* 0.806 
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                                            Figure 4-3: Concentration of  plasma hormones (ghrelin (A), GLP-1(B), PP (C) and PYY (D)  for participants versus time during the test morning. 
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 VAS, TFEQs, gut hormones, food cravings and TEI and macronutrient 
intake.  
4.3.5.1  Relationships between VAS (fasting scores and AUC fasting composite appetite 
score) and TEI and macronutrient intake 
Tables 4.3 and 4.4 present fasting scores for VAS and TEI and macronutrient intake as 
measured using the food diaries. The fasting prospective food intake score was positively 
correlated (r=0.505**, p=0.009) with TEI of females. AUC fasting composite was positively 
correlated (r=0.396*, p=0.045) with TEI of females. In males, fasting hunger (r=-0.570*, 
p=0.014), fasting desire to eat (r=-0.478*, p=0.045) and fasting prospective food intake 
(r=-0.551*, p=0.018) were negatively correlated with percentage fat intake, as measured 
by the food diary. AUC fasting composite was negatively correlated with percentage of fat 
but not significantly.  
The data in table 4.3 also shows that in women, all VAS measures correlate with EI 
reported in the food diary, but this effect was not as strong in men.  Also strong 
relationships between fat intake and all VAS scores in both men and women, and men 
who eat more CHO are hungrier.  There was a negative correlation between VAS fasting 
hunger (r= -0.586*, p=0.011) and fat measured by the food diary. 
After adjusting for BMI the correlation remained between VAS fasting, prospective food 
intake and TEI in females (r= 0.505*, p=0.010), AUC fasting composite (r=-0.606*) 
(p=0.010) and TEI of females and, after adjusting for age, the correlation also remained 
between VAS fasting prospective food intake and TEI (r=0.499*, p=0.011) in females and 
between AUC fasting composite (r=-0.528*, p=0.029) and TEI. For males after adjusting 
for age the correlation remained between fasting hunger and percentage fat intake (r=-











Table 4-3: The correlations of fasting and AUC fasting composite appetite score of VAS and TEI 
and macronutrient intake. 
Correlations of primary variables for females and males. All significance tests were two-tailed (*p <0 .05; 
**p < 0.01). 
 
Table 4-4: The correlations of fasting and AUC fasting composite appetite score of VAS 
and macronutrient intake  
 
Female 








AUC fasting  
composite 
appetite score 
% CHO  -0.039 -0.122 -0.072 -0.174 -0.035 
% Protein 0.041 0.225 -0.039 -0.035 -0.075 
% Fat -0.586* -0.402 -0.402 0-402 0-.402 




Fasting desire to 
eat 
Fasting prospective 
food intake AUC fasting  composite appetite score 
Fasting  
Fullness 











AUC fasting  
composite 
appetite score 
% CHO  0.206 0.097 0.213 0.335 0.197 
% Protein -0.266 -0.034 -0.181 -0.040 0.013 
% Fat -0.570* 0.166 -0.478* -.0551* -0.525* 
Fibre (g) .086 0.191 0.034 0.259 0.222 
Correlations of primary variables for females and males. All significance tests were two-tailed (*p <0 .05; 
**p < 0.01). 
Female Fasting hunger Fasting fullness Fasting 







TEI  (kcal) 0.295 -0.272 0.373 0.505** 0.396* 
Male Fasting hunger 
Fasting fullness 





















AUC fasting  
composite 
appetite score 
TEI (kcal) 0.156 -0.047 0.208 0.082 -0.177 
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4.3.5.2  Post-breakfast VAS scores and TEI and macronutrient intake 
Tables 4.5 and 4.6 show post breakfast VAS scores and TEI and macronutrient intake. 
There was a positive correlation between VAS post-breakfast hunger (r= 0.412*, p= 0.037) 
and TEI in females. Whereas, in males there were a negative correlation between VAS 
post-breakfast desire to eat scores (r=-.499*, p=0.035) and VAS post breakfast 
prospective food intake (r=-0.500*) (p=0.035) percentage of fat intake. Moreover, there 
was a negative correlation between prospective food intake (r=-0.556*, p=0.17) and 
percentage CHO in food diary. The data in this table also shows that in women and men 
VAS measures correlate with EI reported in the food diary but these did not reach 
significance. Also, there were strong relationships between fat intake and all VAS scores 
in women and men who eat more CHO are hungrier. 
 
After adjusting for BMI, the correlation remained between VAS post-breakfast hunger (r= 
0.417*, p= 0.038) and TEI in females, after adjusting for age the correlation remained 
between VAS post-breakfast hunger and TEI in females (r= 0.407*, p= 0.043). After 
adjusting for BMI, the correlation remained between VAS post-breakfast desire to eat and 
VAS post-breakfast prospective food intake (r=-0.516*, p=0.034), percentage of fat intake 
(r=0.498*, p=0.042) in males after adjusting for age, the correlation also remained (r=-
0.505*, p=0.039), (r=-0.496*, p=0.043). After adjusting for BMI, the correlation remained 
between VAS post breakfast and post-breakfast prospective food intake (r=-0.575*, 
p=0.20), after adjusting for age the correlation also remained between VAS post-breakfast 
post breakfast prospective food intake (r=-0.570*, p=0.17). 
 






desire to eat 
Post- breakfast 
prospective food intake 






desire to eat 
Post- breakfast 
prospective food intake 
TEI  (kcal) .0124 0.037 -0.034 -0.328 
Correlations (r values) of primary variables for females and males. All significance tests were two-tailed (*p 








Table 4-6: The correlations of VAS post-breakfast and TEI and macronutrient intake 
Correlations of primary variables for females and males. All significance tests were two-tailed (*p < 0.05; 
**p < 0.01).  
 
4.3.5.3  Thirty minute VAS scores and TEI and macronutrient intake 
Tables 4.7 and 4.8 represent the relationship between thirty minute VAS scores and TEI 
and macronutrient intake. As can be observed, there was a positive correlation between 
VAS at 30 min hunger (r=0 .390*, p= 0.049) and VAS 30 min desire to eat (r= 0.536**, p= 
0.005) and TEI in females. In addition, VAS 30 min fullness was negatively correlated (r=-
0.480*, p=0.013) with TEI in females. Whereas, for males the VAS at 30 min fullness rating 
was negatively correlated with TEI and VAS 30 min prospective food intake was positively 
correlated with percentage of CHO intake but these did not reach significance. 
 
After adjusting for BMI, the correlation remained between desire to eat (r= 0.535*, p= 
0.006) and VAS 30 min fullness (r=-0.481*, p=0.015) TEI in females. Moreover, after 
adjusting for age the correlation remained between VAS 30 min desire to eat (r= 0.541*, 






Female Post-breakfast hunger Post-breakfast fullness Post-breakfast 




% CHO 0.118 -0.007 0.168 0.143 
% Protein 0.279 -0.232 0.146 0.211 
% Fat -0.248 -0.080 -0.038 -0.032 
Fibre (g) 0.122 -0.223 0.261 0.279 
Male Post-breakfast hunger Post-breakfast fullness Post-breakfast 




% CHO 0.152 0.014 0.461 0.556* 
% Protein 0.413 0.111 -0. 103 0. 176 
% Fat -0.303 0.168 -0.499* -0.500* 
Fibre (g) -0.491* 0.159 0.251 0.537* 
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Table 4-7: The correlations of VAS 30 min and TEI.  
Correlations of primary variables for females and males. All significance tests were two-tailed (*p < 0.05; **p 
<0 .01). 
 
Table 4-8: The correlations of VAS 30 min visual analogue scale and TEI and macronutrient intake. 
Correlations of primary variables for females and males. All significance tests were two-tailed (*p < 0.05; 
**p <0 .01). 
 
4.3.5.4   AUC hunger, fullness, desire to eat, prospective food intake, composite 
appetite score and TEI and macronutrient intake 
Tables 4.9 and 4.10 show AUC hunger, fullness, desire to eat, AUC prospective food 
intake, composite appetite score and TEI and macronutrient intake. There was a positive 
correlation between AUC desire to eat (r=0.601**, p=0.001) and AUC prospective food 
intake (r= 0.417*, p=0.034) and TEI. Moreover, AUC composite appetite score (r= 0.510**, 
p=0.008) was positively correlated with TEI of females. In males, the only significant 
relationship was between AUC composite of appetite score, which was inversely 
correlated (r=-0.525*, p=0.025) with percentage fat intake.  
Female 30 min hunger 30 min fullness 30 min desire to eat 30 min prospective 
food intake 
TEI (kcal) 0.390* -0.480* 0.536** 0.345 
Male Fasting hunger 
Fasting fullness, 
Fasting desire to eat 
Fasting prospective 
food intake AUC 
fasting  composite 
appetite score 
Fasting fullness 
Fasting desire to eat 
Fasting prospective 
food intake AUC fasting composite appetite score 
Fasting desire to eat Fasting prospective 
food intake 
TEI (kcal) -0.229 -0.291 -0.020 -0.147 
Female 30 min hunger 30 min fullness 30 min desire to eat 30 min prospective food intake 
% CHO -0.065 -0.005 0.005 0.143 
% Protein 0.053 0.135 0.016 0.010 
% Fat -0.155 0.177 -0.210 -0.143 
Fibre (g) 0.029 -0.173 0.241 0.090 
Male 30 min hunger 30 min  fullness 30 min  desire to eat 30 min prospective food intake 
% CHO 0.330 0.045 0.198 0.401 
% Protein 0.265 0.246 0. 255 0.264 
% Fat -0.392 -0.149 -0.284 -0.391 
Fibre (g) 0.141 0.322 -0.032 0.122 
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After adjusting for BMI, the correlation remained significant between AUC composite of 
appetite score (r=0.513*, p=0.009) and TEI, AUC desire and TEI (r=0.607, p=0.001) and 
AUC prospective food intake (r= 0.417*, p=0.038) and TEI in females, after adjusting for 
age, the correlation also remained between AUC prospective food intake (r= 0.430*, 
p=0.030) and TEI, AUC composite of appetite score (r=0.540**, p=0.005) and TEI in 
females. After adjusting for BMI, the correlation also remained between AUC composite 
of appetite score (r=0.513**, p=0.009) and percentage fat intake. 
 
Table 4-9: Correlations between AUC hunger, AUC fullness, desire to eat, AUC prospective food 
intake, AUC composite of appetite score and TEI. 
     Correlations of primary variables for females and males. All significance tests were two-tailed (*p < 0.05; 
**p < 0.01). 
 
Table 4-10: Correlations between AUC hunger, AUC fullness, desire to eat, AUC prospective food 
intake, AUC composite of appetite score and macronutrient intake. 
Correlations of primary variables for females and males.  All significance tests were two-tailed (*p < 0.05; 
**p < 0.01). 
 
 





desire to eat 
AUC prospective 
food intake 
AUC composite  
appetite score 









AUC composite  
appetite score 
TEI (kcal) 0.002 -0.053 -0.028 -0.201 -0.240 
Female AUC 
hunger 
AUC fullness AUC desire to eat AUC prospective 
food intake 
AUC composite  
appetite score 
% CHO  0.090 0.006 0.010 0.038 0.030 
% Protein  -0.006 -0.005 -0.071 -0.056 -0.137 
% Fat  -0.324 0.217 -0.306 -0.444 -0.273 
Fibre (g) -0.315 -0.192 0.334 0.161 0.255 
Male AUC 
hunger 
AUC fullness AUC desire to eat AUC prospective 
food intake 
AUC composite  
appetite score 
% CHO  0.195 0.124 0.063 0.366 0.356 
% Protein  0.276 0.046 0. 297 0.266 -0.040 
% Fat  -0.267 -0.076 -0.274 -0.348 -0.525* 
Fibre (g) 0.360 0.174 -0.051 0.168 0.307 
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4.3.5.5  SQ of VAS (4 questions), SQ composite score, TEI and macronutrient intake 
Tables 4.11 and 4.12 show SQ of VAS for hunger, fullness, desire to eat and prospective 
food intake and TEI and macronutrient intake. No significant correlation was observed 
between SQ of VAS and TEI and macronutrient intake. 
 
Table 4-11:  Correlation between SQ of VAS and TEI. 
  Correlations of primary variables for females and males. All significance tests were two-tailed (*p < 0.05; 
**p <0 .01). 
 














Correlations of primary variables for females and males. All significance tests were two-tailed (*p < 0.05; 
**p <0 .01). 
 
 
Female SQ hunger SQ fullness SQ desire to eat SQ prospective 
food intake 
SQ composite  
appetite score 
TEI (kcal) -0.045 0.192 -0.046 0.195 -0.033 
   Male SQ hunger SQ fullness SQ desire to eat SQ prospective 
food intake 
SQ composite  
appetite score 
TEI (kcal) 0.302 0.146 0.258 0.322 -0.014 
Female SQ hunger SQ fullness SQ desire to eat SQ prospective 
food intake 
SQ composite  
appetite score 
% CHO  -0.024 -0.120 -0.080 -0.294 -0.053 
% Protein  .019 .099 -0.055 -0.042 -0.056 
% Fat  -0.256 0.267 -0.222 -0.060 -0.243 
Fibre (g) 0.331 0.047 0.090 0.664 0.136 
Male SQ hunger SQ fullness SQ desire to eat SQ prospective 
food intake 
SQ composite  
appetite score 
% CHO  -0.100 0.031 0.012 -0.230 -0.100 
% Protein  -.459 -0.112 -0.446 -0.126 -0.201 
% Fat  -0.317 0.234 -0.232 -0.016 -0.275 
Fibre (g) 0.032 -0.210 0.059 -0.423 -0.184 
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4.3.5.6   Subscales of TFEQ (Hunger, Restraint and Disinhibition) and TEI and 
macronutrient intake 
Table 4.13 and 4.14 present data of TFEQ subscales and TEI and macronutrient intake. 
There was no significant correlation between TFEQ Hunger and TFEQ-Disinhibition scores 
and TEI, or macronutrient intake recorded in the food diaries of both females and males. 
However, there was a significant negative correlation between TFEQ Restraint (r=-
0.664**, p=0.003) and percentage fat intake in females. Moreover, TFEQ Restraint was 
negatively correlated (r=0-.445*, p= 0.049) with TEI in males. 
 
After adjusting for BMI, the correlation remained between TFEQ Restraint (r=-0.665**, 
p=0.004) and percentage fat intake in females. After adjusting for age, the correlation 
remained between TFEQ Restraint (r=-0.673**, p=0.003) and percentage fat intake in 
females. After adjusting for BMI, the correlation remained between TFEQ-Restraint (r=-
0.461*, p=0.047) and TEI in males. 





Correlations of primary variables for females and males. All significance tests were two-tailed (*p <0 .05; 
**p < 0.01). 
 
Table 4-14: Relationship between subscales of TFEQ and macronutrient intake of food diary. 
Correlations of primary variables for females and males. All significance tests were two-tailed (*p <0 .05; 
**p < 0.01). 
Female TFEQ Hunger TFEQ Restraint TFEQ Disinhibition  
TEI (kcal) 0.256 -0.140 0.066 
Male TFEQ Hunger TFEQ Restraint TFEQ Disinhibition  
TEI  (kcal) -0.220 -0.445* -0.163 
Female TFEQ Hunger TFEQ Restraint TFEQ Disinhibition  
% CHO 0.193 -0.131 0.069 
% Protein -0.217 0.276 -0.248 
% Fat  -0.022 -0.664** -0.175 
Fibre (g) -0.042 -0.086 0.024 
Male TFEQ Hunger TFEQ Restraint TFEQ Disinhibition  
% CHO 0.088 0.083 -0.084 
% Protein -0.210 0.366 -0.119 
% Fat  0.011 -0.175 0.239 
Fibre (g) -0.408 -0.199 -0.277 
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4.3.5.7  Fasting gut hormones and AUC hormones and TEI and macronutrient intake 
Tables 4.15 and 4.16 display fasting gut hormone concentrations, AUC of hormones and 
TEI and macronutrient intake. There was a negative correlation between fasting levels of 
PYY (r= -0.854**, p=0.007) and AUC PYY (r=-0.933**, p=0.007) and TEI. Moreover, AUC 
ghrelin was inversely correlated (r=-0.440*, p=0.024) with fibre intake in females. 
However, all fasting gut hormones and AUC PP and AUC GLP-1 showed no significant 
correlation with macronutrient intake in females. There was a negative correlation 
between fasting PP hormone and TEI (r=-0.467*, p=0.038) and fasting ghrelin was 
negatively correlated (r=-0.651**, p=0.003) with percentage protein intake in males. AUC 
GLP-1 showed a positive correlation with percentage fat intake in males (r=0.579*, 
p=0.012). Some of the samples for PPY measurement were missed and for this reason it 
was not included in the regression model. 
 
After adjusting for BMI, the correlation remained between AUC ghrelin (r=-0.422*, 
p=.036) and fibre intake in females and fasting PP hormone (r=-0.490*) (p=0.033) and TEI. 
After adjusting for BMI, correlation between fasting ghrelin and protein (r=-0.641*, 
p=0.006), and AUC GLP-1 and % fat intake (r=0.561*, p=0.019) remained. After adjusting 
for age, the correlation remained between AUC ghrelin and fibre (r=-0.576*, p=0.003) 
fasting ghrelin and percentage protein intake (r=-0.652*, p=0.005) in males. After 
adjusting for age, the correlation remained between fasting PP hormone and TEI (r=-
0.471*, p=0.042). AUC GLP-1 (r=0.593*, p= 0.012) and percentage fat intake in males. 
           
                   
Table 4-15:  Correlation between fasting hormones and AUC hormones and TEI 
 Correlations of primary variables among females and males. All significance tests were two-tailed (*p <0 .05; 





































TEI (kcal) -0.467* 0.115 -0.228 0.338 -0.225 -0.039 -0.319 0.379 
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Table 4-16:  Correlation between fasting hormones and AUC hormones and total energy 






















two-tailed (*p <0 .05; **p < 0.01). 
 
4.3.5.8  Food cravings and TEI and macronutrient intake 
Tables 4.17 and 4.18 show data for food cravings and total energy and macronutrient 
intake. There was a correlation between food craving scores and TEI and macronutrient 
intake but these did not reach to significance in females. Whereas, there was a strong 
negative correlation between fast food cravings (r=-0.802**, p=0.005) and TEI in males. 
Moreover, sweet food craving was positively correlated (r=0.651**, p=0.006) with protein 
intake.  
 
After adjusting for BMI, the correlation remained between fast food cravings and TEI (r= -
0.785*) (p=0.001), sweet food cravings (r=0.630*, p=0.012) and protein intake and fast 
food cravings (r=-0.803**, p=0.000) and fibre intake. In males moreover, after adjusting 
for age, the correlation remained strong between fast food cravings and TEI (r=-0.833**, 





















% CHO -0.269 0.067 0.036 -0.435 -0.236 -0.256 -0.004 -0.342 
 % Protein 0.325 0.024 0.233 0.039 0.331 -0.164 0.343 0.097 
% Fat  -0.039 -0.225 -0.161 -0.041 0.014 -0.105 -0.107 0.089 
















% CHO -0.041 -0.257 0.524 -0.035 0.190 -0.328 0.507 -.099 
 % Protein 0.375 0.331 -0.466 -0.651** -0.062 -0.072 -0.467 -0.455 
% Fat  0.209 0.481 0.162 -0.014 -0.252 0.579* -0.243 -0.058 
Fibre (g) -0.371 0.166 -0.331 0.312 -0.057 -0.092 0.023 0.189 
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Table 4-17: Correlation between food craving and TEI.  
Female Fast food 
craving 
Sweet craving Fat food craving CHO craving 
TEI (kcal) 0.407 0.410 -0.256 0.146 
Male Fast food 
craving 
Sweet craving Fat food craving CHO craving 
TEI (kcal) -0.802** -0.468 -0.248 -0.475 
Correlations of primary variables for females and males. All significance tests were two-tailed (*p < 0.05; 
**p <0 .01). 
 
Table 4-18:  Correlation between food craving and macronutrient intake. 
Female Fast food 
craving 
Sweet craving Fat food craving CHO craving 
% CHO  -0.060 -0.137 -0.008 0.149 
% Protein  -0.349 -0.231 0.139 -0.076 
% Fat  -0.302 -0.143 -0.337 -0.086 
Fibre (g) .384 -.241 -.171 .543 
Male Fast food 
craving 
Sweet craving Fat food craving CHO craving 
% CHO  -0.405 -0.005 -0.202 -0.072 
% Protein  -0.274 0.651** 0.047 0.075 
% Fat  0.352 0.028 0.221 0.178 
Fibre (g) -0.293 0.027 -0.096 -0.065 
Correlations of primary variables for females and males. All significance tests were two-tailed (*p < 0.05; 
**p <0 .01). 
 
  VAS, TFEQ, gut hormones and ad libitum lunch intake 
4.3.6.1 Relationships between fasting and AUC fasting and ad libitum lunch intake 
Figure 4.4 presents fasting and AUC fasting VAS scores and ad libitum lunch intake. There 
was a positive correlation between VAS fasting hunger (r=0.400*, p=0.042) and ad libitum 
lunch intake in females. However, there were no significant correlations between VAS 
fasting fullness, desire to eat and prospective food intake and ad libitum lunch intake in 




After adjusting for BMI, the correlation remained between VAS fasting hunger (r=0.440*, 
p=0.013) and ad libitum lunch intake in females. However, after adjusting for age there 
was no correlation between VAS fasting hunger (r=.385*, p=0.058) and ad libitum lunch 












































) Female  r=-0.239 P=0.239
Male r= -0.065 p=0.790



























Female  r=0.295 P=0.144
Male r= 0.090 p=0.715

































  Figure 4-4 : VAS fasting and AUC fasting scores and ad libitum lunch intake (kcal) scores for females and males (A= VAS fasting hunger,  
B= VAS fasting fullness, C= VAS fasting desire to eat and D=VAS fasting prospective food intake)  
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4.3.6.2   Post-breakfast results of VAS appetite scale and ad libitum lunch intake 
Figure 4.5 displays the post-breakfast VAS measurement and ad libitum lunch intake. 
As can be seen VAS post-breakfast hunger (r=0.536**, p=0.005) and VAS post-
breakfast prospective food intake (r=0.494*, p=0.010) were positively correlated with 
ad libitum lunch intake in females. Whereas, VAS post-breakfast fullness was 
negatively correlated (r=-0.446*, p=0.022) with ad libitum pasta intake in females. 
However, post-breakfast desire to eat was correlated with ad libitum pasta intake in 
females but did not reach significance. There was a positive correlation between post-
breakfast hunger, fullness, desire to eat and prospective food intake and ad libitum 
lunch intake in males, but these did not reach significance. 
 
After adjusting for BMI, the correlation remained between VAS post-breakfast hunger 
(r=0.536*, p=0.006), VAS post-breakfast prospective food intake (r=0.496*, p= 0.012) 
and VAS post breakfast fullness (r=0-.445*, p= 0.026) and ad libitum lunch intake in 
females. After adjusting for age the correlation remained between VAS post-breakfast 
hunger (r=0.532*, p=0.006), VAS post-breakfast prospective food intake (r=-.510**, p= 

















































Male r= -0.415 p=0.077


























































 Figure 4-5: The relationship of VAS post-breakfast scores and Ad libitum lunch intake (kcal) scores for females and males (A= VAS post breakfast 
 hunger, B=VAS post breakfast fullness, C= VAS post breakfast desire to eat and D=VAS post breakfast prospective food intake)  
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4.3.6.3   Thirty-minute VAS and ad libitum lunch intake 
Figure 4.6 represents thirty-minute VAS scores and ad libitum lunch intake. As can be 
seen there was a positive correlation between VAS 30 min prospective food intake 
(r=0.443**, p=0.023) and ad libitum lunch intake in females. However, VAS 30 min 
hunger, fullness and desire to eat were not significantly correlated with ad libitum 
lunch intake in females. In males, VAS 30 min prospective food intake was positively 
correlated with ad libitum lunch intake (r=0.493*, p=0.032). However, there was no 
significant correlation between VAS 30 min hunger, fullness and desire and ad libitum 
lunch intake. 
 
After adjusting for BMI, the correlation remained between VAS 30 min prospective 
food intake (r=0.452*, p=0.023) and ad libitum lunch intake in females. Moreover, 
after adjusting for age the correlation remained between VAS 30 mins prospective 
food intake (r=0.452*, p=0.023) and ad libitum lunch intake in females. After adjusting 
for BMI, the correlation remained between VAS 30 mins prospective food intake 
(r=0.588*, p=0.010) and ad libitum lunch intake in males. Moreover, after adjusting for 
age the correlation remained between VAS 30 min prospective food intake (r=0.494*, 
p=0.037) and ad libitum lunch intake in males. 
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Female  r=0.314 P=0.119
Male r=0.347- p=0.145


















) Female  r=-0.384 P=0.053
Male r=-0.002 p=0.992




















) Female  r=0.333 P=0.095
Male r=0.358 p=0.133






























                      Figure 4-6 : The relationship of 30 min scores  of  four questions of VAS and Ad libitum lunch intake  (kcal) scores for females and males  
                                    (A= VAS 30 min hunger, B=VAS 30 min fullness, C=VAS 30 min desire to eat and D= VAS 30 min prospective food intake) 
134 
 
4.3.6.4 AUC hunger, fullness, desire to eat, prospective food intake, composite 
appetite score and fasting composite appetite score and ad libitum lunch 
intake 
Figure 4.7 presents scores of AUC from VAS appetite ratings and ad libitum lunch 
intake. There was a positive correlation between AUC hunger (r= 0.460*, p= 0.017) and 
ad libitum lunch intake in females. Moreover, AUC prospective food intake (r= 
0.0415*, p=0.035) were positively correlated with ad libitum lunch intake in females. 
However, AUC desire to eat, composite appetite score and fasting composite of 
appetite score were correlated with ad libitum lunch intake in females but these did 
not reach significance. AUC fullness was negatively correlated (r= -0.495*, p= 0.010) 
with and ad libitum pasta intake in females. Whereas, in males there was a correlation 
between AUC of all VAS appetite scores and ad libitum lunch intake, but these did not 
reach significance. 
 
After adjusting for BMI, the correlation remained between AUC hunger (r= 0.477*, p= 
0.016), AUC prospective food intake (r=0.429*, p=.032) and AUC fullness (r= -0.594*, 
p= 0.012) and ad libitum lunch intake in females. Furthermore, after adjusting for age, 
the correlation remained between AUC hunger (r= 0.562*, p= 0.020), AUC fullness (r= -
0.599*, p= 0.011), AUC prospective food intake (r=0.432*, p=0.031) and ad libitum 





















Female  r=0.460 P=0.017*
Male r=  0.266 p=0.270



















Female  r= -0.495 P=0.010*
Male r=-0.261 p=0.280

























































             Figure 4-7: The relationship of AUC hunger, fullness, desire to eat and prospective food intake and ad libitum lunch intake 











































Female  r=0.353 P=0.076
Male r=0.251 p=0.2997






































Female  r= 0.347 P=0.082
Male r=0.165 p=0.500
E F
                                   
                         Figure 4-7: The relationship of  AUC  composite of appetite score and  fasting composite of appetite score and ad libitum lunch intake (kcal)scores 
for females and   males (E=AUC composite appetite score and F=AUC fating composite score) (continued) 
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4.3.6.5  SQ for all questions (hunger, fullness, desire to eat and prospective food 
intake) and SQ composite and ad libitum lunch intake 
There were no significant correlations between SQ and (hunger, fullness, desire to eat 
and prospective food intake) and SQ composite and ad libitum lunch intake.    
4.3.6.6  Subscales of TFEQ (hunger, cognitive restraint and disinhibition) and ad 
libitum lunch intake 
Figure 4.8 represents TFEQ subscales and ad libitum lunch intake. As can be observed 
in the figure there was no significant correlation between TFEQ Hunger, TFEQ Restraint 
and TFEQ Disinhibition and ad libitum lunch intake. 
4.3.6.7  The fasting gut hormones and AUC hormones and ad libitum lunch intake 
Figure 4.9 shows the fasting gut hormone levels and AUC of gut hormones and ad 
libitum lunch intake. There was no significant correlation between fasting and AUC of 
gut hormones and ad libitum lunch intake in females and males. 
4.3.6.8  Food cravings and ad libitum lunch intake 
Figure 4.10 represents food craving (fast, sweet, fat and CHO) and ad libitum lunch 
intake. No significant correlation was found between fast food cravings and ad libitum 
lunch intake in both females and males
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F e m a le  r = 0 .0 6 1  p = 0 . 7 7 1
M a le  r = 0 .0 3 9 p = 0 . 8 7 4


















F e m a le  r = - 0 .2 7 1  p = 0 . 1 8 9
M a le  r = 0 .4 0 7 p = 0 . 0 8 4
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                           Figure 4-8: The relationship between TFEQ subscales and ad libitum lunch intake (A= TFEQ restraint, B=TFEQ Disinhibition and C= TFEQ hunger).    
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female  r=-0.173 P=0.396
Male r= -0.138 p=0.572

















l) Female r=-0.021 p=0.919
Male r=-0.003 p=0.992








































Figure 4-9: The relationship between fasting gut hormones and ad libitum lunch intake scores for females and males (A= fasting PP, B= fasting 










































) Female r=-0.147 p=0.473
Male r= -0.295 p=0.221






















Male r= 0.059 p=0.807





















Figure 4-9: The relationship between AUC gut hormones and ad libitum lunch intake scores for females and 
 males (E = AUC PP, F=AUC ghrelin, G= fasting GLP-1 and H= fasting PYY) (continued) 
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Female r= -0.520  p=0.099
Male r=-0.365 p=0.164















Female r= -0.441 p=0.174
Male r=-0.321 p=0.226






































 Figure 4-10: The relationship between food cravings and ad libitum lunch intake (A= fast food craving, B= Sweet craving, C= fat   
craving and D= CHO craving).
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  Models for baseline of variables, as predictors to identify 
individual satiety phenotypes. 
4.3.7.1 TEI model 
Table 4.19 presents the regression model of all independent variables that have the 
largest correlations for females based on TEI from the food diary. Table 4.20 presents 
the regression model of all independent variables that have the largest correlations for 
males based on energy food diary intake. Independent variables in both tables were 
chosen based on significant and non-significant correlation with TEI from the food 
diary. 
 
Table 4-19: Regression model identifying predictors (VAS appetite scores at different time 
points, gut hormones) of energy food diary intake in females 

















   
 
  Coefficients 
Independent variable Beta ± SE t p 
AUC composite appetite score -2.20±0.44 -13.52 0.04 
VAS fasting prospective food intake 2.29±4.19 12.93 0.05 
AUC desire to eat 2.32±1.65 10.74 0.06 
Fasting PP -0.70±0.48 -6.85 0.09 
VAS post breakfast desire to eat 0.40±0.93 6.58 0.10 
AUC prospective food intake -1.68±2.21 -6.359 0.10 
VAS fasting desire to eat -2.53±7.85 -5.15 0.12 
VAS fasting fullness 0.94±4.16 4.46 0.14 
VAS fasting hunger 1.67±9.16 3.23 0.19 
Fasting GLP-1 0.89±15.61 3.22 0.19 
Fasting ghrelin 0.33±0.69 3.13 0.20 
VAS30 min fullness -0.99±8.23 -2.32 0.26 
TFEQ-H  0.15±11.65 2.29 0.26 
AUC Fasting composite appetite score 2.55± 3.95 1.230 0.29 
SQ composite score 0.36± 3.74 1.89 0.31 
AUC fullness 0.14±1.61 0.61 0.65 
AUC huger 0.12±0.36 0.485 0.712 
BMI 0.11±14.29 0.34 0.75 
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Table 4-20: Regression model identifying predictors (VAS appetite scores at different time 








































Independent variable Beta ± SE t p 
AUC fullness 1.59±31.55 0.96 0.51 
TFEQ-H 0.83±204.34 0.79 0.57 
VAS fasting fullness -1.392±87.412 -0.77 0.58 
BMI 0.18±39.19 0.47 0.67 
VAS fasting hunger -2.32±140.19 -0.54 0.68 
Fasting PP -0.42±13.47 -0.53 0.692 
AUC composite appetite score 0.95±16.59 0.41 0.75 
Fasting GLP-1 0.52±304.49 0.41 0.75 
AUC prospective food intake -0.61±33.05 -0.41 0.75 
VAS 30 min fullness -0.67±83.45 -0.39 0.76 
VAS post breakfast desire to eat 0.32±46.23 0.35 0.79 
VAS fasting prospective food intake 0.70±119.83 0.32 0.80 
VAS fasting desire to eat 0.73±87.17 0.29 0.82 
Fasting ghrelin -0.27±18.47 -0.27 0.83 
SQ composite score 0.69±142.83 0.21 0.87 
AUC huger -0.21±35.92 -0.14 0.91 
AUC desire to eat 0.12±39.47 0.08 0.95 
AUC Fasting composite appetite score 0.04±10.70 0.02 0.99 
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4.3.7.2   Ad libitum lunch intake model 
Table 4.21 presents the regression model of independent variables that have the 
largest correlations for females, based on ad libitum lunch intake. Table 4.22 presents 
the regression model of independent variables that have the largest correlations for 
males, based on ad libitum lunch intake. Independent variables in both tables were 
chosen based on significant and non-significant correlation with ad libitum lunch 
intake. 
 
Table 4-21: Regression model identifying predictors (VAS appetite scores at different time 























Independent variable Beta ± SE t p 
AUC prospective  food intake -4.37±3.09 -4.73 0.01 
VAS fasting hunger 4.15±6.63 4.28 0.02 
VAS fasting prospective food intake 2.37±5.79 3.61 0.03 
Fasting GLP-1 0.77±1.44 3.55 0.04 
AUC hunger 1.19±0.23 3.11 0.05 
SQ composite score -1.74±5.43 -2.55 0.08 
TFEQ hunger -0.49±13.24 -2.52 0.09 
VAS fasting desire to eat -2.45±6.38 -2.36 0.10 
AUC composite score 1.29±.59 2.20 0.12 
AUC desire to eat 1.25±2.19 1.72 0.18 
AUC Fasting composite appetite score 2.55±3.95 1.23 0.29 
VAS30 mins fullness 1.11±7.95 1.08 0.36 
VAS fasting fullness 0.61±4.20 1.01 0.39 
Fasting PP -0.28±0.53 -0.99 0.39 
AUC fullness -0.34±1.85 -0.52 0.64 
Fasting ghrelin 0.07±0.51 0.37 0.74 
BMI 0.11±14.29 0.34 0.75 
VAS post breakfast desire to eat 0.03±1.26 0.16 0.88 
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Table 4-22: Regression model identifying predictors (VAS appetite at different time points, gut   


















Independent variable Beta ± SE t P 
AUC hunger -2.02±6.15 -2.71 0.22 
VAS fasting prospective food intake 2.52±17.92 2.73 0.22 
TFEQ-H 1.54±40.58 2.61 0.23 
Fasting GLP-1 1.59±64.91 2.08 0.28 
VAS fasting fullness -1.43±12.33 -1.98 0.30 
VAS fasting desire to eat -1.84±12.63 -1.79 0.33 
AUC composite of appetite score 1.68±2.76 1.55 0.36 
AUC fullness 1.04±4.72 1.48 0.38 
VAS 30 min fullness 0.96±11.86 1.41 0.39 
VAS post breakfast desire to eat 0.4±6.64 1.15 0.45 
AUC desire to eat 0.81±6.19 1.13 0.46 
VAS fasting hunger -2.14±23.65 -1.04 0.49 
SQ composite of appetite score 1.37±27.26 0.76 0.59 
BMI 0.57±62.08 0.64   0.59 
Fasting ghrelin 0.25±2.68 0.60 0.66 
AUC Fasting composite of appetite score -0.94±9.86 -0.40 0.73 
Fasting PP -0.09±1.95 -0.27 0.83 
AUC prospective to food intake 0.14±4.89 0.22 0.86 
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  TEI, ad libitum lunch intake based on food diaries and 
independent variables that identify individual satiety phenotypes. 
4.3.8.1  Ad libitum lunch intake 
Table 4.23 presents the heat map of ad libitum lunch intake and independent variables 
that have the largest correlations from the regression model for females. Participants 
were determined as low, medium or high satiety phenotype based on the colour 
coding as previously described. Satiety scores were calculated from this equation = 
(R*2+O*1). Participants were divided into 3 groups being low, medium and high satiety 
by using method one. The lowest score of satiety from the equation was 2 and the 
highest was 13. The first group had high satiety scores from 2-9, 10-11 scores were 
medium satiety and 12-13 scores was low satiety.  
   
Table 4.24 presents the heat map of ad libitum lunch intake and independent variables 
that have the largest correlations from the regression model for males. Participants 
were determined as low, medium or high satiety phenotype with the colour coding as 
previously described. Satiety scores were calculated as in Table 4.15.  
 
Table 4.25 displays the heat map of ad libitum lunch intake and all independent 
variables that that have the largest correlations from the regression model. Females 
were determined as low, medium or high satiety phenotype the colour coding as 
previously described. Satiety scores were calculated from this equation = (R*2+O*1). 
Participants were divided into 3 groups being low, medium and high satiety by using 
method two. Satiety scores were from 2-15, with the first group with high satiety 
scores from 2-6, 7-11 scores medium satiety and 12-15 was low satiety. 
 
Table 4.26 presents the heat map of ad libitum lunch intake and all independent 
variables for males according to satiety scores. Males were determined as low, 
medium or high satiety phenotype and the colour coding was as previously described. 






Table 4-23: Heat map of satiety phenotype of females based on ad libitum pasta intake in 



























































































































































N22 356         2 High satiety 
N30 362         4 High satiety 
N17 381         5 High satiety 
nut22 400         6 High satiety 
nut12 405         6 High satiety 
nut30 413         6 High satiety 
nut33 423         5 High satiety 
nut24 432         10 Medium satiety 
nut14 435         9 Medium satiety 
N8 445         7 Medium satiety 
N10 455         12 Low satiety 
nut10 455         12 Low satiety 
nut15 482         11 Low satiety 
N9 483         9 Medium satiety 
N12 500         11 Low satiety 
N35 530         4 High satiety 
N5 535         4 High satiety 
nut21 639         6 High satiety 
N13 691         11 Low satiety 
N4 744         10 Medium satiety 
nut17 748         4 High satiety 
N24 750         7 Medium satiety 
N3 769         8 Medium satiny 
nut7 796         10 Medium satiny 
N2 807         11 Low satiety 
N14 1147         9 Medium satiety 






Table 4-24: Heat map of satiety phenotype of males based on ad libitum pasta intake in                               

































































































































































nut19 431                 10 Low satiety 
N26 440                 6 High satiety 
nut31 467                 5 High satiety 
nut18 471                 11 Low satiety 
N21 482                 11 Low satiety 
nut34 493                 9 Medium satiety 
nut3 521                 5 High satiety 
nut32 576                 7 Medium satiety 
nut1 602                 8 Medium satiety 
nut5 650                 7 Medium satiety 
nut36 692                 13 Low satiety 
nut27 776                 9 Medium satiety 
nut2 898                 6 High satiety 
N11 913                 11 Low satiety 
nut6 999                 10 Low satiety 
nut35 1000                 10 Low satiety 
nut11 1012                 6 High satiety 
nut16 1249                 9 Medium satiety 









Table 4-25: Heat map of satiety phenotype of females based on ad libitum pasta intake in 

















































































































































N22 356                 13 Low satiety 
N30 362                 3 High satiety 
N17 381                 13 Low satiety 
nut22 400                 10 Medium hunger 
nut12 405                 9 Medium hunger 
nut30 413                 2 High satiety 
nut33 423                 9 Medium satiety 
nut24 432                 11 Medium satiety 
nut14 435                 10 Medium satiety 
N8 445                 3 High satiety 
N10 455                 6 High satiety 
nut10 455                 12 Low satiety 
nut15 482                 13 Low satiety 
N9 483                 13 Low satiety  
N12 500                 12 Low satiety 
N35 530                 10 Medium satiety 
N5 535                 11 Medium satiety 
nut21 639                 11 Medium satiety 
N13 691                13 Low satiety 
N4 744                 12 Low satiety 
nut17 748                 10 Medium satiety 
N24 750                 11 Medium satiety 
N3 769                 7 Medium satiety 
nut7 796                 8 Medium satiety 
N2 807                 11 Medium satiety 




Table 4-26:  Heat map of satiety phenotype of males based on ad libitum pasta intake in males 
























































































































































nut19 431                 10 Medium satiety 
N26 440                 6 High satiety 
nut31 467                 5 High satiety 
nut18 471                 12 Low satiety 
N21 482                 12 Low satiety 
nut34 493                 11 Medium satiety 
nut3 521                 2 High satiety 
nut32 576                 8 Medium satiety 
nut1 602                 6 High satiety 
nut5 650                 8 Medium satiety 
nut36 692                 14 Low satiety 
nut27 776                 8 Medium satiety 
nut2 898                 6 High satiety 
N11 913                 9 Medium satiety 
nut6 999                 13 Low satiety 
nut35 1000                 15 Low satiety 
nut11 1012                 9 Medium satiety 
nut16 1249                 9 Medium satiety 







4.3.8.2  Energy intake food diary 
Table 4.27 displays the heat map of all scores of TEI and all independent variables that 
have the largest correlations from the regression model. Females were determined as 
low, medium or high satiety phenotype, with the colour coding as previously described. 
Satiety scores were calculated from this equation = (R*2+O*1). Participants were 
divided into 3 groups, being low, medium and high satiety by using method one. The 
lowest score of satiety from the equation was 2 and the highest was 13. The first group 
with high satiety scores from 2-9, 10-11 scores were medium and 12-13 scores who 
low satiety. 
 
Table 4.28 shows all scores of TEI and all independent variables that have the largest 
correlations from the regression model. Males were determined as low, medium or 
high satiety phenotype with the colour coding as previously described. Satiety scores 
were calculated as in Table 4.27.  
 
Table 4.29 displays all scores of TEI and all independent variables that have the largest 
correlations from the regression model. Females were determined as low, medium or 
high satiety phenotype with the colour coding as previously described. Satiety scores 
were calculated from this equation = (R*2+O*1). Participants were divided into 3 
groups being low, medium and high satiety by using method two, with satiety scores 
from 2-14. The first group with high satiety scores from 2-5, 6-9 scores medium and 
10-14 low satiety. 
 
Tables 4.30 presents all scores of TEI and all independent variables that have the 
largest correlations from the regression model. Males were determined as low, 
medium or high satiety phenotype, with the colour coding as previously described. 









       
Table 4-27: Heat map of satiety phenotype of females based on TEI and independent variables 




















































































































































nut 24 432                 10 Medium satiety 
nut7 651                 4 High satiety 
N30 836                 4 High satiety 
nut14 1021                 7 High satiety 
nut21 1134                 8 Medium satiety 
nut12 1136                 9 Medium satiety 
N24 1155                 6 High satiety 
N17 1196                 9 Medium satiety 
N3 1248                 3 High satiety 
N22 1271                 7 High satiety 
nut30 1345                 5 High satiety 
N8 1416                 4 High satiety 
nut15 1453                 10 Medium satiety 
nut17 1585                 8 Medium satiety 
N5 1625                 4 High satiety 
N2 1631                 11 Low satiety 
nut10 1650                 12 Low satiety 
N10 1703                 5 High satiety 
N12 1717                 10 Medium satiety 
N13 1737           
 
    10 Medium satiety 
N35 2001                 7 High satiety 
nut22 2006                 9 Medium satiety 
N4 2074                 11 Low satiety 
nut33 2146                 7 High satiety 
N9 2331                 12 Low satiety 
N14 2629                 9 Medium satiety 
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Table 4-28: Heat map of satiety phenotype of males based on TEI and independent variables 





















































































































































nut16 1052                 9 medium satiety 
N11 1142                 9 medium satiety 
nut31 1480                 3 high satiety 
nut1 1511                 5 high satiety 
nut5 1561                 8 medium satiety 
N26 1584                 4 high satiety 
nut19 1613                 9 medium satiety 
nut18 1658                 12 low satiety 
nut27 1689                 8 medium satiety 
nut3 1706                 4 high satiety 
nut32 1754                 7 high satiety 
nut20 1890                 7 high satiety 
nut36 1907                 14 low satiety 
N21 2532.3                 12 low satiety 
nut2 2646                 7 high satiety 
nut35 2886                 12 low satiety 
nut34 3022                 11 medium satiety 
nut6 3458                 12 low satiety 











                                  Table 4-29: Heat map of satiety phenotype of females based on TEI and independent variables 














































































































































nut24 432                 9 Medium satiety 
nut7 651                 8 Medium satiety 
N30 836                 3 High satiety 
nut14 1021                 9 Medium satiety 
nut21 1134                 11 Low satiety 
nut12 1136                 9 Medium satiety 
N24 1155                 11 Low satiety 
N17 1196                 13 Low   satiety 
N3 1248                 6 Medium satiety 
N22 1271                 13 Low satiety 
nut30 1345                 2 High satiety 
N8 1416                 2 High satiety 
nut15 1453                 11 Low satiety 
nut17 1585                 10 Low satiety 
N5 1625                 9 Medium satiety 
N2 1631                 12 Low satiety 
nut10 1650                 12 Low satiety 
N10 1703                 7 Medium satiety 
N12 1717                 12 Low satiety 
N13 1737                13 Low satiety 
N35 2001                 11 Low satiety 
nut22 2006                 10 Low satiety 
N4 2074                 13 Low satiety 
nut33 2146                 9 Medium satiety 
N9 2331                 13 Low satiety 
N14 2629                 12 Low satiety 
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   Table 4-30:  Heat map of satiety phenotype of males based on TEI and independent variables by 










































































































































nut16 1052                 8 Medium satiety 
N11 1142                 10 Low satiety 
nut31 1480                 5 High satiety 
nut1 1511                 7 Medium satiety 
nut5 1561                 8 Medium satiety 
N26 1584                 6 Medium satiety 
nut19 1613                 10 Low satiety 
nut18 1658                 13 Low satiety 
nut27 1689                 10 Low satiety 
nut3 1706                 2 High satiety 
nut32 1754                 7 Medium satiety 
nut20 1890                 10 Low satiety 
nut36 1907                 14 Low satiety 
N21 2532                 13 Low satiety 
nut2 2646                 5 High satiety 
nut35 2886                 14 Low satiety 
nut34 3022                 11 Low satiety 
nut6 3458                 13 Low satiety 













  Participants averages of BMI of low, medium and high satiety 
participants based on TEI and ad libitum lunch intake. 
 
4.3.9.1  Participants average for BMI in low, medium and high satiety phenotype 
based on ad libitum lunch intake 
 
Figure 4.11 (A) presents average BMI of females based on ad libitum lunch intake for 
females by using method one. One-way ANOVA analysis shows no significant 
differences between groups (F=2.267) (p= 0.126). (B) presents average BMI of females 
based on ad libitum lunch intake by using method two. One-way ANOVA again showed 
no significant differences between groups (F=2.441) (p=0.1103). Figure 4.12 (A) 
presents average BMI of males based on ad libitum lunch intake according using 
method one. One-way ANOVA showed no significance differences between low, 
medium and high satiety males in average BMI (F=1.972) (p=0.1716). (B) presents 
average BMI of males based on ad libitum lunch intake using method two. One-way 









































































                          Figure 4-11 : Average BMI female based on ad libitum lunch intake by using (A) method one and (B) method two. 






































































                                                    Figure 4-12:  Average BMI male based on ad libitum lunch intake by using (A) method one (B) method two. 




4.3.9.2  Participants average BMI for low, medium and high satiety based on TEI 
 
Figure 4.13 (A) presents average BMI of females based on TEI using method one. One-
way ANOVA showed no significant differences between low, medium and high satiety 
females in average BMI (F= 1.079) (p=0.357). (B) presents average BMI of females 
based on TEI using method two. One-way ANOVA showed no significant differences 
between low, medium and high satiety females in average BMI (F= 0.210) (p=0.811). 
Figure 4.14 (A) present average BMI of males based on TEI using method one. One-way 
ANOVA showed no significant differences between low, medium and high satiety 
males in average BMI (F= 0.597) (p=0.560). (B) presents average BMI of males based on 
TEI using method two. One-way ANOVA showed no significant differences between 

















































































                                                            
                                                Figure 4-13: Average BMI of female based on total energy by using (A) method one (B) method two. 


































































                                                Figure 4-14: Average BMI male based on TEI in males by using (A) method one (B) method two. 
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   Average TFEQ subscales in low, medium and higher satiety 
participants based on TEI and ad libitum lunch intake. 
 
4.3.10.1 Participants TFEQ subscales for low, medium and high satiety based on 
TEI.  
Figure 4.15 (A) presents TFEQ subscales in low, medium and high satiety participants 
based on TEI for females using method one. One-way ANOVA showed no significant 
differences between the three groups; TFEQ Restraint (F= 0.365) (p= 0.698), Hunger 
(F= 0.424) (p= 0.661) and TFEQ Disinhibition (F= 4.366) (p= 0.026).  
 
 
(B) represents TFEQ subscales in low, medium and high satiety female participants, 
based on TEI using method two. One-way ANOVA showed no significant differences 
between the groups; TFEQ Restraint (F=1.057) (p= 0.364), Hunger (F= 0.809) (p= 0.458) 
and TFEQ Disinhibition (F= 2.292) (p= 0.124). Figure 4.16 (A) represents TFEQ subscales 
in low, medium and high satiety male participants based on TEI using method one. 
One-way ANOVA showed no significant differences between the three groups; TFEQ 
restraint (F= 0.365) (p=0.698), TFEQ Hunger (F=1.703) (p=0.205) and TFEQ Disinhibition 
(F=2.292) (p=0.124).  (B)  presents TFEQ subscales in low, medium and high satiety 
male participants based on TEI using method two. One-way ANOVA showed no 
significant differences between low, medium and high satiety females in TFEQ 
Restraint (F=0.273) (p=0.764), Hunger (F=0.0750) (p= 0.928) and TFEQ Disinhibition (F= 

















































































































                                             Figure 4-15: Average TFEQ subscales of female based on TEI using (A) method one (B) method two. 
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                                           Figure 4-16 : Average TFEQ subscales of male based on TEI  using (A) method one (B) method two. 
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4.3.10.2  Participant average TFEQ subscales for low, medium and high satiety 
based on ad libitum lunch intake. 
 
Figure 4.17 (A) represents TFEQ subscales in low, medium and high satiety of female 
participants based on ad libitum lunch intake according to divide females by using 
method one. One-way   showed no significant differences between low, medium and 
high satiety females in TFEQ Disinhibition (F=2.6) (p= 0.098) and Hunger (F=2.43) (p= 
0.112). There was a significant difference between the 3 groups in TFEQ Restraint 
(F=3.621) (p= 0.044). (B) presents TFEQ subscales in low, medium and high satiety 
female participants based on ad libitum lunch intake using method two. One-way 
ANOVA showed no significant differences between low, medium and high satiety 
females in TFEQ Restraint (F=0.2429) (p= 0.786), Hunger (F=1.679) (p= 0.209) and TFEQ 
Disinhibition (F=0.555) (p= 0.581). 
 
Figure 4.18 (A) displays TFEQ subscales in low, medium and high satiety male 
participants based on ad libitum lunch intake using method one. One-way ANOVA 
showed no significant differences between low, medium and high satiety females in 
TFEQ Restraint (F=0.609) (p=0.555), Hunger (F=2.891) (p= 0.083) and TFEQ 
Disinhibition (F=0.156) (p= 0.856). (B) shows TFEQ subscales in low, medium and high 
satiety male participants based on ad libitum lunch intake using method two. One-way 
ANOVA showed no significance differences between low, medium and high satiety 
females in TFEQ Disinhibition (F=0.354) (p= 0.707), Hunger (F=1.034) (p= 0.378) and 


























































H ig h  s a t ie t y
M e d iu m  s a t ie t y






















































H ig h  s a t ie t y
M e d iu m  s a t ie t y
L o w  s a t ie t y
A B
 
                                           Figure 4-17 : Average TFEQ subscales of females based on ad libitum lunch intake by using (A) method one (B) method two. 
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                                           Figure 4-18:  Average TFEQ subscales of males based on ad libitum lunch intake by using (A) method one (B) method two. 





Some people have a low satiety response to food, and therefore have a tendency to 
overconsume when feeding, so the present study aimed to identify satiety phenotypes 
in individuals, which can then be used to identify those at risk of overeating (Dalton et 
al., 2015). The methods used in this chapter have enabled the development of heat 
maps to identify satiety phenotypes. The potential application of this developed 
method is to help professionals working in weight-loss programmes, as will be 
described in chapters 5 and 6.  A heat map can be used as a grid to score each 
participant for a set of variables as ‘high’, ‘medium’ or ‘low’ satiety against 
predetermined ranges and an overall score determined.  This can then be used to 
identify people prior to the start of a weight loss programme who may struggle to lose 
weight due to their reduced satiety phenotype and allow for additional specific advice 
to support these people.   
The aim of this chapter was to develop this heat map concept, including identifying 
predictive variables and determining the ranges for each of these variables to use in 
the heat map.  Potential variables were studied to determine their relationship with 
food intake in a controlled laboratory setting (ad libitum pasta lunch) and in the free-
living environment (calorie intake measured by a 3-day food diary).  The variables 
investigated were VAS appetite scores in response to a test breakfast, gut hormone 
concentrations and TFEQ subscale scores.  
 Participant characteristics at baseline 
The current study showed males consumed more fat than females and that females 
tended to crave CHO more than males. These results are in line with Kiefer, 
Rathmanner and Kunze (2005) who reported the same findings. Females had 
significantly higher scores for Restraint and Disinhibition in this current study, which 
has been described previously by Provencher et al., (2003).  The possible explanation 
for this may be that women in our society have more often greater concern about 
dieting and their body weight than men. It appears that women consciously restrict 
their food intake more than men to control their body weight or to promote weight 
loss, even if their BMI is in the normal range (Carmody et al., 1995). 
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 VAS, TEI, macronutrient intake and ad libitum lunch intake 
4.4.2.1   Relationships of fasting, post-breakfast, thirty minute and AUC of VAS and 
TEI 
In the present study based on the different assessment time points of the VAS appetite 
score measures, people who had higher scores for VAS fasting prospective food intake 
and AUC fasting composite appetite score consumed more energy according to their 
food diaries. All VAS measures (fasting prospective food intake, AUC fasting composite, 
post-breakfast hunger, 30 min hunger and 30 min desire to eat) were strongly 
correlated with TEI in females, but this effect was not as strong in men. Although the 
data showed that VAS scores in females at the fasting, post breakfast and 30 min time 
points were significantly correlated with TEI, there was no difference in correlation 
between males and females in VAS post-breakfast hunger and 30 min fullness.  
These finding agree with Drapeau et al., (2019) who found people with low satiety 
consumed more TEI measured by their food diary. 
 
These findings are partly in accordance with a previous observation by Drapeau et al., 
(2007) that reported fasting hunger, fullness and desire to eat scores did not correlate 
with TEI in females. However, they found no significant correlation between fasting 
prospective food intake scores and TEI in females.  Moreover, VAS fasting for 4 
questions was correlated with TEI in males, in this current study again in agreement 
with findings by Drapeau et al., (2007). The possible explanation of differences could 
be sample size, which was larger in the Drapeau et al., (2007) study with 139 females, 
whereas in the present study it was 26. Another explanation could be the total energy 
consumption according to the food diary; in Drapeau et al., (2007) the average total 
energy consumed was 2,375 kcal, whereas in the present study it was 1,532 kcal. A 
further explanation may be that the participants were classified as obese in the 
Drapeau et al., (2007) study and in the present study participants were normal weight 
or overweight. Obese and normal weight individuals have different eating behaviours, 
obese people usually under report consumption but in the present study normal 
weight participants showed under reporting compared with the Drapeau et al., (2007) 
study, the reason behind this may be that teenagers focus on their body shape that 
could explain the differences. 
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 In contrast to the present study Doucet et al., (2003) reported that fasting hunger, 
fullness, desire to eat and prospective food consumption did not predict reported EI. 
The possible explanation may be body weight status in the participants in the Doucet 
et al., (2003) study, which included 19 people with obesity, whereas the present study 
typically recruited people who were normal or overweight. Further, age may be an 
influencing factor in which the average age for men was 44 years and 39 years for 
women in Doucet’s study, compared to the average age for men was 30 and women 
was 21 in this study. Older adults have been reported to experience less hunger than 
their younger adult counterparts (Chapman et al., 2002; Hays and Roberts, 2006).
   
When the VAS scores for the assessments over the whole morning were combined as 
the AUC, similar results were found with people who have high hunger scores typically 
eating more energy as reported in the food diaries. AUC VAS appetite scores were 
strongly correlated with TEI in females, but this effect was not as strong in men.  Two 
previous studies agreed with this finding where Drapeau et al., (2007) included men (n 
=176) and women (n = 139) found that there was a strong positive correlation between 
AUC desire to eat and AUC prospective food and TEI as measured using the food diary 
in females. Doucet et al., (2003) showed that AUC 'hunger' AUC 'fullness' 'desire to eat' 
and AUC 'prospective food consumption' were not significantly correlated with 
reported 24 hour EI in males. 
 Relationship of SQ, VAS and TEI 
The SQ was investigated as a measure in this current study, as other published studies 
have used this approach and it is less time consuming than the AUC measurements. SQ 
is a measure of the satiating effect of foods relative to their energy content. The 
current study showed no correlation between SQ for each of the four questions as well 
as the SQ composite score and TEI. This agrees with Drapeau et al., (2007) who also 
found no significant correlation between SQ for each question and TEI reported in food 
diaries. McNeil et al., (2014) showed the SQ of prospective food consumption and 
fullness predicted TEI and percentage CHO intake, respectively, when compared with 
food diary records. The r values in this study compared to the results reported here, 
but the McNeil et al., (2014) results were significant and in the present study they 
were not due to it being under powered with a lower participant number. 
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 Relationship between fasting VAS and macronutrient intake 
In the current study, people who were hungrier reported a lower percentage of fat in 
their diet. There was a negative correlation between fasting scores for all 4 questions 
and fat intake in females and males. Males who were hungry had a higher percentage 
of CHO in their diet. This finding agrees with Beasley et al., (2009) who found appetite 
ratings are higher on a CHO diet compared with a protein diet. 
 Relationships SQ of VAS macronutrient intake of food diary 
In the present study SQ was not related to the percentage CHO intake. Based on the 
published literature only one study examined SQ and macronutrient intake. This 
finding of the current study agrees with McNeil et al., (2014) who showed that SQ 
'prospective food consumption' and 'fullness' predicted TEI and percentage CHO intake, 
respectively, when measured with food diaries.  
 VAS and ad libitum lunch intake 
4.4.6.1  Fasting, post-breakfast and thirty minute VAS and ad libitum lunch intake 
In the current study, people who were hungrier based on their VAS appetite measures 
at the different time points consumed more at the ad libitum lunch. VAS scores were 
strongly correlated with ad libitum lunch intake in females but this effect was not as 
strong in men and did not reach significance. Females who had low scores on the VAS 
30 min fullness measure, consumed a lower amount of ad libitum lunch intake which 
was also seen in males. The interpretation of this difference could be the small sample 
size, such that the study is underpowered. The results of the present study corroborate 
a previous study highlighting that prospective food consumption predicted 
forthcoming EI (Barkeling et al., 1995). In addition, the findings also show 'desire to 
eat' scores predicted forthcoming EI that was also found by Barkeling et al., (1995).  
 
Gibbons et al., (2013) agreed with the present study where they found changes in 
ghrelin and hunger immediately before the lunch meal (at 180 minutes), which was 
positively associated with EI (hunger, high-fat/low-CHO: r= 0.461, P=0.073 and high 
CHO/ low-fat: r = 0.550, P < 0.05) However, there was no difference in ad libitum 
energy intake at the standard lunch meal after either the high-fat/low-CHO (947 kcal) 
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or high-CHO/low-fat (939kcal) breakfasts. A greater suppression of ghrelin and hunger 
was associated with the smaller meal size.  
 
The current study demonstrated that there was a strong correlation between AUC VAS 
scores and ad libitum lunch in females. Females consumed more based on AUC hunger 
and AUC prospective food intake, this effect was not as strong in men. The AUC 
composite score did not correlate with ad libitum lunch intake in females and males. 
These results are in contrast with those of Deighton, Frampton and Gonzalez (2016) 
who found AUC composite appetite scores were more strongly correlated with ad 
libitum lunch intake in males.  A possible explanation for differences in results may 
again be due to sample size as the in Deighton, Frampton and Gonzalez study it was 10 
participants, which was smaller than in the current study.  
 SQ of VAS and ad libitum lunch intake 
The present study revealed that there was no significant correlation between ad 
libitum lunch intake and SQ composite score and SQ of each of the four questions in 
the VAS appetite score. These results agree with McNeil et al., (2014) who reported 
that SQ fullness and SQ prospective food consumption were better predictors for 
subsequent EI. They found an increase in 'fullness' and 'prospective food consumption' 
predicted overall decreases in energy at lunch at 3 and 5 years.   
 
The present findings contrast with previous research that found that SQ for fullness 
was the best predictor of ad libitum energy intake, compared to 1 h AUC (Drapeau et 
al., 2005 and Drapeau et al., 2007). A possible explanation for SQ related to findings in 
this current study did not predict ad libitum lunch intake, was that the current study 
was carried out on normal weight and overweight participants and Drapeau et al., 
(2007) study included people with obesity as well as there being a difference in ages in 
the two study cohorts with Drapeau et al., (2005) and Drapeau et al., (2007) studies 
including subjects with 20-50 age range, whereas the present study majority of 
participants were students,  which could explain these differences. Lastly one 
explanation for the differences may be the calorie content in the breakfast test meal, 
males were given different quantities compared to females, in both studies. Males and 
females in Drapeau et al., (2005) and Drapeau et al., (2007) consumed a higher calorie 
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breakfast test meal than in the present study and both sexes consumed different 
amounts of energy. In Drapeau et al., (2005) and Drapeau et al., (2007) the calories for 
breakfast were 598·7 kcal for women and 733·1 for men. Whereas in the current study 
males and females consumed the same energy, which was 327kcal.  The 
interpretations for this could be a high energy test meal can affect SQ scores because 
SQ measures the satiating effect of foods relative to energy content. This high EI may 
make participants feel less hungry for a longer time period than the lower energy 
consumed in the present study. 
 The correlation between subscales of TFEQ and food intake (ad 
libitum lunch and TEI and macronutrient intake) 
4.4.8.1  Subscales of TFEQ and TEI and macronutrient intake 
A limited number of studies have reported interactions between Disinhibition and 
Restraint scores in association with EI. Only a few studies have examined TFEQ Hunger 
for predicting ad libitum lunch intake or macronutrient intake from food diaries. The 
present study found no significant correlation between TFEQ Hunger and TFEQ 
Disinhibition and TEI, measured by a food diary in either females or males, however, 
females who had high scores of TFEQ Restraint consumed less total energy. In contrast 
to the results of current study, French et al., (2014) reported a strong correlation 
between TFEQ Hunger, TFEQ Disinhibition and TFEQ Restraint and TEI. The 
interpretation as to why French et al., (2014) study results differed from the current 
study was the sample size, which in the French study was over 2000 and allowed 
detection of people with different satiety levels. Another potential interpretation was 
age, French et al., included older people, which affects food consumed by participants 
as food intake reduces with age as mentioned in earlier sections. 
 Moreover, a previous study has observed positive associations between hunger and EI 
(Provencher et al., 2003). They reported that people with chronically high levels of 
hunger are more susceptible to overeating compared with those who do not report 
being often hungry. The mean for age, BMI, weight, percentage of macronutrients and 
daily energy were larger than the present study which may have led to different results. 
 The explanation why the present study differs from the finding of Provencher et al., 
(2003)  was the sample size was much bigger than the present study with 401 
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participants. Another explanation was mean age, BMI, weight and percentages of 
macronutrients and daily energy was larger than the present study, which may lead to 
different results.  
4.4.8.2  Subscales of TFEQ and macronutrient intake 
The findings of the current study agree with Lindroos et al., (1997) who showed no 
correlation between TFEQ Hunger and daily EI of food diary and percentage of 
macronutrients (protein, CHO and fat) in a non-obese group. However, in the same 
study there was a positive association between TEI and hunger in the obese group. 
Moreover, there was a strong relationship between TFEQ Disinhibition and TEI based 
on food diaries. A potential explanation may be that there were 179 people with 
obesity in Lindroos et al., (1997) study compared to much lower numbers in the 
current study. Disinhibition has been related to higher BMI and EI (Provencher et al., 
2003; Bellisle et al., 2004; Dykes, et al., 2004; Bryant et al., 2008). Moreover, it has 
widely been reported that people with obesity and overweight individuals have higher 
disinhibition scores compared to normal weight individuals (Provencher et al., 2003). 
Normal BMI in participants in the present study affects TFEQ subscales to predict 
macronutrient intake. 
4.4.8.3  The correlation of subscales of TFEQ and ad libitum lunch intake 
Findings of the current study found no correlation between any of TFEQ subscales and 
ad libitum lunch intake. This observation is concordant with previous studies that 
showed no association between TFEQ Disinhibition and increase ad libitum lunch 
intake (Dalton et al., 2015). One reason for the lack of correlation in the present study 
could be BMI, most participants had normal BMI. It has been reported that high BMI is 
correlated with high TFEQ Hunger and Disinhibition and food intake (Provencher et al., 
2003; Bellisle et al., 2004), therefore a similar study carried out in people with obesity 
might find a relationship between TFEQ scores and lunch intake. The present study 
agreed with Bellisle and Dalix (2001) which was carried out on 41 healthy women with 
normal weight. They reported TFEQ Hunger and TFEQ Disinhibition did not correlate 
with lunch intake.  
In contrast to the present study, a lab based experimental study carried out by 
Westerhoefer et al., (1994) found high disinhibition with high restraint was associated 
with higher EI in an ice cream ad libitum test and 200 ml of milkshake. This difference 
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in results could be explained by sample size in Westerhoefer et al., (1994) study which 
was 141. Another explanation may be the palatability of the food.  In Westerhoefer et 
al., (1994) study ad libitum test was ice cream and 200 ml of milkshake and it was 
highly palatable food and high fat and sugar, whereas in the present study it was pasta.  
 The correlation of hormones and food intake (ad libitum lunch 
intake and TEI and macronutrient intake) 
4.4.9.1  Gut hormones and TEI and macronutrient intake of food diary 
The results of the present study showed that females with higher scores of PYY 
reported lower TEI in their food diaries and males who had higher PP consumed less 
energy. The present study also reported that males with higher PP had a lower 
percentage of protein and higher percentage of fat in their diet. Fasting ghrelin and 
fasting GLP-1 showed no significant correlation with total energy and macronutrient 
intake in both sexes. In contrast to the present study, Ratliff et al., (2010) found that 
there was no correlation between reduction in macronutrient intake and PPY and GLP-
1. The explanation may be age and gender of cohort as Ratliff et al., (2010) included 
only males aged 20-70 years. Several studies have suggested that age decreases the 
circulating acyl ghrelin levels (Rogers et al., 2016). 
4.4.9.2  Gut hormones and ad libitum lunch intake 
The present study data indicated that there was no significant correlation between 
fasting PP, ghrelin and GLP-1 and PYY and ad libitum lunch intake. Moreover, AUC of 
gut hormones (AUC PP, AUC ghrelin and AUC GLP-1 and PYY) were not significantly 
correlated with ad libitum lunch intake. The finding of the current study is in 
accordance with Chowdhury et al., (2016) who observed no significant correlation 
between fasting ghrelin at baseline and ad libitum lunch intake. They indicated that 
fasting reduced satiety hormone responses to a subsequent lunch meal but 
counterintuitively also reduced concentrations of the appetite-stimulating hormone 
ghrelin during the afternoon, relative to lunch consumed after breakfast. This may be 
explain why fasting ghrelin in the present study did not predict ad libitum lunch intake.  
Moreover, partially, this finding agrees with a previous study carried out by Votruba et 
al., (2009) who found daily fasting ghrelin concentration did not predict ad libitum 
lunch intake over 3 days. The explanation of why fasting ghrelin concentration did not 
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predict ad libitum lunch intake may be because plasma ghrelin levels rise before the 
start of a meal and fall again rapidly after the initiation of the meal in humans 
(Cummings et al., 2004; Cummings et al., 2001).  
 
In contrast to the present study, Ratliff et al., (2010) used a crossover design with each 
participant having two different breakfasts in a randomized and balanced order 
separated by 1 week.  Both test breakfasts were isocaloric; the egg-based breakfast 
(EGG) consisted of 3 scrambled eggs and 1.5 pieces of white toast. The bagel-based 
breakfast (BAGEL) consisted of 1 white bagel, 1/2 tablespoon of low-fat cream cheese, 
and 6 oz of low-fat yogurt. This study reported that reduction in ghrelin and ghrelin 
AUC after an egg-based breakfast, which consisted of 3 scrambled eggs and white 
toast, resulted in reduced EI at an ad libitum lunch buffet. The possible explanation for 
differences of both studies could be the breakfast test meal which contained high 
protein, as previous studies showing that high protein decreases the concentration of 
ghrelin, which is as satiety effect (Veldhorst et al., 2009).  In contrast to results of the 
present study, Salbe et al., (2004) found that there was a negative correlation between 
fasting ghrelin and ad libitum food intake. Salbe et al., (2004) provided butter, peanut 
butter, cream cheese, jams, salad items and dressings, crackers, bread, tortillas, Indian 
fried bread, spices and salsa, orange juice, apple juice, milk, and a six-pack of soda for 
3 days as food intake. The possible explanation could be palatability of food and 
variety in food. Ad libitum food intake in Salbe et al., (2004) was much more palatable 
and varied than the present study, so participants can eat without becoming bored 
with the food. 
 
In contrast to the present study, Gibbons et al., (2013) found that GLP-1 and PYY 
increased more after a high-fat breakfast meal. GLP-1 was negatively associated with 
EI but the PYY profile was not associated with food intake. A possible explanation as 
discussed in previous section was sample size in the Gibbons et al., (2013) study which 
was 16 participants, including 11 females; it was smaller than present study. Moreover, 
the test meal consisted of yogurt, honey and fruit accompanied by a choice of tea or 
coffee (about 590 kcal), which could make participants not feel hungry until lunch time. 
Moreover, Gibbons et al., (2013) study included overweight and obese individuals and 
in the present study participants had normal weight.  A decrease in total fasting PYY, or 
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no changes in fasting, or impaired postprandial PYY have been reported in overweight 
people (Moran et al., 2007).  This may explain the differences with the current study.  
   Food craving, TEI and macronutrient intake and ad libitum lunch 
intake 
In the present study, food cravings did not predict ad libitum lunch intake. However, 
food craving scores were correlated with intake of some macronutrients, as measured 
by the food diary. Male participants with lower scores for fast food craving consumed 
more energy. Moreover, males with higher scores of sweet food craving consumed 
more protein. The interpretation could be related to sex because of differences in food 
cravings with men reporting higher craving for savoury foods (e.g. meat, fish, eggs), 
whereas women report more craving for sweet foods (e.g. chocolate, pastries, ice 
cream. Several studies have shown that men may crave different types of sweets than 
women do (e.g. sugar sweetened beverages, but not chocolate) (Zellner et al., 1999; 
Weingarten and Elston, 1991). 
 
These findings contrast to those reported by Chao et al., (2014) who found significant 
positive relationships between specific categories of food cravings and habitual intake 
of those foods, fast food craving was association with sweet, high fat and CHO. 
Cravings for sweets were significantly associated with intake of sweets and high fat 
and fast food.  
The potential explanation could be body weight as Chao et al., (2014) included 
overweight and obese participants and there is evidence that people with obesity have 
higher frequencies of food cravings than normal weight individuals (Abilés et al., 2010). 
  Heat map 
Previous studies have been studied low satiety phenotypes. Drapeau et al., (2005) 
used 1h post meal AUC and the SQ as predictors of EI and Drapeau et al., (2007) also 
used VAS (fasting, fullness, desire and prospective) to identify low satiety phenotype. 
Dalton et al., (2015) also examined SQ to identify low satiety phenotype. They found 
that a low SQ was associated with a greater implicit wanting for high fat foods and 
higher scores on the TFEQ Disinhibition subscale.  
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In the current study, a heat map based on food diaries predicted hunger of participants 
more than ad libitum lunch by method one. The heat map was used in this chapter to 
identify individual phenotypes with different independent variables. Scores of these 
variables were used in chapters 5 and 6 to predict phenotype in a clinical population 
and to help professionals at these clinics with a visual presentation sheet to identify 
reduced satiety people. In this chapter a heat map designed with independent 
variables used linear regression to predict which variables have the larger r value and 
those variables will be applied in chapters 5 and 6. These variables are fasting of VAS 
for4 questionnaire, post breakfast desire to eat, TFEQ hunger, SQ composite of 
appetite score and fasting PP.  
 
The key findings of the heat maps, heat map based on food diaries predict more low 
satiety people than heat map based on the ad libitum by using method one. There was 
no significant difference in average BMI in males and females by using methods one 
and two. There were no significant differences in average TFEQ scores for low, medium 
and high satiety participants based on TEI and ad libitum lunch, except TFEQ 
disinhibition scores females based on TEI and TFEQ Restraint scores females based on 
ad libitum lunch. In heat map participants nut31 and N26 who were high satiety ate 
less energy in ad libitum and food diary. 
  Summary 
In conclusion, in the current study VAS appetite measures are the best tool to predict 
ad libitum food intake and food diary intake in a laboratory setting. Because these 
measures showed a strong correlation with ad libitum food intake and food diary 
intake. Gender impacted on the results of this study; females' VAS scores showed a 
greater correlation with total energy, macronutrient intake and ad libitum than males. 
TFEQ subscales did not predict TEI and macronutrient intake, measured by food diary 
and ad libitum food intake. The results of the present study showed that females with 
higher levels of PYY reported lower TEI in their food diaries. Males who had higher PP 
consumed less energy and reported less percentage of protein and higher percentage 
of fat in their diet. Food cravings scores in males were negatively correlated with TEI. 
Sweet food cravings were positively correlated with protein intake and fast food 
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cravings was negatively correlated with fibre intake in males. Food craving data results 
did not correlate with ad libitum food intake.  
 
The possible explanation why fasting ghrelin, PP and GLP-1 did not predict ad libitum 
pasta intake may be the characterisation of the low satiety phenotype as realized in 
the laboratory environment, which is clearly different from natural real-life situations. 
As a result, it is possible that environmental factors could play a role in the expression 
of the low satiety. The duration of the trial day of this study was approximately 3 hours 
to achieve all blood sample, with more participants VAS and ad libitum lunch meal. 
Results of this chapter show that no additional information was gained by using AUC 
compared to measures that take a shorter time, thus in the clinical study, a shorter 
duration with one fasting sample collected would allow more participants to be 
recruited, if they knew just one blood sample would be collected and a short waiting 
time. The fasting sample of VAS shows best predicted for food intake to assess study 
phenotype. Moreover, even the AUC alone shows a strong prediction with linear 
regression analysis but it was excluded from the heat map because duration of setting 
for trail in clinic is less than 3 hours and this duration may make people who are 
waiting for 3 hours feel more hunger than setting shorter. 
  Study strengths and limitations 
This study had strengths and limitations. The strength of the study was that it used 
multiple measurements to predict satiety phenotype.  The limitations of the study 
were the small number of participants and the study sample consisted of students so 
the age range was limited. The results could differ in other populations because people 
eat less and make different food choices as they get older (Drewnowski and Shultz, 
2001). The other limitation is that only 1-day assessments of all measurements were 
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5 Introduction  
Overweight and obesity are major public health concerns worldwide and more than 
forty percent of all adults struggle to control their body weight with the use of weight 
loss strategies (Santos et al., 2017). Many researchers have focussed on identifying 
effective weight loss treatments to benefit adults who are overweight or obese. 
Despite this effort, long‐term outcomes vary substantially across individuals. No single 
intervention works well for everyone, thus the identification of individual factors that 
predict successful weight loss could help to enhance personalised interventions. 
Assessment of these factors at baseline before the intervention could allow for tailored 
delivery of extra support for individuals who are less responsive to treatment (James et 
al., 2018). 
Recently a review by Carraça et al., (2018) summarised the evolution of research on 
pre-treatment predictors of weight loss over the last decade. The most consistent pre-
treatment predictor of weight loss, according to the literature, was fewer previous 
weight loss attempts. In this review several potential factors were identified as non-
significant predictors including: binge eating, eating self-efficacy or cognitive eating 
restraint, suggesting that overweight/obese individuals might successfully manage 
their weight, even if initially presenting unfavourable scores on these predictors. 
However, more high-quality research is required to draw more reliable conclusions 
about the role of these factors.  
Considering the lack of success in the long term treatment of obesity, there is still a 
need to investigate more reliable markers of predictors of body weight loss (Drapeau 
et al., 2007).  
 
 Factors previously studied in predicting weight loss 
 VAS to measure subjective ratings of appetite 
Subjective ratings of appetite, as measured using VAS, have been shown in some 
studies to predict subsequent EI and changes in body weight and are frequently used 
in studies assessing appetite (Flint et al., 2000; Drapeau et al., 2007).  
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  Eating behaviours  
Behavioural traits are another variable which have been reported to predict weight 
loss. Eating behavioural traits assessed by tools such as the TFEQ have been studied in 
weight loss intervention trials. Three eating behaviour traits: Restraint, Disinhibition 
and Hunger have been used as predictors of weight loss. The definition of these traits 
was discussed in chapter 1. Stunkard and Messick (1985) have shown an interaction 
between Restraint and Disinhibition and predicted BMI, high BMI associates with lower 
Restraint and higher Disinhibition scores. Disinhibition has been shown to be the 
strongest predictor of increased BMI and weight gain over time and the development 
of obesity (Bryant, King and Blundell, 2008; Williamson et al., 1995). 
 
Previous studies have focused on eating behaviours in short- and long-term weight loss 
programmes in several environments, including research environments (Teixeira et al., 
2010; Foster et al., 1998), clinic-based (Byrne, Barry and Petry, 2012; Dalle et al., 2009), 
and community based programmes (McGuire et al., 2001). In most studies, the higher 
scores at baseline of restraint were positively correlated with greater weight loss. In 
addition, it has also been shown that in individuals taking part in weight loss 
treatments, restraint increases with weight loss. Disinhibition has been shown to be 
inversely associated with weight loss, with greater reductions in disinhibition 
associated with greater weight loss (Batra et al., 2013) However, examining the Hunger 
subscale of the TFEQ for predicting body weight loss has had little attention in the 
literature. A negative correlation with weight loss has been shown with individuals 
who had higher scores on the TFEQ Hunger scale who were struggling to lose weight 
and lower baseline Hunger subscale scores were associated with greater weight loss 
(Batra et al., 2013).  This subscale of TFEQ refers to the desire to eat in response to 
physiological signals and external cues and higher scores on this subscale may indicate 
individuals who have a low satiety phenotype, leading to increased hunger and thereby 
identify those who may struggle to lose weight.  
   Gut hormones  
Another variable studied to predict weight loss is the concentration of plasma gut 
hormones. Body weight is controlled by complex physiologic systems in which 
hormones signal body energy stores and nutrient intake to the CNS pathways 
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controlling energy homeostasis. Gut hormones play an important role in the regulation 
of body weight (Sumithran et al., 2011) and may be involved in the pathogenesis of 
obesity (Le Roux et al., 2006;  Batterham et al., 2003a). Much research has focussed on 
gut hormones including ghrelin, GLP-1, PYY and PP that fluctuate episodically and are 
believed to have contrasting actions on appetite control (Cummings et al., 2002; 
Batterham et al., 2002). Episodic hormones are those that change during the day, 
particularly before and after meals. Fasting ghrelin concentrations have been shown to 
be lower in people with obesity, when compared with normal weight controls 
(Cummings et al., 2002). This lower in plasma ghrelin level may contribute to increased 
appetite and weight gain (Cummings et al., 2002).  It has been shown that the 
concentration of plasma PP increases following a meal and the action of PP involves a 
reduction in food intake (Troke, Tan and Bloom, 2014). As a result, it plays a vital role 
in the regulation of body weight (Karra and Batterham, 2010) and has been shown to 
be reduced in people with obesity. GLP-1 is of relevance to appetite and weight 
maintenance because it has actions on the GI tract, as well as being involved in the 
direct regulation of appetite, decreasing hunger (Troke, Tan and Bloom, 2014). PYY has 
been reported to reduce food intake and prompt weight loss (Mishra, Dubey and 
Ghosh, 2016) and is reduced in overweight people in total fasting (Moran et al., 2007). 
Several studies have examined these gut hormones in blood to predict weight loss. 
Koska et al., (2004) demonstrated that fasting PP levels were negatively associated 
with weight loss and Hainer et al., (2008) found there was an inverse correlation 
between baseline PP levels and body weight change. In contrast, Polsky et al., (2013) 
have observed that baseline plasma ghrelin and PP and GLP-1 did not predict weight 
loss in subjects who participated in a 16-week intervention. 
The present study was designed to examine subjective measures of appetite, TFEQ 
scores and plasma gut hormone concentrations prior to a weight loss programme in 
order to identify people who were less likely to succeed in weight loss. If it is possible 
to identify people with a low satiety phenotype at the beginning of an intervention, 




 Rotherham Institute for Obesity 
The current study was carried out in The Rotherham Institute for Obesity (RIO), which 
is a unique and specialist centre for the management of weight problems with a 
multidisciplinary approach to reducing and maintaining weight loss. RIO brings 
together all the National Health Service (NHS) approved and evidence-based methods 
for weight loss into one primary care based centre that maximises the chances for 
successful weight loss. 
RIO delivers Tier 3 multidisciplinary weight management services to manage weight 
problems via providing specialists that can offer different approaches. This includes 
dedicated Obesity Specialist Nurses, Healthcare Assistants, Dietetics input for complex 
dietary needs, and “Rotherham Cook and Eat” skills education, Talking Therapies 
including psychological input and support, Exercise Therapists to offer a personalised 
training programmes and facilities to provide group work for exercise, therapies and 
nutritional advice.  
 Aims  
The main aim of the present study was to develop methods to identify individuals who 
may struggle to lose weight on a weight management programme due to their reduced 
satiety. 
Specific objectives were: 
 
1- To investigate the relationship between VAS appetite rating scores and subsequent 
weight loss. 
2- To investigate the relationship between fasting concentrations of plasma gut 
hormone concentrations and subsequent weight loss.   
3- To investigate the relationship between TFEQ subscales and subsequent weight loss.   
4- To combine these data to investigate whether it is possible to identify individuals 






 Materials and methods  
Study design, setting, anthropometry, questionnaires, test meal, assessments of 
appetite, blood sample collection, laboratory methods, gut hormone analysis are 
described in the relevant sections in the general methods chapter 2. 
The timing and frequency of completed VAS appetite scores in chapter 4 was 3 hours 
and 5 times, whereas in this study the timing was one hour and 15 minutes and VAS 
appetite scoring completed respectively four times. This was chosen for 3 reasons 1) 
Fasting, post and 30 min VAS appetite scores showed the strongest correlation with 
total energy and ad libitum intake 2) Following previous work by Dalton et al., (2015) 
measurement of the SQ in 75 minutes post-breakfast was established and 3) Reduced 
participant burden making the study more convenient for participants. 
The results from chapter four showed that the fasting blood sample provided the most 
useful information, therefore in this study just one finger prick blood sample was 
taken. The advantage of this was that it reduced the cost of the analysis and made it 
more likely that people would be willing to take part as they only had to give one blood 
sample. It also fitted well with the as participants at RIO do not provide venous blood 
samples as part of their routine care. 
 Participants and recruitment 
Thirty-four people with obesity and overweight were enrolled in this study prior to 
starting a weight loss programme. Eight participants dropped out from the study; of 
these, four participants signed up for the RIO programme on the first day but did not 
attend, and four took questionnaires to complete at home and made an appointment 
to give a blood sample but then did not come to the appointment. So, this study 
included twenty-six (17 females 9 males) participants. Twenty two of the participants 
gave blood samples for hormone analysis. Four participants just completed the 
questionnaires and did not agree to blood sample collection. Twenty six participants 
completed up to one month and thirteen participants carried on for three months. 
Exclusion criteria were if participants were unwilling or unable to provide informed 
consent to undertake the study and if they disliked or were allergic to the foods used 
in the study. Participants were aged between 27-77 years (56.6 ± 12.1). All participants 
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were recruited from RIO, Rotherham, UK. Ethical approval for the study was granted 
by the Integrated Research Approval System (IRAS) (ID/208879) (Appendix 14). 
 Blood sample and VAS  
A fasting blood sample was collected when participants first arrived in the morning at 
RIO after a 12 hour overnight fast. Participants filled out VAS appetite scoring before 
consuming a test breakfast and another VAS appetite score was completed at 15, 45 
and 75 minutes post consumption of breakfast. 
The test breakfast consisted of cornflakes, milk and juice as described in the methods 
section in chapter 2. The VAS appetite questions were used to evaluate sensations of 
appetite measured hunger, fullness, desire to eat and prospective food intake. Blood 
samples were collected into ice-chilled tubes containing protease inhibitors after 
centrifugation and 100 μL of 1 M hydrochloric acid (HCL) was added per mL of plasma. 
Plasma concentrations of acylated ghrelin, PYY, PP and GLP-1 concentrations were 
measured as described in chapter 2. 
 Statistical analysis 
All data were analysed using the Statistical Package for the Social Science (SPSS) 
software version 24.0 (IBM) for Windows (SPSS Inc., Chicago, IL, U.S.A.) and Prism 
version 7.03 (GraphPad Soft-ware Inc., La Jolla, CA). Correlation coefficients were used 
to assess relationships between variables. T-tests were used to assess sex differences 
in age, height, body mass, BMI and TFEQ.  Repeated measures one way ANOVA was 
used to determine whether there were any statistically significant differences between 
females and males for VAS appetite scores over time. 
AUC composite appetite scores were calculated using the equation  hunger score+ 








 Baseline characteristics of the study participants 
The baseline characteristics of all the participants are displayed in table 5.1. There was 
a significant difference in TFEQ restraint between males and females, with females 
having higher scores on this measure. 
Table 5-1 : Baseline characteristics of the study participants 
Variables 
 
All  (n=26) 
Mean ± SD 
Females (n=17) 
Mean ± SD 
Males (n=9) 
Mean ± SD 
t P d 
Age (y) 56.7±12.5 53.7±14.1 61.3±7.1 -1.517 0.142 0.685 
Height (m) 166.8±10.1 163.5±9.7 173±7.9 -2.407 0.018 1.080 
Body mass (kg) 114.8±17.5 113.6±16 117.00±21 -0.457 0.652 0.179 
BMI (kg/m2) 41.1±5 42. 4±4.7 39.4±5.8 1.465 0.165 0.532 
WC (cm) 124.6±11.5 123.5±10.7 126.7±13.2 -0.668 0.510 0.265 
TFEQ Hunger 5.4±3.9 5.3±4.1 5.4±3.7 -0.013 0.989 0.005 
TFEQ Restraint 9.4±3.2 10.4±3.2 7.1±1.9 2.481 0.007 1.245 
TFEQ Disinhibition  7±3.7 7.1±4.1 6.9±2.85 0.158 0.876 0.078 
Values are mean ± standard deviation, n=26, WC = waist circumference, BMI = body mass index, p < 0.05 
for the differences by between males and females. d= Cohen's d.  
 
 Percentage weight loss after one month 
Figure 5.1 shows individual percentage weight loss after one month. Twenty four of 
the participants lost weight (17 female and 7 males) and two males gained weight. 
There were no differences in average weight loss between females and males. Average 








Figure 5-1: Individual percentage weight loss and weight gained after one month on  
Advice diet and regular exercise. 
 
 Percentage weight loss after three months 
Figure 5.2 shows percentage weight loss after three months. 13 participants lost 
weight (9 female and 4 males) over three months. Average weight loss for females was 





























































































 VAS scores versus time post breakfast, during the test morning.  
Figure 5.3 shows mean and SD of VAS appetite scores for females and males. Based on 
repeated measure one way ANOVA there were no significant differences in mean VAS 
























































































Figure 5-3 :  The VAS scores for hunger (A), fullness (B), desire to eat (C) and prospective food intake (D) versus time post breakfast,  
                during the test morning. p= 0.07 for hunger, p= 0.456 fullness, p= 0.190 desire to eat and p=0.083 prospective food intake.
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 VAS appetite scores and subsequent weight loss 
5.3.5.1  Relationship between VAS scores (different time points, AUC and SQ) and 
percentage weight loss after one month 
 
Table 5.2 shows the relationship between VAS scores (different time points, AUC and 
SQ) and percentage weight loss after one month of all participants. None of the scores 
at individual time points, AUC or SQ of VAS were significantly correlated with 
percentage weight loss after one month on advice diet and regular exercise. There was 
an inverse correlation between the 75 min desire to eat and percentage weight loss 
after one month and a positive correlation between SQ desire to eat score and the 
percentage weight loss after one month, but these did not reach significance. In 
females after adjusting for age, SQ hunger (r=0-.590*, p=0.034) and SQ fullness (r=-
0.555*, p=0.049) were significantly negatively correlated with percentage weight loss 
after one month. 
When the participants were split by gender (shown in figure 5.4 (A)) the analysis 
showed a negative correlation in females between fasting hunger scores (r=-0.561*, 
p=0.037) and percentage weight lost after one month. Whereas, there was no 
correlation in males between fasting hunger scores and percentage weight loss after 
one month. Moreover, in figure 5.4 (B) there was a significant inverse correlation 
between VAS 30 min fullness (r=-0.574, p=0.032) and percentage weight loss after one 










Table 5-2 : Relationship between VAS scores (different time points, AUC and SQ) and percentage 





weight loss after 
one month  




Fasting   
prospective food intake 
Spearman 
correlation 
-.0234 -0.259 0.028 -0.015 
Sig. (2-tailed) 0.295 0.244 0.902 0.948 
     
Percentage 







desire to eat 




--0.330 -0.101 -0.371 -0.254 
Sig. (2-tailed) 0.133 0.655 0.089 0.243 
     
Percentage 







desire to eat 




-0.318 0.205 -0.367 0.019 
Sig. (2-tailed) 0.149 0.359 0.093 0.932 
     
Percentage 
weight loss (after 
one month) 
AUC  hunger AUC  
fullness 












-0.171 0127 -0.185 -0.118 -0.268 
Sig. (2-tailed) 0.445 0.574 0.409 0.602 0.228 
      
Percentage 
weight loss after 
one month 
SQ hunger SQ 
fullness 












-0.175 -0.213 0.393 -0.043 -0.008 
Sig. (2-tailed) 0.436 0.342 0.071 0.849 0.973 
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5.3.5.2  Relationship between VAS scores (different time point, AUC and SQ) and 
percentage weight loss after three months. 
Table 5.3 represents the relationships between VAS (different time points, AUC and 
SQ) and percentage weight loss after three months for all participants. There was a 
negative correlation between the 15 mins prospective food intake (r=-0. 615*, 
p=0.044) and percentage weight loss after three months.  Fasting hunger, fasting 
fullness, ratings at 15 mins after breakfast for hunger, fullness and desire to eat 
questions, 75 min desire to eat for 4 questions and AUC composite of appetite score 
were negatively correlated with percentage weight loss after three months and SQ 
desire to eat was positively correlated with percentage weight loss after three months, 
but none of these correlations reached significance. There were no correlations 

















Table 5-3 : Relationship between VAS scores (different time points, AUC and satiety quotient) 
and percentage weight loss after three months for all participants. (N=11) 
Percentage weight 







desire to eat 
Fasting prospective food intake 
Spearman 
correlation 
-0.312 -0.457 -0.137 -0.034 
Sig. (2-tailed) 0.350 0.158 0.689 0.920 
     
Percentage weight 







desire to eat 
15 mins prospective food intake 
Spearman 
correlation 
-0.538 -0.303 -0.557 -0. 615* 
Sig. (2-tailed) 0.088 0.365 0.075 0.044 
     
Percentage weight 







desire to eat 
75 mins prospective food intake 
Spearman 
correlation 
-0.155 0.102 -0.366 -0.041 
Sig. (2-tailed) 0.649 0.766 0.268 0.905  
      
Percentage weight 
















-0.509 0.022 -0.291 -0.270 -0.391 
Sig. (2-tailed) 0.110 0.949 0.386 0.422 0.234 
      
Percentage weight 
















-0.299 -0.231 0.452 0.013 0.034 








5.3.5.3  Relationship between VAS (different time points, AUC and SQ) and BMI 
change 
Table 5.4 displays relationships between VAS scores (different time points, AUC and 
SQ) and BMI change in all participants. None of the measures at different time points, 
AUC and SQ of VAS correlated with percentage weight loss after one month. Fasting 
hunger, 75 min desire to eat and SQ desire to eat and SQ composite of appetite score 
were negatively correlated with BMI change and SQ fullness was positively correlated 
with BMI, but these correlations did not reach significance. In females, after adjusting 
for BMI, SQ hunger values were negatively correlated (r=0-.641, p=0.018) with BMI 
change. When the participants were split by gender (figure 5.5 (A)) the analysis 
showed a significant negative correlation between fasting hunger (r=-0.552, p=0.04) 
and BMI change in females. Whereas, there was no correlation found in males 
between VAS fasting hunger and BMI change. Moreover, in figure 5.5 (B) there was no 
















Table 5-4: Relationship between VAS scores (different time points, AUC and SQ) and BMI change 
for all participants. (N=22) 











-0.354 -0.265 -0.036 -0.036 
Sig. (2-tailed)  0.106 0.233 0.873 0.875 
     











-0.284 -0.184 -0.276 -0.189 
Sig. (2-tailed) 0.200 0.411 0.214 0.399 
     












-0.229 0.148 -0.349 -0.005 
Sig. (2-tailed) 0.305 0.510 0.111 0.982 
     
BMI change  AUC hunger  AUC 
fullness 
AUC desire 
to eat  
AUC 
prospective 







-0.240 0.063 -0.182 -0.120 -0.268 
Sig. (2-tailed) 0.282 0.782 0.416 0.596 0.228 
      










-0.239 0.308 0.009 -0.218 -0.310 






5.3.5.4  VAS (different time points, AUC and SQ) and waist circumference change. 
Table 5.5 presents relationships between VAS scores (different time points, AUC and 
SQ) and waist circumference change of all participants. None of the measures at 
different time points, AUC and SQ of VAS scores were correlated with waist 
circumference change. There was a negative correlation between 75 min desire to eat 
and waist circumference change and a positive correlation between SQ desire to eat 
and SQ composite of appetite score and waist circumference change, but these did not 
reach significance However, after adjusting for age there was a negative correlation 
between SQ composite appetite scores (r=0-.444*, p=0.044) and waist circumference 
change of all participants. Moreover, after adjusting for age, SQ composite appetite 
score was strongly negatively correlated (r=-0.688*, p=0.009) with waist circumference 
change in females. After adjusting for BMI, SQ desire to eat was positively correlated 
(r=0.559*) (p=0.047) with waist circumference change in females. Furthermore, in 
males after adjusting for BMI, SQ desire to eat was negatively correlated (r=0-.930*, 
p=0.002) with waist circumference change and AUC hunger (r=-.785*, p=.036) and AUC 
composite appetite scores (r=-0.802*, p=0.030) were also inversely correlated with 
waist circumference change. In figure 5.5 (c), when the participants were split by 
gender the analysis showed no correlation between SQ desire to eat and waist 













Table 5-5 : Relationship between VAS scores (different time points, AUC and SQ) and waist 















-0.037 -0.018 0.088 0.089 
Sig. (2-tailed) 0.869 0.936 0.698 0.693 








15  mins 
desire to 
eat   
15  mins can eat more  
Spearman 
correlation 
-0.092 0.183 -0.150 -0.107 
Sig. (2-tailed) 0.684 0.416 0.505 0.635 











75 mins can eat more 
Spearman 
correlation 
-0.217 0.075 -0.308 -0.026 
Sig. (2-tailed) 0.332 0.740 0.163 0.909 




















-0.042 0.198 -0.142 -0.090 -0.214 
Sig. (2-tailed) 0.853 0.378 0.528 0.692 0.339 




















0.134 -0.053 0.369 0.152 0.282 
Sig. (2-tailed) 0.552 0.816 0.091 0.500 0.216 
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Female  r=-0.561 P=0.037
Male r=0.0231 p=0.957
-2 0 2 4 6 8
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Female  r=-0.574 P=0.032
Male r= 0.286 p=0.493
























                            Figure 5-4: Relationship between VAS and percentage weight loss after one month. (A=VAS fasting hunger B= VAS 30 min fullness and C= SQ fullness scores). 
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Female  r=-0.252 P=0.383
Male r=-0.236 p=0.573



















Female  r= -0.552 P=0.040
Male r=-0.069 p=0.872

























        
Figure 5-5 : Relationship between VAS scores and BMI and waist circumference change. (A=VAS fasting hunger B= SQ hunger scores and 
C= SQ desire to eat scores). 
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 The correlation between TFEQ subscales and subsequent weight 
loss   
Table 5.6 displays relationships between the scores for the TFEQ subscales and 
subsequent weight loss. There was no correlation between the TFEQ subscales and 
subsequent weight loss. TFEQ Hunger and TFEQ Disinhibition were inversely correlated 
with percentage weight loss after one month, but this did not reach significance.  
  Table 5-6 : Correlation between TFEQ subscales and subsequent weight loss 








Spearman correlation -0.311 -0.145 -0.385 
Sig. (2-tailed) 0.130 0.490 0.057 
N 25 25 25 








Spearman correlation 0.152 0.033 0.012 
Sig. (2-tailed) 0.620 0.914 0.970 
N 13 13 13 






Spearman correlation -0.144 -0.063 -0.242 
Sig. (2-tailed) 0.493 0.766 0.245 
N 25 25 25 






Spearman correlation -0.084 0.040 -0.142 
Sig. (2-tailed) 0.689 0.850 0.499 




                                                      
 Fasting plasma gut hormones concentrations and subsequent 
weight loss 
Table 5.7 presents the relationships between fasting plasma concentrations of ghrelin, 
PP, PYY and GLP-1 and subsequent weight loss for. PYY levels showed a positive 
correlation (r=0.432*, p=0.045) with percentage weight loss after one month. 
Moreover, PYY was positively correlated with BMI change and negatively correlated 
with percentage weight lost after three months, but these correlations did not reach 
significance.  In figures 5.6, 5.7 and 5.8 when the participants were split by gender, 
analysis highlighted that no correlations were seen between gut hormone 
concentrations and subsequent weight loss. 
         Table 5-7 : The correlation between fasting plasma gut hormone concentrations and weight   
loss subscales  
  *Correlation is significant at p< 0.05 level (2-tailed). 
 
Percentage weight 
 loss after one month 
ghrelin PP PYY GLP-1 
Spearman correlation 0.035 0.198 0.432* -0.025 
Sig. (2-tailed) 0.878 0.378 0.045 0.911 
N 22 22 22 22 
Percentage weight 
 loss after three months 
ghrelin PP PYY GLP-1 
Spearman correlation -0.263 0.086 -0.343 0.078 
Sig. (2-tailed) 0.434 0.803 0.302 0.819 
N 11 11 11 11 
BMI change  ghrelin PP PYY GLP-1 
Spearman correlation -0.088 0.218 0.383 -0.029 
Sig. (2-tailed) 0.696 0.330 0.079 0.897 
 N 22 22 22 22 
Waist circumference 
change 
ghrelin PP PYY GLP-1 
Spearman correlation 0.123 0.080 0.207 -0.223 
Sig. (2-tailed) 0.584 0.722 0.356 0.319 























Female  r= 0.12P=0.683
Male r=0.165 p=0.696















Female  r=0.254 P=0.382
Male r=0.178 p=0.674















Female  r=-0.082 P=0.781
Male r=0.754 p=0.031













































Female  r= -0.012 P=0.967
Male r=0.123 p=0.772

















Female  r=0.076 P=0.800
Male r=-0.288 p=0.488















Female  r=0.154 P=0.598
Male r= 0.7107 p=0.048




















Figure 5-7: Relationships between plasma gut hormones and BMI change (A= fasting ghrelin B= fasting PP C= fasting PYY and D= fasting GLP-1). 
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Female  r=-0.072 P=0.807
Male r=0.217 p=0.607
















Female  r=0.152 P=0.603
Male r=-0.034 p=0.936
















Female  r= -0.122 P=0.677
Male r=0.595 p=0.120























                                         Figure 5-8: Relationships between fasting plasma gut hormones and waist circumference change (A= ghrelin, B= PP,  C= PYY and D= GLP-1 ). 
206 
 
 Identification of individual satiety phenotypes  
The independent variables selected in chapter 4 were used to assess satiety phenotype 
in the present study to determine whether satiety phenotype predicted weight loss. As 
the participant numbers in this part of the study were low, the heat map included all 
participants rather than splitting them by gender.  
Table 5.8 presents the heat map and satiety phenotypes determined for all 
participants. Using the scoring system developed in chapter 4, this identified that 
seven people had a low satiety phenotype, eleven people with a medium satiety 













































































































































1                 9 Medium satiety 
2                 10 Low satiety 
5                 5 High satiety 
8                 4 High satiety 
10                 8 Medium satiety 
11                 8 Medium satiety  
13   
 
            6 Medium satiety 
15                 13 Low satiety 
18                 11 Low satiety 
19                 2 High satiety 
20                 4 High satiety 
21                 7 Medium satiety 
22                 9 Medium satiety 
23                 7 Medium satiety 
24                 5 High satiety 
25                 4 High satiety 
26                 11 Low satiety 
28                 6 Medium satiety 
30                 5 High satiety 
31                 6 Medium satiety 
32                 8 Medium satiety 
33                 9 Medium satiety 
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 Weight loss of participants by satiety phenotype 
Figure 5.9 A, B and C presents the average subsequent weight loss of all participants 
divided by their phenotype of low, medium and high satiety. As can been seen in figure 
(A), (B) and (C) there were no differences between the 3 groups based on one way 
ANOVA.  Average BMI change p=0.523, average waist circumference change p=0.6496 
and average body weight change   p= 0.6739. In general people who had low satiety, 
had lower average weight loss and lower average BMI change, but there was wide 


































































































































         Figure 5-9 : Average subsequent weight loss of all participants one month on a diet (A= 




  Average TFEQ subscales and subsequent weight loss 
Figure 5.10 represents the average TFEQ subscale and subsequent weight loss after 
one month on Advice diet and regular exercise. Based on one way ANOVA there were 
differences between low, medium and high satiety groups in TFEQ Restraint scores p= 
0.0120 and TFEQ Hunger scores p=0.0014. However, there were no significant 
differences between low, medium and high satiety groups for TFEQ Disinhibition 
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     Discussion 
Gaining a better understanding of and identifying the factors that influence weight 
change prior to weight loss programmes is important to encourage successful weight 
loss (James et al., 2018). The main aim of this study was to investigate variables which 
might predict weight loss and thus identify those individuals, prior to their 
participation in a weight management programme, who may struggle to lose weight 
due to impaired satiety.  
   Baseline characteristics of participants  
Females showed higher scores of TFEQ Restraint than males at baseline, which is in 
agreement with previous reports that Restraint and Disinhibition scores were higher in 
women compared to men (Bellisle et al., 2009; Lesdema et al., 2012; Westenhoefer,  
Stunkard and Pudel, 1999). 
 VAS scores at different time points and percentage of weight loss 
after one month 
The present study indicates that people who had high VAS hunger scores at different 
time points, measured by AUC and SQ subsequently struggled to lose weight. Taking 
gender of participants into account, the present study showed that females with 
higher fasting hunger scores lost less percentage of weight after one month (r=-0.561*, 
p=0.037). Whereas, fasting hunger scores in males did not predict percentage weight 
lost after one month. The current study’s findings are in accordance with those 
recently observed in another weight loss intervention where Sayer et al., (2018) 
reported that higher baseline hunger VAS scores were inversely associated with weight 
loss at 16 and 24 weeks in 120 participants.  
The finding of the current study showed VAS fullness score did not predict weight 
change in males. Similarly, Sayer et al., (2018) found that fullness ratings were not 
associated with changes in body weight in all participants. Furthermore, the findings of 
the current study reported that females who were less full at 30 min (r=-0.554, 
p=0.032) based on fullness VAS, lost more percentage of weight after one month. 
Whereas, fasting hunger VAS in males and SQ fullness scores in females and males did 
not predict percentage weight loss after one month. The explanation for this result 
could be low sample numbers.  Adam et al., (2006) also reported a similar outcome 
211 
 
after, an 8% weight loss. Moreover, Drapeau et al., (2007) reported that they did not 
find a correlation between SQ fullness and weight change in males. 
In agreement with the present study, Nymo et al., (2017) examined relationships 
between VAS scores and weight loss and reported that hungrier people found it harder 
to lose weight at baseline in 31 participants. Two previous studies by Drapeau et al., 
(2007) and Doucet et al., (2000) reported that higher fasting hunger scores were 
associated with a lower body weight loss in men, a possible explanation for the 
present study not finding a relationship, may be the smaller sample size and the study 
did not have the power to show any relationship. 
5.4.2.1   SQ of VAS and percentage of weight loss after one month 
The present study indicates that SQ did not significantly correlate with percentage 
weight loss after one month. This finding agrees with an earlier study by Drapeau and 
colleagues who found the baseline of SQ did not correlate with weight loss in men (n = 
176) and women (n = 139) (Drapeau et al., 2007).  
5.4.2.2  SQ of VAS and BMI change 
In females, after adjusting for BMI, SQ hunger was negatively correlated (r=-0.641, 
p=0.018) with BMI change.  The present study showed that females who had lower 
fasting hunger scores (r=-0.552*, p=0.040)  had a reduced BMI after one month, while  
fasting hunger and SQ hunger scores in males did not predict BMI change after one 
month. 
5.4.2.3  SQ of VAS and waist circumference change 
Based on the literature, few studies have focused on the SQ to predict weight change. 
The present study’s findings are in agreement with McNeil et al., (2014) who reported 
SQ desire to eat was negatively correlated with waist circumference change.   
 Fasting plasma gut hormones and percentage weight loss after one 
month 
The present study indicated that participants who had higher fasting concentrations of 
plasma PYY showed the greatest percentage weight loss after one month. This finding 
is in accordance with those observed in a weight loss intervention, reported by Roth et 
al., (2005) which indicated that higher baseline fasting PYY levels were associated with 
weight loss, and the increase in PYY is positively related to the extent of weight loss. 
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The finding of the present study showed that ghrelin did not predict weight loss after 
one month. Similarly, Polsky et al., (2013) also observed that baseline ghrelin and PP 
did not predict weight loss in 61 subjects participating in a 16-week intervention for 
weight loss. However, this finding is in contrast with Williams et al., (2016) who found 
that a higher baseline concentration of unacylated ghrelin predicted greater weight 
loss at six months in males and females. However, the types of ghrelin measured was 
different in both studies, Williams et al., measured baseline unacylated ghrelin for 
predicting weight loss whereas in the current study acylated ghrelin was measured to 
predict weight loss. Acylation is thought to be essential for ghrelin to bind to the GHS-
R1 and to cross the BBB.  In humans, unacylated ghrelin does not possess the pituitary 
and pancreatic activity of acylated ghrelin. Therefore, unacylated ghrelin is considered 
to be unimportant for appetite regulation (Broom et al., 2007) and it is recommended 
that acylated ghrelin is studied, as in the current study.   
Furthermore, Sumithran et al., (2011) observed that high baseline ghrelin in 34 women 
was associated with weight loss at 12 months after caloric restriction and exercise. The 
current study included both sexes, whereas the Sumithran et al., study included only 
females. A potential explanation why ghrelin predicted weight loss in the Sumithran et 
al., study   is the weight loss period was shorter in this present study (one month and 3 
months) than in Sumithran et al., (2011) which was 62 weeks. Sumithran et al., (2011) 
only included females, it has also been suggested that females have higher baseline 
ghrelin (Makovey et al., 2007) which could explain the differences between the studies. 
In the present study, baseline PP concentration was not significantly correlated with 
percentage weight loss after one month in female participants. This finding is in 
contrast with Hainer et al., (2008) who reported that PP was inversely correlated with 
BMI change in women. A potential explanation for differences in the result may be 
sample size. Hainer et al., (2008) included sixty seven women whereas the current 
study included only seventeen.   
In the present study, GLP-1 hormone levels did not correlate with subsequent weight 
loss. The present study found that baseline GLP-1 levels did not predict weight loss 
percentage after one month. A previous study by Polsky et al., (2013) showed GLP-1 
did not predict weight loss, which agrees with the present study.  
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5.4.3.1  Plasma gut hormones and BMI change 
The findings of the present study showed no correlation between baseline ghrelin and 
BMI change. However, other authors have found higher baseline ghrelin 
concentrations were inversely correlated with BMI changes at 12 months (Garcia, et al., 
2006). The difference is likely to be due to the longer period of the intervention. It has 
also been reported that there are sex differences in the plasma concentrations of 
ghrelin, overweight females having higher fasting concentrations (Makovey et al., 
2007) than overweight males.  
In the present study, baseline plasma levels of PP hormone did not predict BMI change 
in female participants. This finding is in contrast with Hainer et al., (2008) who 
reported that PP was inversely correlated with BMI change in 67 women.  
5.4.3.2  Plasma gut hormones and waist circumference change 
In the current study, there was no correlation between baseline PP and change in 
waist circumference. The finding of the current study differs from a study by Koska et 
al., (2004) who demonstrated that fasting PP level was negatively associated with 
waist circumference change. However Koska's study was carried out in Pima Indians 
who have a genetic propensity to weight gain. 
 In the current study there was no correlation between baseline measurement of 
plasma ghrelin and waist circumference and percentage of weight lost change after 
one month. Similarly, Santosa et al., (2007) showed initial level of ghrelin did not 
predict weight loss in 35 women. 
There was no correlation between baseline PP and percentage of weight loss change 
after one month and BMI. This agrees with Dixon et al., (2011) who have also indicated 
that fasting level of PP did not predict weight loss.  
When split by gender of participants, plasma level gut hormones did not predict 
subsequent weight loss. This finding is in agreement with a previous study of a weight 
management programme where Hainer et al., (2008) found no significant correlation 
between baseline levels of PYY and weight loss after a 3-week weight management in 
67 women with obesity.  
When split by gender of participants, plasma levels PP hormone did not predict 
subsequent weight loss. However, findings of Hainer et al., (2008) contrasts with the 
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findings of the present study as they reported baseline PP concentrations were 
inversely related to waist circumference change in women.  
 TFEQ subscales and subsequent weight loss 
The results of the current study reported that people with low scores of hunger (TFEQ 
Hunger and TFEQ Disinhibition) lost more weight. Previous research showed a similar 
pattern in which baseline TFEQ Hunger scores were negatively correlated with weight 
change (R= - 0.25, p = 0.03) at 6 months (Batra et al., 2013). Moreover, other previous 
findings are also in agreement with the present study result, Bas and Donmez, (2009) 
reported that lower TFEQ Hunger and TFEQ Disinhibition scores show associations with 
weight loss at 20 weeks.  A previous study by Hays et al., (2006) was in partial 
agreement with the present study finding, which showed low hunger scores at 
baseline predict weight loss whereas TFEQ Restraint did not predict weight loss. 
However, it was in contrast to the current study finding where reported disinhibition 
did not predict weight change. The potential explanation for these differences may be 
longer duration of weight loss interventions. Larger samples of females in Hays et al., 
(2006) could also explain these differences.  
The findings of the current study are in contrast to Teixeira et al., (2010) who reported 
TFEQ Hunger and TFEQ Disinhibition did not predict weight change at 12 months in 
225 overweight and obese women. This difference in findings may be duration of 
weight loss programme in Teixeira et al., (2010) which was 12 months.  
In contrast to the present study, James et al., (2017) indicated that lower baseline 
TFEQ restraint predicted greater weight loss over the year and  baseline levels for all 
other subscales were not significantly related to weight change over one year. The 
differences in findings could be explained by the large sample of females in James et 
al., (2017) which was 186 females, whereas the present study only had 17 females.  
Duration of weight loss could also explain the differences with the duration study of 
James et al., (2017) being one year and present the study one month. 
The findings of the current study showed TFEQ Hunger did not predict BMI and waist 
circumference change. This is in contrast with Provencher et al., (2003) who showed a 
positive association between susceptibility to hunger and BMI and waist circumference. 
The results of Provencher et al., (2003) differ from the current study in sample size as 
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their study included 596 participants and mean weight, BMI and waist circumference 
were lower than the present study, which may explain the different result. Another 
explanation may be age, as in the current study the average age was 27-77 years which 
is higher than the age of participants in the previous study mentioned above and 
people eat less and make different food choices as they get older and it could explain 
the differences (Drewnowski and Shultz, 2001). 
 Identification of satiety phenotype 
The heat map was constructed using the methodology developed in the previous 
chapter.  Using this method, the satiety phenotype of twenty two participants was 
determined, seven participants were identified with a high satiety phenotype and four 
participants with a low satiety phenotype and the remainder with a medium satiety 
phenotype. The findings of the present study indicated that people with the high 
hunger phenotype on average had a lower change in BMI, percentage of weight loss 
after one month and waist circumference change compared to the other groups. 
Moreover, low satiety phenotype participants had the highest TFEQ Hunger scores at 
baseline compared to people with the lower and medium hunger phenotypes and had 
medium TFEQ-R and low TFEQ-D, although this is not surprising as the TFEQ hunger 
score was one of the variables used to build the heat map. 
The heat map is a visual representation of data and is designed to make an easy score 
sheet that could be used in the clinic to determine someone’s satiety phenotype. This 
method of using a heat map could allow clinical staff to predict satiety phenotypes of 
individuals prior to their participation in a weight loss programme. This heat map 
method will direct clinical staff to make plans for personalised programmes to 
facilitate weight loss for each participant.       
  Summary  
The key findings of this chapter are that people who had high hunger scores at 
different times points, measured by AUC and SQ of VAS subsequently struggled to lose 
weight. VAS fullness did not predict weight change in males. In the present study 
females who had higher fasting hunger scores, lost a lower percentage of weight after 
one month. Whereas, fasting hunger in males did not predict percentage weight loss 
after one month. Changes in waist circumference were positively associated with 
desire to eat SQ in females. Fasting plasma gut hormones did not correlate with 
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subsequent weight loss.  The results of the current study report that, people with low 
scores of hunger (TFEQ Hunger and TFEQ Disinhibition) had more weight loss 
subsequently. 
Based on the findings of the current study, the VAS measure (fasting hunger and 30 
min fullness) was the best measure to predict weight loss of people with obesity prior 
to starting on a weight management program. The findings of the present study 
indicated that people with the low satiety phenotype on average had a lower change 
in BMI and lower percentage weight loss after one month and lower waist 
circumference change compared to the other groups and had the highest TFEQ Hunger 
scores at baseline, compared to people with than low and medium hunger phenotypes 
and had medium TFEQ Restraint and low TFEQ Disinhibition. 
In chapter 4 the results showed differences between women and men for the TFEQ 
scores therefor in chapter 6 the data was split into 2 groups only as the distribution of 
the participants meant that one group would only have 1 male participant which is not 
possible to analyse statistically. 
 Study strengths and limitations 
The present study has strengths and limitations. One strength is that it included both 
males and females, which helped to provide more data regarding gender and weight 
loss, as males are a commonly under represented group in these types of interventions. 
Moreover, it has used questionnaires, VAS hunger at different point and fullness SQ 
scores and PPY hormone measurements to predict people who struggle to lose weight. 
The current study presented data for one month, which is valuable to make predictions 
in the short term prior to initiating a weight loss programme as many studies predicted 
weight loss over 6 months or more. A major limitation was the small sample size, 













Evaluation of food cravings, hunger and food intake as predictors of 

















It is well known that imbalance between EI and energy expenditure leads to weight 
gain. There are numerous proven methods to lose weight, including lifestyle 
modification, pharmacotherapy and bariatric surgery. Despite these methods, many 
individuals who attempt weight loss are not successful. One thing that could help in 
improving effective weight loss strategies would be a better understanding of the 
factors that predict the ability to lose weight (Polsky et al., 2013).  
 Factors reported to predict successful weight loss 
6.1.1.1 Food cravings 
Food cravings have been recognised as one possible precursor to overeating (Gendall 
et al., 1998). Food cravings are a powerful physiological and psychological urge that 
induce the seeking and eating of a food (Cepeda-Benito et al., 2000). Thus, cravings 
differ from hunger in that they usually concentrate on specific individual foods that are 
often high energy foods (Christensen, 2007; Gilhooly et al., 2007), whereas hunger is 
relieved by a variety of foods (Martin, O’Neil and Pawlow, 2006) that differ in caloric 
density. Previous research has reported that individuals with higher frequencies of 
food cravings have higher BMI than normal weight individuals (Abiles et al., 2010; Chao 
et al., 2014). Experiencing food cravings has been identified to be a common 
phenomenon (Dalton et al., 2017). However, the frequency and intensity of food 
cravings appear to be more prevalent and intense in people with obesity and are 
associated with excess EI, weight gain, lack of success in weight loss and early drop-out 
from obesity treatment programmes (Delahanty et al., 2002: White et al., 2002). This 
raised level of food cravings may explain why some people with obesity struggle to 
lose weight. Measurement of initial food craving scores for people prior to weight loss 
programmes may improve weight intervention strategies and help participants to 
succeed in weight loss.  
There are gender differences in the risk for, and consequences of obesity. Gender is a 
known risk factor for obesity and being female doubles the chance of becoming 
overweight (Martin and Ferris, 2007). Globally, females are three percent more likely 
to become overweight or obese than men (WHO, 2010). Because females are 
increasingly affected by obesity, there may be a gender-related mechanism that 
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underlies these differences. Given the role of craving in obesity, one mechanism 
underlying gender-based health disparities in obesity could relate to gender 
differences in craving; it has been shown that men and women have different 
experiences of craving and different behavioural responses to it (Hallam et al., 2016). 
6.1.1.2 Measurement of food cravings 
It has been shown that the FCI is a reliable and valid measure of general and specific 
food cravings (White et al., 2002), which can be used in research related to overeating 
and binge eating. Moreover, the FCI may be useful and valuable in treatment studies 
that target obesity and/or food cravings (White et al., 2002). Many studies have 
examined the relationship between food cravings and weight change. Ferguson et al., 
(1992) and Elfhag and Rössner, (2005) suggested that reducing and managing food 
cravings is a key component in the management of obesity and successful weight loss 
maintenance. Moreover, previous findings reported that initial high levels of food 
craving may be related to less successful weight loss (Abilés et al., 2010; Chao et al., 
2014; Franken and Muris, 2005). In contrast, a study by Batra et al., (2013) reported a 
positive correlation between food craving and baseline BMI, which demonstrated that 
there was no significant relationship between baseline food craving and weight change.  
 Eating behaviours  
Individual differences in stable eating behaviours have a significant impact on food 
choices, EI and BMI. Most people will overeat to a certain extent in a high-risk food 
environment. However, some people are likely to be more susceptible than others and 
are at higher risk for excess EI and weight gain (French et al., 2012; Blundell and 
Cooling, 2000; Blundell et al., 2005). The TFEQ is one method of measurement that has 
been developed to measure individual differences in eating behaviours related to EI 
and body weight. The TFEQ has been widely applied as a tool in weight loss research to 
measure eating behaviour traits in people with obesity. It has been used to predict 
weight loss in clinical patients, and to monitor changes throughout treatment 
(Stunkard and Messick, 1985; Bryant, King, and Blundell, 2008). Previous studies have 
focused on two eating behaviours traits (Restraint and Disinhibition) in weight loss 
intervention studies. However, examination of the hunger subscale of TFEQ to predict 
weight loss has had little attention in the literature.  
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Two studies have shown that TFEQ Hunger is inversely correlated with weight loss and 
those individuals who had higher baseline scores of TFEQ Hunger struggled to lose 
weight. Bas and Donmez, (2009) have reported that there was a negative correlation 
between baseline hunger and weight change. Batra et al., (2013) have shown that 
reduction in baseline hunger subscale scores was associated with greater weight loss.  
 Food diaries 
Dietary records or food diaries are a prospective, open-ended survey method where 
the subjects are given a recording form to collect data about their foods and beverages 
consumed over a previously specified period of time. They can be useful to estimate 
the current diet of individuals and population groups, as well as to identify groups at 
risk of inadequacy. Food diaries have been used in epidemiological and in clinical 
studies (Ortega, Pérez-Rodrigo and López-Sobaler, 2015). Previous research has 
reported that dietary records have high validity and precision when used following 
adequate procedures and over a sufficient number of days (Yang et al., 2010; Schlundt, 
1998) (More details on food diaries are discussed in chapter one). Macronutrients play 
a role in satiety.  This has culminated in a macronutrients hierarchy of satiating power, 
with protein having the highest potency (protein > CHO > fats) (Blundell and 
Macdiarmid, 1997). 
 
An understanding of macronutrient composition i.e. the relative amounts of protein, 
fat, and CHO on short-term food intake (FI) may assist in the design of longer trials 
aimed at achieving healthier body weights. There is considerable confusion, for 
example, about the dietary mechanism that supports long-term weight reduction and 
the maintenance of reduced body weight. For this reason, a better understanding of 
diet and the short-term effects of its composition may offer approaches and insights 
into the design of strategies and meal plans for successful long-term weight reduction 
(Bellissimo and Akhavan, 2015). Several studies have used food diaries to examine 
macronutrient intake in predicting weight loss.  Buscemi et al., (2017) reported that 
low initial levels of caloric intake were positively associated with changes in BMI.  
Moreover, Hays et al., (2006) indicated that reported fibre intake was significantly 
positively associated with weight change, whereas CHO and protein intakes were 
significantly inversely associated with weight change. Conversely, Savage, Marini and 
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Birch (2008) found that fibre and caloric beverage intakes were not significant 
predictors of weight change.  
 Shape-Up 
The current study was carried out at Rotherham Leisure Complex, Rotherham, UK as 
part of a tier 2 services called Shape-Up. It is a multicomponent lifestyle intervention 
that has been recommended by National Institute for Health and Care Excellence 
(NICE) to manage obesity. Tier 2 programmes include dietary advice, physical activity 
and behavioural therapies and are generally delivered over 10 weeks (Read and Logue, 
2016). These programmes aim to support adults who are classified with BMI of ≥25 
kg/m2 (without comorbidities or managed comorbidities) to lose weight and sustain 
their weight loss through a multicomponent programme (Ells et al., 2018).  Often Tier 2 
programmes are offered within a primary care setting, however some areas have 
commissioned commercial organisations to deliver weight management services in the 
community (Read and Logue, 2016). The Shape-Up Programme is a unique programme 
that gives participants the opportunity to go through the self-help manual together as 
a group.  It consists of 10 week sessions with groups run for 2 hours in the morning and 
evenings at times to suit a range of people. Each session covers a topic including: how 
to limit further weight gain, how to achieve modest weight loss at a healthy, 
sustainable rate, getting into a regular eating pattern and how to balance the types of 
food that participants eat. The Shape-Up programme combines expertise in psychology, 
nutrition, exercise and health promotion to maximise the participants' chance of 
successful weight loss. 
 Aims 
The main aim of the present study was to identify at baseline, individuals with a 
reduced satiety phenotype who may struggle to lost weight on a weight management 
programme. 
Objectives: 
 1- To investigate the relationship between TFEQ subscales and weight loss.  
2- To investigate the relationship between 3- day food diary content and weight loss. 
3- To investigate the relationship between food craving scores and weight loss. 
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4 – To combine these data to investigate whether it is possible to identify individuals 
with a reduced satiety phenotype. 
 Materials and methods  
 Participants and recruitment 
Forty-nine people (37 female and 12 male) with either obesity or overweight were 
recruited from Rotherham Leisure Complex, Rotherham, UK. All participants were on a 
10 week weight loss programme (advice diet and regular exercise). Of those, thirty- 
nine participants (29 females and 10 males) completed the study. Ten were excluded 
from analysis as five of them signed up but then changed their minds, two did not 
meet the inclusion criteria of the study due to having diabetes and three participants 
dropped out after only 3 sessions of the programme. Ethical approval for the study 
was granted by Rotherham Council (ID/ 208879)( Appendix 15). 
Participants were excluded if they had any chronic disease such as heart disease 
diabetes or hypertension. Participants were aged between 23-81 years (Mean ± SD 
50.69±13.82). Details of the study design, study setting, anthropometry and 
questionnaires  (TFEQ, food craving and food diary questionnaires)  were used in this 
study as previously described  in the relevant sections in the general methods (chapter 
2). 
 Questionnaires 
Participants were recruited through two visits by the researcher on two consecutive 
weeks. A presentation was made about the study for participants at the Rotherham 
Leisure Complex during the first session of their programme. They were provided with 
information and a description of the study protocol and study packs were given to 
anyone interested in taking part. The packs included the FCI questionnaire and TFEQ-
51.  Participants were also asked to complete a 3-day food diary during the week. After 
the session in week 1, researchers returned the following week to collect the 
questionnaires. Participants completed and signed the consent form. Food diaries 
were analysed using recorded data to assess total energy and macronutrient intake as 
described previously.   
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 Statistical analysis 
All data were analysed using SPSS software version 24.0 (IBM) for Windows (SPSS Inc., 
Chicago, IL, U.S.A.) and Prism version 7.03 (GraphPad Soft-ware Inc., La Jolla, CA). 
Nutritics software (Libro, Dublin, UK) (version 1.8) was used to calculated 
macronutrients. Correlation coefficients were used to assess relationships between 
variables. T-tests were used to assess gender differences in age, height and body mass.  
T-tests were also used to assess difference in mean of BMI and TFEQ subscales, 
macronutrients and food craving scores.  
A heat map was used to identify individual hunger phenotypes in the participants using 
the methodology developed in chapter 4. Participants were split into two groups high 
and low hunger based on their TFEQ Hunger subscale.  Satiety phenotype was 
determined using the Hunger scores. The Hunger scores were from 0 to 13 with 0 
being least hungry and 13 most hungry. Low hunger participants had a range of scores 
from 0-6 and high hunger participants scores were from 7-13. Data are represented as 
















 Baseline characteristics of the study participants 
The baseline characteristics of all the participants are shown in table 6.1. There was a 
significant difference in waist circumference and TFEQ Restraint between females and 
males. Males had a larger mean waist circumference than females and females had 
higher scores for TFEQ restraint than males. 
 
Table 6-1: Baseline characteristics of the study participants 
Variables All (n=39)   
Mean ± SD 
Female 
(n=29) 
Mean ± SD 
Male (n=10) 
Mean ± SD 
t p d 
Age (y) 50.7±13.8 49.1±13.9 55.2±13.32 -1.203 0.237 0.447 
Weight(kg) 104.5±19 101.1±19 114.2±17.8 -1.917 0.063 0.715 
BMI (kg/m2) 37.1±6.4 37±6.8 37.3±5 -0.134 0.894 0.053 
WC (cm) 118.5±15.7 115.5±16.5 127.0±9.6 -2.077 0.045 0.853 
TFEQ Hunger 4.6±4 4.5±4.3 4.7±3.3 -0.123 0.903 0.048 
TFEQ 
Restraint 
9.1± 3.8 9.9±3.4 6.6±4.2 2.526 0.016 0.872 
TFEQ 
Disinhibition  
6.8±4.5 6.8±4.9 6.8±3.5 .016 0.987 0.007 
Values are mean± standard deviation, t= t-test and d Cohen's d.  BMI: body mass index. WC: Waist 
circumference SD: standard deviation. p < 0.05 for the differences between males and females. 
 
 Food diary results and food craving scores of participants 
Table 6.2 shows the TEI and macronutrient intake recorded based on food diary and 
food craving scores for all participants and then split into females and males. No 
difference was found between males and females for any measure in the food diary, or 







Table 6-2: The mean ± SD of TEI and macronutrient 
intake based on food diaries and food craving. 
Values are mean ± standard deviation, t= t-test and d Cohen's d. SD: standard deviation. TEI and 
macronutrient intake estimated from 3-day food records. g = gram, Kcal = Kilocalories  
  
 Weight loss of all participants after ten weeks  
Figure 6.1 presents weight loss of all participants after ten weeks. 38 participants lost 
weight and one participant did not lose weight. Most participants lost between 2- 5 kg 
and the remainder lost more than 6 kg over 10 weeks.  
 
 

























All (n= 39) 
Mean ± SD 
Females (n= 29) 
Mean ± SD 
Males (n= 10) 
Mean ± SD 
t p d 
Food diary-TEI 
(Kcal) 
1054.5±301.3 1084.6±289.6 960.5±337.7 1.014 0.318 0.394 
CHO (% of  TEI) 46.7±10.6 47.3±9.3 44.9±14.5 0.445 0.667 0.198 
Protein (% of  TEI) 20.1±5.7 20.3±6.1 18.99±4.66 0.290 0.774 0.240 
Fat (% of  TEI) 31.5±9.4 32.4± 9 30.5±10.6 0.249 0.805 0.189 
Fibre (g) 1.4±0.7 1.3±0.5 1.55±1.1 -0.651 0.534 0.309 
Fast food  
craving 
6.5±5.4 5.9±4.8 8.2±6.9 -1.148 0.258 0.381 
Sweet  craving 9.4±6.6 10.1±6 7.4±8.36 1.114 0.272 0.372 
Fat  craving 5.9±4.4 5.1±4.3 8±3.9 -1.846 0.073 0.695 
Carbohydrate  
craving 
11.1±6.7 10.3±6.2 13.6±7.7 -1.361 0.182 0.471 
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 TEI, macronutrient intake of food diary and baseline 
anthropometric measures 
Table 6.3 shows no significant correlation between TEI, macronutrient intake 
measured by food diary and body mass, BMI or WC. Fat intake was negatively 
correlated with all of these baselines anthropometric measurements but this did not 
reach significance.  
   Food craving and baseline anthropometric measures 
As can be seen in table 6.3 there was a positive correlation between craving for high 
fat and the baseline measures of body mass (r=0.352*,p=0.028) BMI (r=0.379*, 
p=0.017) and WC (r=0.518**, p=0.001). Moreover, craving for CHO was positively 
correlated with body mass (r= 0.328*, p=0.042) and WC (r=0.399*, p=0.012).  Cravings 
for fast food were positively correlated with baseline anthropometric measures, but 
this did not reach significance. There was no correlation between sweet food cravings 
and baseline anthropometric measures. The data indicated that people who crave 
higher fat, CHO and fast food had higher baseline anthropometric measures. Figure 6.2 
presents all correlation data between food craving scores and anthropometry 
measures split by gender. A positive correlation was observed between fat food 
craving and waist circumference in females (r=0.617, p=0.004) in contrast, a negative 
correlation was found in males (r=-0.766, p=0.044). Furthermore, fat food cravings 
were positively associated with body mass (r=0.462, p=0.012) BMI (r=0.472, p=0.009) 
in females, but in males, fat craving scores were not significantly correlated with body 
mass (r=-0.207, p=0.564) or BMI (r=-0.150, p=0.679). CHO food craving was positively 
correlated with waist circumference in females (r=0.444, p=0.016). No significant 
relationship was found between CHO craving and waist circumference in males 
(r=0.055, p=0.881).  
 The TFEQ subscales and baseline anthropometric measures 
TFEQ Hunger, Cognitive restraint and Disinhibition did not correlate with baseline body 
mass, BMI and WC. TFEQ Hunger was negatively correlated with WC and Cognitive 






Table 6-3 : Relationships between food craving, macronutrient intake food diary, 
TFEQ subscales and baseline anthropometric measures 





Food diary-Energy 0.011 0.117 -0.021 
Food diary-CHO  0.069 0.171 0.066 
Food diary-Protein  0.034 0.190 0.094 
Food diary-Fat -0.211 -0.271 -0.218 
Food diary-Fibre  -0.311 0.021 -0.127 
Fast food craving 0.288 0.254 0.307 
Sweet craving -0.101 -0.026 -0.098 
Fat craving 0.379* 0.352* 0.518** 
CHO craving  0.328* 0.271 0.399* 
TFEQ Hunger  0.176 0.167 0.293 
TFEQ Restraint 0-.073 -0.008 -.0279 
TFEQ Disinhibition 0.223 0.268 0.230 
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Figure 6-2: Relationship between food craving and baseline of anthropometry measurements for all participants (A= high fat food craving, 




  TEI, macronutrient intake food diary, TFEQ subscales and 
subsequent weight loss (all participants) 
Table 6.4 displays correlations between TEI and macronutrient intake based on food 
diaries, TFEQ subscales and subsequent weight loss of all participants. No correlation 
was found between TEI, macronutrient intake measured by food diary, TFEQ subscales 
and subsequent weight loss in the participants. CHO was negatively correlated with 
body mass change and BMI change and fibre was positively correlated with body mass 
change but these relationships did not reach significance. 
Table 6-4 : The relationship between TEI, macronutrient intake based on food diary, 

















0.041 -0.321 0.156 -0.051 0.142 0.083 -0.125 0.119 
BMI change 0.143 -0.324 0.128 0.053 0.073 0.015 -0.033 0.140 
WC change 0.061 -0.112 0.115 -0.030 -0.102 0.085 -0.054 -0.042 
Values represent Pearson correlation coefficient, r value 
 Food craving and subsequent weight loss 
Table 6.5 shows data for food craving scores and subsequent weight loss values for the 
participants. The data indicate no relationship between food craving scores and 
subsequent weight loss.  CHO craving was negatively correlated with body mass and 
BMI change but this did not reach significance and no correlation was found between 
CHO craving and WC change.  
Table 6-5: The relationship between food craving and subsequent weight loss 




Fat craving CHO craving 
Body mass 
change 
-0.003 -0.249 -0.043 -0.310 
BMI change -0.060 -0.132 -0.092 -0.306 
WC change -0.184 -0.018 0.098 -0.169 




 TEI, macronutrient intake based on food diaries, TFEQ subscales 
and subsequent weight loss 
Tables 6.6 and 6.7 below present the relationships between TEI, macronutrient intake, 
recorded by food diaries, TFEQ subscales and subsequent weight loss in females and 
males. No correlation was found between TEI, macronutrient intake, TFEQ subscales 
and subsequent weight loss of female participants (Table 6.6) or male participants 
(Table 6.7). CHO was negatively correlated with body mass change in males, but this 
relationship did not reach significance.  Fat and cognitive restraint were negatively 
correlated with WC change in males, but this did not reach significance. Moreover, 
fibre was positively correlated with BMI change in males but this did not reach 
significance 
 
Table 6-6 : The relationship between TEI, macronutrient intake based on food diaries, 
TFEQ subscales and subsequent weight loss in females.  


















0.146 -0.040 0.247 -0.157 0.261 0.020 0.173 0.085 
BMI change 0.209 -0.139 0.149 0.008 0.138 0.114 0.158 0.082 
WC change 0.072 -0.116 0.102 0.067 0.112 0.012 0.038 0.032 
Values represent Pearson correlation coefficient, r values 
 
Table 6-7 : The relationship between TEI, macronutrient intake based on food diaries, 




















0.220 -0.688 -0.230 0.150 0.108 0.055 -0.069 0.547 
BMI change 0.448 0.038 -0.022 -0.064 0.462 0.102 0.011 0.012 
WC change 0.025 -0.120 0.185 -0.499 -0.131 -0.179 -0.400 -0.171 
Values represent Pearson correlation coefficient, r values 
 
  Food craving and subsequent weight loss 
Tables 6.8 and 6.9 below show the relationships between food craving and subsequent 
weight loss in participants. There was no relationship between high fat, sweet and fast 
food cravings and subsequent weight change in female participants (table 6.8). 
231 
 
However, CHO craving was negatively correlated with body mass change (r=-0.413*, p= 
0.026) in females. Table 6.9 presents the relationship between food cravings and 
subsequent weight loss in male participants. There was no significant relationship 
between high fat, sweet and fast food and subsequent weight loss in male participants. 
However, CHO craving was inversely correlated with BMI change (r= -0.0647, p=0.043) 
in males.  
Table 6-8: The correlation between food craving and subsequent weight loss in 
females. 
Correlation Fast food craving  Sweet craving  Fat craving  CHO craving  
body mass change  -0.014 -0.040 -0.155 -0.413* 
BMI change 0.083 0.082 -0.277 -0.298 
WC change 0.093 0.081 -0.217 -0.198 
Values represent Pearson correlation coefficient, r values 
Table 6-9 : The correlation of food craving scores and subsequent weight loss in males. 







body mass change -0.445 -0.385 -0.304 -0.611 
BMI change -0.495 -0.371 -0.273  -0.647* 
WC change -0.023 -0.307 -0.260 -0.083 
Values represent Pearson correlation coefficient, r values 
 
  Identification of satiety phenotypes  
The only independent variable studied in chapter 4 that was also assessed in this part 
of the study was TFEQ Hunger. The timing of the Shape-Up sessions meant it was not 
possible to carry out the test breakfast part of the study or to collect fasting blood 
samples.  Therefore the participants were split into 2 groups based on their TFEQ 
scores.   In chapter 4 the results showed differences between women and men for the 
TFEQ scores, therefore in this chapter the data was split into only 2 groups, low (0-6) 
and high  (7-13) not 3 groups  as in chapter 4. This was because when participants 
were allocated to the 3 groups using the range of TFEQ hunger scores, 0-4 for low, 




Table 6.10 presents participants split by TFEQ hunger scores. As can be seen in the 
table there were 27 people with high satiety and 12 with low satiety ratings. 






























PN Gender TFEQ Hunger Phenotype 
56 Female 0 High  satiety 
82 Female 0 High  satiety 
115 Female 0 High   satiety 
77 Female 0 High  satiety 
96 Female 0 High   satiety 
116 Female 0 High  satiety 
103 Female 0 High satiety 
67 Female 0 High  satiety 
31 Female 1 High satiety 
34 Male 1 High  satiety 
23 Male 2 High  satiety 
47 Male 2 High  satiety 
19 Female 2 High   satiety 
94 Female 2 High  satiety 
151 Female 2 High  satiety 
163 Male 2 High  satiety 
117 Female 2 High  satiety 
55 Female 3 High  satiety 
72 Female 4 High  satiety 
120 Female 4 High  satiety 
59 Female 5 High  satiety 
71 Male 5 High  satiety 
97 Male 5 High satiety 
33 Female 5 High  satiety 
73 Female 6 High  satiety 
29 Female 6 High  satiety 
100 Male 6 High satiety 
27 Female 7 Low  satiety 
86 Female 7 Low satiety 
2 Female 7 Low satiety 
85 Female 7 Low satiety 
121 Male 7 Low satiety 
92 Female 8 Low satiety 
159 Female 9 Low  satiety 
106 Female 10 Low  satiety 
22 Male 12 Low satiety 
54 Female 13 Low satiety 
28 Female 13 Low satiety 
99 Female 13 Low satiety 
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  Average subsequent weight loss after 10 weeks on the 
programme 
Figure 6.3 A, B and C present the average subsequent weight loss of all participants 
split into the 2 groups by low and high satiety. As can been seen in figures (A) and (B)  
people with high satiety have a greater  BMI change and weight change after one 
month, but the difference is not significant. Figure (C) shows that the reverse is true 
for average WC change after one month. Based on a t-test there were no statistically 
significant differences between the low and high satiety groups.  


































































































     
Figure 6-3 : Average subsequent weight loss of all participants (A= average BMI change, B= 
average weight change and C= average waist change
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 Average TFEQ subscales for low and high satiety participants 
Figure 6.4 represents the average TFEQ subscale score and subsequent weight loss 
split by low and high satiety groups. Based on a t-test there was no statistical 
difference between low satiety and high satiety groups in TFEQ subscales p= -0.1480 
Hunger and p=0.2483 restraint. There was a significant difference between low and 

























































 Average macronutrient intake in low and high satiety participants 
Figure 6.5 displays the average macronutrient intake in low and high satiety participant 
groups. T-test analysis shows that there was a significant difference between low and 
high satiety groups in CHO intake, p= 0.049. There was no difference between the 2 


















































  Average food craving values in low and high satiety participants 
Figure 6.6 presents the average food cravings in low and high satiety participants. T-
test analysis shows that there were significant differences between low and high 
satiety groups in fast food p= 0. 033, sweet food, p=0.007 and CHO food intake, p=0.08. 
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  Discussion 
Some individuals are more vulnerable to weight gain than others and are at higher risk 
of excess EI. Successful weight loss varies with some people responding well to 
interventions and others finding success more difficult. Methods to predict those 
individuals who struggle to lose weight prior to starting a weight loss programme could 
help them to success fully lose weight with additional support (Dalton et al., 2015; 
Polsky et al., 2013). The main aim of the present study was to develop methods to 
identify predictors of weight loss, in order to identify individuals, prior to participation 
in a weight management programme, who struggle to lost weight due to reduced 
satiety. 
 
 Baseline of food craving scores, food diaries data and TFEQ 
subscales of participants 
In the current study, food cravings and macronutrient intake, measured by a food diary, 
and eating behaviour were investigated as variables that may predict weight loss.  
There were significant differences between males and females in baseline waist 
circumference and TFEQ Restraint. The current study showed no differences between 
males and females in scores of TEI, macronutrient intake as measured by food diaries, 
and food craving questionnaires.  
 TEI, macronutrient intake based on food diaries and baseline 
anthropometric measures  
In the current study TEI and macronutrient intake based on a food diary did not 
correlate with baseline anthropometric measures. The findings of the present study 
contrasts with those of Ma et al., (2005) who found a positive correlation between the 
percentage of calories from fat and TEI based on food diaries and higher BMI in 
females. However, in their study the percentage CHO intake showed no correlation 
with BMI. This study had a larger sample of 572, which could explain the difference as 
the present study only had 39 participants. 
 In the current study, when the data was split by gender, in females, high fat intake 
scores were significantly correlated with WC, body mass and BMI. Moreover, CHO 
intake was significantly correlated with WC. However, in males high fat and CHO intake 
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did not significantly correlate with WC, body mass and BMI. The potential 
interpretation of why these results was observed in females but not in males, may be 
the small sample size of males in the current study.  
6.5.1.1  Food craving and baseline anthropometric measures 
The results of the present study are partially in accordance with Batra et al., (2013) 
who reported there was a positive correlation between food craving and baseline BMI. 
However, Batra et al., found this correlation in all participants and the present study 
showed this result only in females. Another finding from Chaudhari and Huerta-Franco 
(2017) also agrees with the current study. They showed that 98.7% of women had food 
craving behaviours and that food craving was a positive predictor of BMI in females. 
The explanation for this may be food craving behaviour is generated primarily by 
leisure activities and negative moods such as food psychological reactance, followed by 
depression (sadness), anxiety/stress and less frequently anger. Therefore, the study of 
food craving behaviour may be the key to identify possible eating behaviours that lead 
to increased weight and body fat or failure in eating behaviour disorders. 
 TEI and macronutrient intake and subsequent weight loss 
TEI and macronutrient intake from a 3 days food diary did not predict people who 
would struggle to lose weight prior to participation in a structured weight-loss 
programme. A possible explanation for this result may be that people do not always 
fully report their habitual food intake and they feel embarrassed or guilty about 
recording their diet and so leave out more calorie dense items or snacks (Macdiarmid 
and Blundell, 1997). Another explanation may be that there is no relationship between 
food intake measured by a 3 day food diary, prior to starting a weight loss programme 
and subsequent weight loss and that is why this measure did not predict weight loss. 
  
The findings of the present study are in contrast with previous study findings where 
Buscemi et al., (2017) used a 3 day food diary record and found that low initial levels of 
caloric intake at baseline were positively associated with changes in BMI, but they did 
not find a relationship at average and high levels of initial caloric intake with BMI 
change. The explanation of why the results of this study differ from the current study 
may be the duration of the intervention in this study which was 18 months. Moreover, 
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the larger sample could be another explanation; there which were 202 participants in 
the Buscemi et al., (2017) study.   
After the data was spilt by gender, the present study showed no relationship was 
found between TEI based on a 3 day food diary data prior to starting the weight loss 
programme and subsequent weight loss. This finding is supported by Ledikwe et al., 
(2006) who reported no correlation between total energy density and BMI change in 
males. However Martí-Henneberg et al., (1999) also found no correlation between 
total energy density and BMI in 348 females. 
6.5.2.1 Macronutrient intake and subsequent weight loss 
The results of the present study showed no relationship between macronutrient intake 
based on the food diary and subsequent weight loss in all participants. 
 Linde et al., (2006) showed that at baseline, higher fibre intake was associated with 
reduction in BMI at 24 months. This difference may be due to the large sample size in 
Linde et al., (2006) with 508 men and 1293 women or the duration of study which was 
24 months in Linde et al., (2006) , whereas here it was 10 weeks. A further study from 
Du et al., (2009) showed total fibre intake was inversely associated with weight and 
waist circumference. However, this study used a food frequency questionnaire to 
assess nutrients and the duration of the study follow up was 6.5 years. A previous 
study by Champagne, (2011) examined the relationship between dietary intake and 
weight loss. The findings of this study, in contrast with the present findings, indicated 
that lower fat percentage intake was associated with weight loss. The potential 
explanation for the differences in finding may be the larger sample size in the study by 
Champagne (2011) which was 828 and assessment of nutrient intake could be another 
explanation as in the Champagne (2011) study, food frequency questionnaires were 
used and the present study used a food diary. Food frequency questionnaires are often 
filled out over longer time periods e.g. a month, and in that case they probably would 
not give the same answer as a food diary. 
Moreover, when the data was split by gender, the TEI and macronutrient intake 
measured on the food diaries did not correlate with subsequent weight loss. This 
finding is in accordance with Savage, Marini and Birch (2008) who used three day 
recalls to assess TEI and macronutrient intake and they reported dietary fibre and 
caloric beverage intakes were not significant predictors of weight change.  
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In contrast to the current study Hays et al., (2006) indicated that dietary percentage of 
CHO and dietary protein was inversely correlated with weight loss and fibre was 
positively correlated with weight loss. However, the present study finding agrees with 
Hays et al., (2006) that dietary fat percentage did not correlate with weight loss. An 
explanation of this difference could be the body weight of the participants in Hays et 
al., (2006) who were normal weight, while the present study consisted of people with 
obesity. It has been reported that people with obesity intentionally underestimate 
food intake to improve their self-esteem as a form of self-deception or self-
presentation because they want to present themselves in a positive light to others 
(Muhlheim et al., 1998).  
 TFEQ subscales and subsequent weight loss of participants 
The current study evaluated TFEQ subscales to investigate whether people who were 
hungrier were less likely to succeed with weight loss when participating in a structured 
weight-loss programme. The results of the present study indicated that there was no 
correlation between the TFEQ subscale scores and weight loss in all participants or 
when the data was spilt by gender.  
In agreement with the present study finding, Hays et al., (2006) included 76 females. 
They showed cognitive restraint and disinhibition measures did not predict weight loss.  
In contrast to the current study, previously reported findings by Batra et al., (2013) 
have found that baseline TFEQ hunger scores predicted greater weight change (R= - 
0.25, p = 0.03).  The potential explanation for these different results was duration of 
study, which was 6 months in Batra et al., (2013) study and 10 weeks in the present 
study. Sample size could be another explanation for the different finding. Moreover, 
the mean scores of hunger in the Batra et al, (2013) study were higher than in the 
present study which could explain differences. 
In contrast to the present study, James  et al., (2017), Buehler et al., (2017) and Foster 
et al., (1998) reported that lower baseline restraint predicted greater weight loss, 
while baseline Disinhibition and Hunger scores were not related to weight change. This 
difference may be due to the duration of the study with one year in both the James et 
al., (2017) and Foster et al., (1998) studies. Participants in all studies were female and 
larger numbers were studied than in the current study. Differences in statistical 
241 
 
analysis in both studies could contribute to the differences.  However, Bas and Donmez, 
(2009) have reported that reduced TFEQ Hunger and TFEQ Disinhibition score did show 
associations with weight change at 20 weeks. 
In contrast to the present finding Rock et al., (2017) found only TFEQ restraint was 
associated with weight loss.  A possible explanation for this difference may be the 
larger sample In Rock et al., (2017) which included 100 participants and a 6 month 
duration study in Rock et al., (2017) could be another explanation compared with 39 
participants studied over 10 weeks in the current study. 
 Food craving and subsequent weight loss 
In the present study food craving scores did not correlate with subsequent weight loss 
values of all participants. However, although there was no significant correlation, 
results indicated that people who had lower food cravings subsequently lost more 
weight 
This result agrees with current findings of Sayer et al., (2018) who reported that the 
baseline food craving was linearly and inversely associated with weight loss at week 16 
(r = - 0.23, p = 0.037). The people who had higher scores of food craving struggled to 
lose weight. Moreover, Buscemi et al., (2017) reported that higher initial food cravings 
were associated with a more gradual reduction in BMI from baseline to 6 months. The 
findings of the present study are consistent with the existing evidence which shows 
that there was negative correlation between all food cravings at baseline and weight 
change at 6 months (Batra et al., 2013).  
Furthermore, previous studies have found a positive correlation between increased 
level of cravings and BMI, they reported that initial high levels of food craving may be 
related to less successful weight loss (Abilés et al., 2010; Chao et al., 2014; Franken 
and Muris, 2005). Targeting food cravings clinically might be beneficial for individuals 
enrolled in weight loss programmes who report higher levels of food cravings at 
baseline. 
Moreover, the findings of the present study indicated that CHO food craving was 
inversely correlated with body mass change in females and BMI change in males. In 
contrast to the present study Gilhooly et al., (2007) reported participants with a higher 
percentage of weight loss, craved foods with higher energy densities compared to 
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those who lost a lower percentage of weight. However, this study examined changes 
of food craving during 6 months and the present study examined food craving at 
baseline.  
 Identifying a satiety phenotype 
The heat map used the TFEQ Hunger scores to identify satiety phenotypes, twenty- 
seven participants had a high satiety and twelve participants had a low satiety 
phenotype. The findings of the present study indicate that people with a high satiety 
phenotype on average lose less weight and BMI has a smaller change. The 
independent variable used in the heat map is the TFEQ Hunger score. It was chosen 
based on findings in chapter 4, because it predicts an individual phenotype of low and 
high satiety spilt by TFEQ hunger scores. 
  Summary 
The key findings of this chapter are that baseline TEI and macronutrient intake based 
on food diaries did not predict people who would struggle to lose weight, prior to 
participation in a structured weight-loss programme. The results of the present study 
indicated that there was no correlation between the TFEQ subscale and subsequent 
weight loss. Food craving did not predict subsequent weight loss in all participants but 
when data was spilt by gender, CHO food craving was inversely correlated with body 
mass change in females and BMI change in males. 
 Study strengths and limitations 
The strength of the study was that both genders were included. The current study 
presented data from participants on a 10-week weight loss programme. It would be 
valuable to be able to predict in the short term, prior to starting a weight loss 
programme, factors which indicate whether the programme would be successful. 
Many studies predicted weight loss with regards to a 6 month weight loss programmes. 
































7 General discussion  
The overall aim of the studies reported in this thesis was to test methodologies and to 
develop a protocol to identify high hunger and low satiety phenotypes in individuals. 
Such a protocol could potentially help healthcare professionals working in weight-loss 
programmes to identify people at baseline who have low satiety prior to participating 
in a weight management programme. 
 Background to the investigations 
Appetite control plays an important role in energy balance, eating behaviour and body 
weight control (Finlayson et al., 2007). Research has shown large variability in appetite 
control capacities in people with obesity as well as in normal weight individuals. There 
are different methods to assess satiety and hunger in individuals. The use of VASs to 
characterise appetite sensations has been shown to provide a good degree of within-
subject reliability and validity, in that these sensations predict meal initiation and the 
amount of food eaten (Stubbs et al., 2000). Drapeau and colleagues examined fasting 
VAS for 4 questions, AUC and SQ to measure satiety phenotype in people with obesity 
(Drapeau et al., 2005; Drapeau et al., 2007). Their research indicated that high scores 
of fasting hunger, desire to eat and prospective food intake were associated with 
lower body weight loss. Moreover, they showed that AUC of all appetite sensation and 
SQ fullness were predictive of an ad libitum test lunch EI in women. Drapeau et al., 
(2005) also reported that AUC fullness and SQ fullness predicted TEI measured by food 
diary in the Drapeau studies. McNeil et al., (2014) found that prospective food 
consumption and fullness SQ predicted EI and CHO intake, measured by a food diary in 
agreement with the findings of Drapeau et al. 
TFEQ is another measure that can be used in assessment of food intake and weight 
management. People with obesity with weak satiety responsiveness had higher scores 
on TFEQ Disinhibition and Hunger compared to controls (Barkeling et al., 2007), which 
are eating behaviour traits linked to overconsumption and, a higher BMI (Bryant, King 
and Blundell, 2008).  
Gut hormone levels (ghrelin, CCK, GLP1, PP and PYY) are another measure that is used 
in assessing food intake and body weight regulation. These hormones have a vital role 
in the short-term control of appetite. Numerous studies have shown that intravenous 
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administration of ghrelin in both lean people and people with obesity can increase 
feelings of hunger and EI from buffet meals (Druce and Bloom, 2006; Druce et al., 
2005; Wren et al., 2001). IV administration of PYY (3-36) has also been demonstrated 
to lead to a reduction in appetite and an almost 30% restriction in caloric intake in lean 
people and people with obesity (Batterham et al., 2003a).  A number of studies have 
observed that the infusion of PP at 5 pmol/kg min following a buffet meal, reduced EI 
by 11% compared with saline control, together with a decrease in hunger as analysed 
by VAS (Jesudason et al., 2007). Various studies have confirmed that systemic 
administration of GLP-1 hormone decreases food intake slows gastric emptying and 
reduces body weight (Marathe et al., 2011; Van Bloemendaal et al., 2014). 
Food craving is one of the measurements that is used in predicting weight 
management success. Martin et al., (2008) found significant correlation between 
consumption of corresponding types of foods and weight loss. Ferguson et al., (1992) 
and Elfhag and Rössner, (2005) suggested that reducing and managing food cravings is 
important in the management of obesity and successful weight loss maintenance. 
Finally, food diary records have been used in relationship between macronutrient 
intake and weight management.  Johnstone et al., (2008) reported that people who 
had a lower percentage of CHO in their diet had higher scores for hunger using the VAS. 
Buscemi et al., (2017) indicated that low initial levels of caloric intake were positively 
associated with changes in BMI.  Moreover, Hays et al., (2006) reported that fibre 
intake was significantly positively associated with weight loss. 
Although these studies have measured food intake and weight regulation, they did not 
focus on using a baseline satiety phenotype in a clinical setting to predict whether 
people with low satiety found it more difficult to lose weight.  As a result, due to this 








 Key findings 
The table below shows all measures and the key findings of this thesis. 
 
Table 7-1 : Comparison of variables as predictors in the different studies undertaken in this 
thesis 
Variables  Pilot study  Prediction satiety 
phenotype in individuals 
with normal weight study  
Tier 3 study Tier 2 study 
VAS  Low satiety participants 
on VAS (fasting hunger 
and prospective food 
intake) measurement 
ate more calories 
measured by food diary 
Low satiety  participant on 
VAS measurement ate 
more calories measured by 
food diary 




to lose weight 
No VAS 
measurements used  
Gut 
hormones 
Did not predict TEI 
measured by food diary 
Did not predict  TEI 
measured by food diary 
People who had 
higher levels of 
PYY lost more 
weight at one 
month  




Did not predict TEI 
measured by food diary 
TFEQ Restraint measure 
was negatively correlated 
with fat intake in women 
and TEI in males, but did 




weight loss  
Did not correlate 
with weight loss 
Food 
craving  
Obese and overweight 
individuals who have 
high scores for food 
craving ate less protein 
although this correlation 
did not reach 
significance. 
A strong negative 
correlation between fast 
food cravings and  TEI in 
men. Sweet food craving 
was positively correlated 
with protein intake, but 
did not predict ad libitum 
lunch intake in both 
genders 
No food craving 
measured 
Women who crave 
more CHO struggled 
to lose weight and 
men who crave 
more CHO struggled 





 VAS measures in the laboratory reflect real life 
The results for the pilot group (chapter 3) and the normal healthy student group study 
(chapter 4) in the laboratory reflected participant food intake in real life. In the pilot 
study, people who had high hunger indicated by measuring (fasting hunger and 
prospective food intake in the laboratory ate more calories in their real life according 
to their food diaries. Moreover, they ate a lower percentage of CHO in their diets. 
Those, people who had higher scores at fasting and AUC hunger had a lower 
percentage of protein in their daily food intake.  
In the normal healthy weight student study, those who had high scores for hunger at 
fasting, post breakfast, 30 min and AUC VAS ate more calories in their real life. These 
results applied to women, whereas men had higher scores at fasting desire to eat, 
prospective food intake and AUC composite of appetite scores, they had a lower 
percentage of CHO in their food diaries. These results show that VAS in the laboratory 
measurements can reflect real life satiety phenotype in different groups (people with 
obesity and healthy weight). This finding could be applied in a community setting, 
using food diaries to identify people who are more known to have a more hungry 
phenotype before they start a weight loss programme may increase the success rate of 
the programme. 
 Optimal measurements of VAS (fasting, SQ and AUC) in prediction 
of a satiety phenotype 
In this thesis VAS measurements (fasting, SQ and AUC) have been used in three studies 
in different groups of people including individuals who were healthy weight, 
overweight or obese and in different settings i.e.  In a university laboratory or a 
community, to investigate which measure of VAS is the best to identify a satiety 
phenotype. 
In the pilot and healthy student studies the fasting VAS scores showed strong 
correlation with EI measured by a food diary and AUC showed some correlation with 
EI. However, in contrast to previously published papers (McNeil et al., (2014) and 
Dalton et al., (2015) SQ was not a good predictor of satiety phenotype in the 
laboratory setting, as a result, the protocol of VAS measurements in the community 
was changed. The timing and frequency of completed VAS appetite scores in the 
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laboratory setting were 3 hours and 5 assessment times within this period, whereas in 
the community setting, this was changed to one hour and 15 minutes and the VAS 
appetite scoring completed respectively four times. As the results from the pilot study 
showed that you can get similar information about someone's hunger or satiety by 
only measuring VAS scores for hunger and appetite for a shorter time period. 
  Plasma gut hormone levels as a measure to predict a satiety 
phenotype 
Gut hormones were used in the laboratory setting study, and in the community to 
investigate their predictive value for satiety phenotypes in participants. In this thesis 
four gut hormones were investigated using five blood samples taken at different time 
points in the laboratory setting to identify the optimal hormones to measure, as well 
as the timing of blood sampling to identify satiety phenotypes. These findings were 
then used to inform the studies based in the community settings. The results from 
chapters 3 and 4 showed that fasting PYY and PP hormones predicted a satiety 
phenotype. Females who had low levels of PYY consumed more calories measured by a 
food diary and males with low level of PP consumed more calories. The fasting blood 
sample provided the most useful information in the laboratory setting, therefore in the 
community setting just one fingerpick blood sample was taken after the participant 
fasted. The advantage of this was that it reduced the cost of the analysis and made it 
more likely that people would be willing to take part as they only had to give one blood 
sample.  
  TFEQ 
TFEQ measurement was used in all studies in this thesis but this measure did not 
predict satiety phenotype in any. Some subscales showed a correlation with EI and 
macronutrient consumption, but this correlation did not reach significance. Although 
in some reports this measure showed good correlation with satiety (Bryant, King and 
Blundell, 2008; Barkeling et al., 2007), the small samples size in the studies carried out 





  Food craving 
In the pilot study people with obesity and overweight who crave fast food, CHO or fat 
food, ate less protein, even though this correlation did not reach significance. In the 
student study where participants had a healthy weight, food cravings did not predict 
ad libitum lunch intake in either women or men. However, men who had higher fast 
food cravings consumed less calories measured by a food diary and if participants 
craved sweet food, then they consumed more protein as evidenced by their food 
diaries. In the Tier 2 community setting food craving predicted weight loss. In this 
study CHO food craving was the best measure for predicting weight loss.  
   Gender   
In this thesis the numbers of female participants was higher than males and in many 
studies in the literature it has been shown that females predominantly participate in 
weight loss trials (Ahern et al., 2017).   
In the student study, participants with a healthy weight showed that some measures 
are more significant in females compared to males. For example, fasting hunger at 
different time points and AUC VAS predicted calorie intake measured by a food diary in 
females. Whereas, VAS measures (fasting desire to eat and prospective food intake) 
predicted percentage of fat intake recorded in the food diary. TFEQ Restraint measure 
showed a negative correlation with fat intake in females and TEI in men. Fasting and 
AUC PYY showed an inverse correlation with TEI in females. Whereas, in men there 
was a negative correlation between fasting PP and TEI. Moreover, fasting ghrelin was 
negatively correlated with the percentage protein intake in males and there was no 
correlation between macronutrient intake measured by food diaries and gut hormone 
levels in females. 
Food craving did not predict TEI or macronutrient intake in females whereas there was 
a strong negative correlation between fast food cravings and TEI. Moreover, sweet 
food craving was positively correlated with protein intake in males. 
This study showed a strong correlation between VAS (fasting hunger, prospective food 
intake and AUC) and ad libitum lunch intake in females. Whereas, in males there was 
no significant correlation between VAS and ad libitum lunch intake, this may be 
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because of the low number of male participants. Other measurements such as TFEQ, 
gut hormone levels and food craving were not significantly correlated with ad libitum 
lunch intake in either gender. 
In the Tier 2 community study, VAS measures showed a strong correlation with weight 
loss. Females who had a higher score for fasting hunger struggled to lose their body 
weight at one month, whereas VAS measures did not predict weight loss in men. TFEQ 
and gut hormone levels did not predict weight loss in either gender. 
In the Tier 3 community setting study, food diaries and TFEQ did not predict weight 
loss in either gender whereas CHO food craving showed a significant correlation with 
weight loss.   Females who craved more CHO struggled to lose weight and males who 
craved more CHO struggled to reduce their BMI. 
   Heat map 
The methods used in chapter 4 in a laboratory setting with healthy weight people 
enabled the development of heat maps to identify satiety phenotypes. The potential 
application of this developed method is to help professionals working in weight-loss 
programmes. The result of the heat map showed that a heat map based on food diary 
records better predicted hunger of participants than the ad libitum lunch using 
method one. In method one, heat maps of participants spilt by gender were analysed. 
For each variable, participants were ranked in order from small to large values of the 
variable.  The participants were then split into tertiles according to the value of the 
variable.  Each participant was allocated a colour for that variable: i.e.  green cells for 
low scores, orange for medium and red for high scores for variables, where a low score 
was associated with satiety e.g. ghrelin, or hunger and a high score associated with 
hunger or low satiety.  For other measures e.g. fullness or PP hormones, large values 
were green and small values red. This process was repeated with each variable so that 
each participant was allocated a colour for each variable and this was used to build a 
heat map for each person. After that the heat map was reordered by ad libitum lunch 
intake and the same process was used to rank by food diary  TEI.  
The heat map was applied in a Tier3 community setting to help to identify satiety 
phenotypes and those participants that would struggle to lose weight. The findings of 
the present study indicated that people with the high hunger phenotype on average 
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had a lower change in BMI, percentage of weight loss after one month and WC change 
compared to the other groups. Moreover, low satiety phenotype participants had the 
highest TFEQ Hunger scores at baseline, compared to people with the lower and 
medium hunger phenotypes and had medium TFEQ Restraint and low TFEQ 
Disinhibition, although this is not surprising as the TFEQ Hunger score was one of the 
variables used to build the heat map. 
In the Tier 2 study in a community setting the heat map used the TFEQ Hunger scores 
to identify satiety phenotypes. The findings of this study indicated that people with a 
high satiety phenotype on average lose less weight and had a reduced change in BMI. 
The independent variable used in the heat map is the TFEQ Hunger score. It was 
chosen based on findings in chapter 4 because it predicts an individual phenotype of 
low and high satiety spilt by TFEQ hunger scores. The heat map results in the Tier 3 
community setting showed good results with VAS and TFEQ which can help to identify 
people prior to the start of a weight loss programme who may struggle to lose weight 
due to their reduced satiety phenotype and allow for additional advice to support 
these people.   
  Future work 
To apply this protocol in the future in a clinical setting or community, the focus should 
be on certain measures. VAS provide the best measurement for professionals working 
in community weight-loss programmes to focus on to identify people who have low 
satiety at baseline prior to participation in a weight management programme.  They 
also have the advantage of being one the cheapest tools studied in this thesis. 
When gut hormones were studied, fasting samples showed the best predictive value 
especially fasting PPY and PP. TFEQ Hunger and food diaries are important to 
understand the eating behaviour of people who want to lose weight. CHO appeared to 
be the best items of food craving to study satiety phenotype in the community setting.  
Applying gut hormone level measurements in a Tier 2 study would be useful to predict 
high hunger phenotype people because they gave good results in the laboratory and 
the method can be applied by dividing people into groups following overnight fasting 




 Limitations of the study 
Assessments of all measurements should be repeated on several days as studying only 
on one day does not account for normal day-to-day variations in these measurements. 
Another limitation was participants on a high protein diet were lost to follow up. In the 
pilot study people found the high protein diets hard to follow, which may be related to 
the recipes provided and the cost of a high protein diet. 
The results of the ad libitum lunch meal could be validated in future studies taking in 
to account whether people like or dislike the food, as the results in the current study 
may depend on whether people liked pasta, influencing the amount they ate. 
A larger sample population is needed in all future studies.  
In chapter 4, the original method development study could have varied the breakfast 
food amount by BMI to control for this. A high protein diet could be tried in a 
randomised control trial as a personalised diet for low satiety people.  People could be 
split into two groups and allocated two diets, high protein diet and normal care diet, 
this will help to identify whether the high protein diet is the best diet for low satiety 
people or not.    
 Final conclusion 
This study has developed a methodology that could be used to identify people with a 
low satiety phenotype in a way that could be reproduced in a clinical setting.  This 
method is cheap and easy to apply without the use of complex data analysis.  Further 
studies are required to refine the choice of variables and to test the validity of the 
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9  APPENDICES 
 Appendix 1 Pre-Test Medical Questionnaire 
 
 
Faculty of Health and Wellbeing Research Ethics Committee 
Sport and Exercise Research Ethics Review Group 
 






Date of Birth: _____________   Age: _______________Sex: ________________ 
 
Telephone/Mobile: ___________________________ E-mail: ________________ 
 
Please answer the following questions by putting a circle round the appropriate response or filling in 
the blank. 
 
  1. How would you describe your present level of activity? 
 Sedentary / Moderately active / Active / Highly active 
 
  2. How would you describe you present level of fitness? 
 Unfit / Moderately fit / Trained / Highly trained 
 
    3. How would you consider your present body weight? 




   4. Did your weight fluctuate in the past 6 months?   Yes / No 
 
 4.1 If yes, how much?............................................................................... 
 
   5. Are you currently trying to lose or gain weight?   Yes / No 
 
 5.1 If yes, how? ……………………………………………………………….. 
 
   6. Smoking Habits Are you currently a smoker?   Yes / No 
           How many do you smoke   ……..  per day 
           Are you a previous smoker?  ………… Yes / No 
          How long is it since you stopped?  .........  years 
         Were you an occasional smoker?                 ……..      Yes / No      
         Were you a regular smoker?         …………………Yes / No 
           
  7. Do you drink alcohol? Yes / No 
 If you answered Yes, do you usually have? 
 An occasional drink / a drink every day / more than one drink a day? 
 
  8.    Have you had to consult your doctor within the last six months?   Yes / No 
If you answered Yes, please give details………………………………… 
………………………………………………………………………………… 
…………………………………………………………………………………  
  9. Are you presently taking any form of medication?   Yes / No 
If you answered Yes, please give details…………………………………. 
 




            a Diabetes?         Yes / No b Asthma?         Yes / No 
              c Epilepsy?         Yes / No d Bronchitis?         Yes / No 
           e *Any form of heart complaint?  Yes / No f      Raynaud’s Disease?                         Yes / No 
 g *Marfan’s Syndrome?       Yes / No h *Aneurysm/embolism?                       Yes / No 
 I   Anaemia         Yes / No    
 
11. *Is there a history of heart disease in your family?        Yes / No 
 
12. *Do you currently have any form of muscle or joint injury?       Yes / No  
If you answered Yes, please give details………………………………………….   
  
13. Have you had to suspend your normal training in the last two weeks?   Yes / No 
 If the answer is Yes please give details……………………………………………. 
 
If blood is not being taken from you please disregard Section 14. below. 
 
14. *  Please read the following questions: 
a)  Are you suffering from any known serious infection?              Yes / No 
b) Have you had jaundice within the previous year?  Yes / No 
c) Have you ever had any form of hepatitis?   Yes / No 
d) Are you HIV antibody positive                   Yes / No 
e) Have you had unprotected sexual intercourse with any 
              person from an HIV high-risk population?   Yes / No 
f) Have you ever been involved in intravenous drug use? Yes / No 
g) Are you hemophiliac?      Yes / No 
 
 
15. As far as you are aware, is there anything that might prevent you from 






IF THE ANSWER TO ANY OF THE ABOVE IS YES THEN: 
a) Discuss the nature of the problem with the Principal Investigator.  
b) Questions indicated by ( * ) Allow your Doctor to fill out the ‘Doctors 
Consent Form provided.       
 
As far as I am aware the information I have given is accurate. 
Signature:  ……………………………………………………………......................................... 































  Appendix 3 Participant information sheet 1 
 
Faculty of Health and Wellbeing Research Ethics Committee 
Biomedical Research Centre Review Group 
Participant Information Sheet 
 
Project Title Pilot study for developing methods to identify individuals 
with blunted satiety by measured hormone, appetite and 
eating behaviour 
 
Supervisor/Director of Studies Dr. Caroline Dalton 
 
Principal Investigator  Hameida El Farssi 
 
Principal Investigator  
telephone/mobile number 
0114 225 3695 
 
Purpose of Study and Brief Description of Procedures 
You are being invited to take part in a research study.  Before you decide if you wish to take part 
it is important for you to understand why the research is being undertaken and what it will 
involve for you.  Please take time to read the following information carefully.  The investigators 
will go through this information sheet with you and answer any questions you have.  Please ask if 
there is anything that is not clear or if you would like more information.  Take your time to 
decide if you would like to take part.   
Procedures 
• Read participant information sheet 
• Consider study, ask questions 
• Complete and sign consent form 
• Height and weight measurements 
• Completion of eating behaviours and food cravings questionnaires 
• Collection of a cheek cell sample.  The process to take the cheek cell sample is entirely painless; 
it is very similar to gently brushing the inside of your cheek with a toothbrush.  You would 
carry out this process yourself with help from our researcher (if required). 
•  
1. Benefits of the study 
The study will provide important information regarding eating behaviours and food cravings and 
the influence of genetics on these effects. The study is anonymised, so we will not be able to give 
you any individual feedback on your results, but we will be happy to discuss the overall findings 
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of the study with you. 
What will happen to the results at the end of the study?   
The results will be published as academic reports in scientific journals.  There will be no 
identifying information published.  We will also write a summary report of anything we discover 
which we will send to any of the people who participated in the study who want to see it.  This 
will not contain any identifying information. 
Will my taking part in this study be kept confidential?   
Yes, no one will know you have taken part in the study except the members of the research 
team.  Your consent form will be placed by you in a sealed envelope separate from the 
questionnaires and the DNA sample.  You will be allocated a participant number, and this will not 
be linked to your consent form therefore the data we collect from you will be completely 
anonymous and cannot be traced back to you.  
What will happen to my DNA sample? 
Your DNA sample will be stored in our laboratories which have restricted access.  The samples 
will be coded with a participant number which cannot be traced back to you.  We will only use 
the sample to study genes involved in the topics covered by this ethics application and we will 
not allow access to your dna sample by any third party.  
Has this study got ethical approval?   
Yes, this study was approved by the local Ethics Committee.  This means that experts who are not 
involved in the study have carefully considered the aims and methods of the study and agreed 
that they meet their guidelines.  You can find out more about their work on their website   
www.sth-research.group.shef.ac.uk/research/index.html  
Right to Withdraw 
Remember that you always have the right to withdraw from the study at any time. 
 
It has been made clear to me that, should I feel that these Regulations are being infringed or that my 
interests are otherwise being ignored, neglected or denied, I should inform Dr Nikki Jordan-Mahy, 
Chair of the Faculty of Health and Wellbeing Research Ethics Committee (Tel: 0114 225 3120) who 











  Appendix 4 : Informed consent form 
 
 
INFORMED CONSENT FORM  
 
TITLE OF PROJECT:  Study to investigate the factors influencing body weight plan IRAS number: 
208879 
Please read the questions below and circle your answer.  If you do not understand any of the 
questions, please ask the researcher. 
Have you read and understood the Participant Information Sheet? (version 3 
January 2017) 
YES/NO 
Have you had an opportunity to ask questions and discuss this   study? YES/NO 
Have you received satisfactory answers to all of your questions? YES/NO 
Have you received enough information about the study? YES/NO 
To whom have you spoken? .................................................. 
Do you understand that you are free to withdraw from the study? 
 at any time 
 without having to give a reason for withdrawing 
YES/NO 
Do you agree to the secure storage of your anonymised data?  YES/NO 
Do you agree to provide blood samples and a DNA sample; these will also be stored 
securely? 
YES/NO 
Do you agree that your samples and data can be used in future studies? YES/NO 
Do you agree that medical notes and data collected during the study can be looked 
at by individuals from regulatory authorities or sponsors, where it is relevant to you 




Do you agree to take part in this study?                     YES/NO  
Signed........................................................           Date .........................…………. 
(NAME IN BLOCK LETTERS) ....................................................…………………… 
Original to be filed in the Investigator site file, 1 copy for patient, 1 copy to be kept in the 













































 Appendix  5     Dieting and Weight History Questionnaire 
 
Participant number    …………………………………………………………….. 
           
1. What is the most you have ever weighed since reaching your full height? (Do not count 
any weight gain due to medical conditions or medications). 
 
The most I have weighed since reaching my full height is …………………pounds 
 
2. What is the least you have ever weighed since reaching your full height? (Do not count 
any weight loss due to medical conditions or medications).  
 
The least I have ever weighed since reaching my full height is……………………..pounds 
 
3. What is your current weight?........................................pounds 
 
4. If the difference between the answer to question 1 and question 3 is less than 5lbs 
please go to question 5.  If this difference is 5lb or more please circle the statement 
below that best describes this difference: 
a. The difference between my highest weight and my current weight is due to weight 
that I lost on purpose. 
b. The difference between my highest weight and my current weight is due to weight I 
lost even though I wasn’t trying to 
c. I’m not sure why I weigh less than I once did 
 
5. For how long have you been at or close to (within 2lbs) your present 
weight………………months 
 
6. Which of these statements best describes what has happened to your weight during 
the past 6 months? (please circle one) 
a. My weight has stayed about the same 
b. I’ve been losing weight 
c. I’ve been gaining weight 
d. My weight has fluctuated a lot 
 
7. Are you currently on a diet?  YES/NO  if No please go to Q13 
 
8. Are you currently dieting to lose weight or to avoid gaining weight?  (Please circle one) 
To lose weight    To avoid gaining weight 
 




10. How much longer do you anticipate being on your 
diet?............................................weeks 
 
11. How much weight (if any) have you lost on your current 
diet?.....................................pounds 
 
12. How much more weight do you intend to lose on your current 
diet?...............................pounds 
 
13. Have you ever been on a diet to lose weight (not including a current diet)?  YES/NO 
If your answer is No skip Q14-17 
14. About how long ago were you last on a diet to lose weight (if you are on a diet refer to 
the most recent previous diet)? …………………………………………………………………….weeks 
 
15. About how old were you when you went on your first diet?..............................years old 
 
16. Please estimate as best you can the numbers of times in your life you have dieted and 
purposely lost the amount of weight listed 




21 or more pounds………..times 
17. Please give details of any of the following diets have you previously tried? 
 
Calorie counting       Atkins 
Low fat        SlimFast 
Low Carbohydrate       High Protein 
Weight watchers       Slimming World 
5:2         Other 
 
Diet:                            How long you followed the diet:                         weeks 
 
Weight loss:……………pounds How long you kept the weight off……………………….weeks 
 
Diet:                            How long you followed the diet:                          
 
Weight loss:……………pounds How long you kept the weight off……………………….weeks 
 
Diet:                            How long you followed the diet:                           
 





18. What do you consider a good weight for yourself? ………………………….pounds                    
 
19. Were you overweight as a child (12 years or below)?  YES/NO 
 
20. Were you overweight as a teenager (12-18 years?  YES/NO 
 




22. How often do you eat out?  …………….. 
 
What types of meals?......................................................................................................... 
 
10. Do you drink alcohol? Yes / No 
 If you answered Yes, how many drinks do you have a week?......................... 
 What kind of drinks (beer, wine, spirits ? 
 
12. Do you feel your weight accurately reflects the amount you eat?          YES/NO 
 
13. List any foods that you consider:  
       
     Bad to eat      ………………………………………………………………………………………. 
       
     Good to eat    ………………………………………………………………………………………. 
 
 14. How many hours of sleep do you get each night?  
 
     Less than 6 hours 􀂅            6-7 hours 􀂅              7-9 hours 􀂅            more than 9 hours 􀂅 
 
15. Do you feel rested on most days?      No 􀂅      yes 􀂅 
 
16. How many meals a day do you eat? ………………………………. 
 
 


















































































































































































Milk-whole     Beetroot     Apples     
Milk-low Fat     Onions     Lemons     
Milk-Non fat     Green peppers      Pears     
Cottage-cheese     Garlic     Apricots     




    Green salad     Peaches     
Flavoured yogurt     Sweet corn     Grapes     
Meat  Like Dislike Definitely must 
be in my diet 
Definitely 
must not 
be in my 
diet 
Carrots     Mandarins/ 
Satsumas 
    
Roast beef      Celery      Fruit Cocktail      
Burgers      Spinach     Dried fruit     
Meatloaf     Cauliflower     Watermelon     
Hot Dogs     Broccoli     Pineapple     
Pork Chops     Asparagus     Bananas     
Pork Roast     Courgettes          
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Ham     Squash     Strawberries     
Lamb     Cabbage     Prunes     








be in my 
diet 
Liver     Tomatoes     Apples     
Sausages     Lettuce     Oranges     
Bacon     Mushrooms     Prunes     
Chicken-White 
Meat 
    Beans     Cranberry     
Chicken-Dark 
Meat 
    Lentils     Tomato     
Turkey-White 
Meat 
    Mashed 
potatoes 
         
Turkey-Dark 
Meat 








be in my 
diet 
Eggs     Macaroni     Ice Cream      
Fish Like Dislike Definitely must 
be in my diet 
Definitely 
must not 
be in my 
diet 
Rice     Cheesecake     
Tuna fish     Pasta     Biscuits     
Shell fish e.g. 
mussels 
    Chips     Cakes     
Salmon     Roast potatoes     Pudding     
Haddock     Boiled potatoes     Custard      
Cod     Jacket potatoes     Fruit Pies     
White fish          Dessert with 
nuts 
    
Prawns               
Bread Like Dislike Definitely must 
be in my diet 
Definitely 
must not 
be in my 




White Bread               
Wholemeal 
Bread 
              
Rye Bread               
Bread with nuts 
and seeds 
              
               
Soups Like Dislike Definitely must 
be in my diet 
Definitely 
must not 
be in my 
diet 
          
Broth/Clear               
Creamy               
Vegetables               
Chicken               
Beef               
Tomato               
Potato                
Preferences 
Beverages 
Like Dislike Definitely must 
be in my diet 
Definitely 
must not 
be in my 
diet 
          
Regular soft 
drinks 
              
Beer               
Decaffeinated 
coffee 
              
Milk               
Milk in coffee or 
tea 
              
Tea               
Spirits               
Wine               
Juice                
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Other               
Snacks Like Dislike Definitely must 
be in my diet 
Definitely 
must not 
be in my 
diet 
        
Crisps             
Salted Nuts             
Unsalted nuts            
Savoury biscuits             
Sweet biscuits            
Chocolate bars            
Restaurant food Like Dislike Definitely must 
be in my diet 
Definitely 
must not 
be in my 
diet 
       
Italian food            








Chinese food                 
Indian food            
Fish and chips            




          
Signature    Title      Date  
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 Appendix  7    Food diary   
 
FOOD DIARY 
Instructions for the food diary: 
Please fill out this food diary for 3 days, noting down what you have eaten as close as possible 
to the time you ate it (to help you to remember). 
Please try to be as specific as possible about the amount of each item, what time you ate it and 
any brand names. 
For example: 
Breakfast 8am - 1 piece of Warburton's white bread with Olivio spread, 2 scrambled eggs, I 
large cup of coffee with 1 level teaspoon sugar. 
Lunch 12.30pm - 1 small plate of lettuce and tomatoes, half a large tin (160g) of Princes tuna in 
brine, 2 small new potatoes, boiled, small portion of full fat salad dressing, 1 can Coke. 
Evening meal 7pm - Beef chilli con carne with white rice (average portion).  Cup of black coffee 
with 1 level teaspoon sugar.  1 medium slice Tesco own brand blackcurrant cheesecake. 
Don't forget to include all drinks and any between meal snacks! 




Day 1- Date:…………………………………………………….. 
Breakfast: Include all food and drinks (example: 8am - 1 piece white toast and butter, 2 scrambled eggs, 1 cup of 











Lunch : Include all food and drinks (example: 12.30pm 1 small plate of lettuce and tomatoes, half a large tin (160g) of 












Evening meal: Include all food and drinks (example: Beef chilli con carne with white rice (average portion).  Cup of 











Snack and drinks (not taken at mealtimes): (example: 1 apple, 1 Mars bar, 1 small glass full fat milk, 1 plain biscuit, 















Breakfast: Include all food and drinks (example: 8am - 1 piece white toast and butter, 2 scrambled eggs, 1 cup of 











Lunch : Include all food and drinks (example: 12.30pm 1 small plate of lettuce and tomatoes, half a large tin (160g) of 











Evening meal: Include all food and drinks (example: Beef chilli con carne with white rice (average portion).  Cup of 











Snack and drinks (not taken at mealtimes): (example: 1 apple, 1 Mars bar, 1 small glass full fat milk, 1 plain biscuit, 














Day 3- Date:…………………………………………………….. 
Breakfast: Include all food and drinks (example: 8am - 1 piece white toast and butter, 2 scrambled eggs, 1 cup of 











Lunch : Include all food and drinks (example: 12.30pm 1 small plate of lettuce and tomatoes, half a large tin (160g) of 












Evening meal: Include all food and drinks (example: Beef chilli con carne with white rice (average portion).  Cup of 











Snack and drinks (not taken at mealtimes): (example: 1 apple, 1 Mars bar, 1 small glass full fat milk, 1 plain biscuit, 















 Appendix 8   Food craving  
 
 
FOOD CRAVING INVENTORY (FCI) 
 
Name: _________________Participant number_____ Date: 
___________ 
 
Food craving is defined as an intense desire to consume a particular food 
(or food type) that is difficult to resist. 
 
For each of the foods listed below (Items 1-28), please circle the 
appropriate letter using the following scale. 
 
Over the past month, how often have you experienced a craving for the 
food? 
 
A = Never 
 
B = Rarely (once or twice) 
 
C = Sometimes 
 
D = Often 
 




List of foods                  Never       Rarely    Sometimes    Often         
Almost                                           
everyday 
 
Cakes     A B  C  D         E  
Pizza                A B  C  D   E  
Fried Chicken    A  B  C  D   E  
Sausages     A B  C  D   E  
French Fries/Chips             A          B         C          D         E 
Rice                A         B         C          D          E  
Sausage Rolls   A B  C  D   E  
Gravy                 A  B         C          D         E 
Hamburger/Beefburger  A B  C  D   E 
Biscuits     A  B  C  D  E  
Ice Cream     A B  C  D  E  
Pasta             A   B  C  D  E 
Fried Fish            A            B  C  D        E  
Cookies            A           B   C  D  E  
Chocolate            A           B  C  D  E  
Pancakes/Waffles           A B  C  D  E  
Bread Rolls/Bagels/Baps          A B  C  D  E  
Doughnuts             A B  C  D         E  
Sweets            A            B          C         D          E  
Brownies/Muffins    A  B  C  D  E  
Bacon               A        B          C        D  E 




List of foods                  Never       Rarely    Sometimes    Often         
Almost                                           
everyday 
Danish pastry      A     B     C       D       E  
Baked Potatoes      A     B      C        D       E  
Sponge Cake               A     B      C        D       E  
Cereals     A    B     C        D       E 
Sandwich Bread    A    B      C       D       E  





















 Appendix  9   Three factor eating questionnaire 
Participant number……………………………………………………….  Date…………………. 
 
We are interested in the reasons underlying peoples’ attitudes to food and eating.  Please 
indicate to what extent each of the following statements is true for you.  Please note there are 
no right or wrong answers or trick questions.  We simply want to know how you personally 
feels about food and eating.  Please CIRCLE your response. 
 
1. When I smell a sizzling steak or a juicy piece of meat (or vegetarian equivalent), I find it very 
difficult to keep from eating, even if I have just finished a meal.  
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
2.  I usually eat too much at social occasions, like parties and picnics. 
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
3. I am usually so hungry that I eat more than three times a day.  
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
4. When I have eaten my quota of calories, I am usually good about not eating any more.  
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
5. Dieting is so hard for me because I just get too hungry.  
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
6. I deliberately take small helpings as a means of controlling my weight. 
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
7. Sometimes things just taste so good that I keep on eating even when I am no longer hungry. 
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
8. Since I am often hungry, I sometimes wish that while I am eating, an expert would tell me that 
I have had enough or that I can have something more to eat.  
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
9. When I feel anxious, I find myself eating. 
 




10. Life is too short to worry about dieting. 
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
11. Since my weight goes up and down, I have gone on reducing diets more than once. 
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
12. I often feel so hungry that I just have to eat something. 
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
13. When I am with someone who is overeating, I usually overeat too. 
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
14. I have a pretty good idea of the number of calories in common food.  
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
15. Sometimes when I start eating, I just can't seem to stop. 
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
16. It is not difficult for me to leave something on my plate. 
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
17. A certain times of the day, I get hungry because I have got used to eating then.  
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
18. While on a diet, if I eat food that is not allowed, I consciously eat less for a period of time to 
make up for it.   
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
19. Being with someone who is eating often makes me hungry enough to eat also. 
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
20. When I feel blue, I often overeat. 
 




21. I enjoy eating too much to spoil it by counting calories or watching my weight.  
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
22. When I see a real delicacy, I often get so hungry that I have to eat right away. 
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
23. I often stop eating when I am not really full as a conscious means of limiting the amount that I 
eat.  
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
24. I get so hungry that my stomach often seems like a bottomless pit. 
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
25. My weight has hardly changed at all in the last ten years. 
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
26. I am always hungry so it is hard for me to stop eating before I finish the food on my plate. 
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
27. When I feel lonely, I console myself by eating. 
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
28. I consciously hold back at meals in order not to gain weight. 
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
29. I sometimes get very hungry late in the evening or at night.  
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
30. I eat anything I want, any time I want. 
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
31. Without even thinking about it, I take a long time to eat. 
 




32. I count calories as a conscious means of controlling my weight. 
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
33. I do not eat some foods because they make me fat. 
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
34. I am always hungry enough to eat at any time. 
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
35. I pay a great deal of attention to changes in my figure.   
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
 
 
36. While on a diet, if I eat a food that is not allowed, I often then eat other high calorie foods.  
 
definitely true for me……quite true for me……occasionally true for me……definitely not true for me 
37. How often are you dieting in a conscious effort to control your weight? 
 
rarely    sometimes    usually    always 
l 
 
38. Would a weight fluctuation of 5 lbs affect the way you live your life? 
 
not at all   slightly     moderately   very much  
 
 
39. How often do you feel hungry? 
 
only at    sometimes    often between   almost 
mealtimes   between meals    meals    always  
 
 
40. Do your feelings of guilt about overeating help you to control your food intake? 
 
never    rarely    often    always 
 
 
41. How difficult would it be for you to stop eating halfway through dinner and not  
      eat for the next four hours? 
  
easy    slightly    moderately   very 
   difficult    difficult    difficult  
  
 
42. How conscious are you of what you are eating? 
 




43. How frequently do you avoid ‘stocking up’ on tempting foods? 
 
almost    seldom    usually    almost always  
never 
 
44. How likely are you to shop for low calorie foods? 
 
unlikely   slightly unlikely   moderately likely  very likely  
 
 
45. Do you eat sensibly in front of others and splurge alone? 
 
never    rarely    often    always  
 
46. How likely are you to consciously eat slowly in order to cut down on how much  
      you eat? 
 
unlikely   slightly likely   moderately likely  very likely  
 
47. How frequently do you skip dessert because you are no longer hungry? 
 
almost   seldom   at least once   almost  
never      a week   every day 
 
48. How likely are you to consciously eat less than you want? 
 
unlikely   slightly likely  moderately likely  very likely  
   
49. Do you go on eating binges though you are not hungry? 
 
never    rarely    sometimes   at least once 
         a week  
 
50. On a scale of 0 to 5, where 0 means no restraint in eating (eating whatever you want, 
whenever you want it) and 5 means total restraint (constantly limiting food intake and never 
'giving in'), what number would you give yourself? (Please circle a response). 
 
0 Eat whatever you want, whenever you want it 
 
1 Usually eat whatever you want, whenever you want it 
 
2 Often eat whatever you want, whenever you want it 
 
3 Often limit food intake, but often 'give in' 
 
4 Usually limit food intake, rarely 'give in' 
 
5 Constantly limiting food intake, never 'giving in' 
 
 
51. To what extent does this statement describe your eating behaviour?  ‘I start dieting in the 
morning, but because of any number of things that happen during the day, by evening I have 
given up and eat what I want, promising myself to start dieting again tomorrow.’ 
 
not like me   a little like me   pretty good   describes me 
      description of me  perfectly  
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   Appendix 10    Appetite Scale 1 
 
                                                 Appetite Scale 
 





How hungry do you feel? 
 
I am not                                                                                                                               I have never              
Hungry at all          been more 
hungry 
 
How satisfied do you feel? 
 
I am                                                                                                                                       I cannot eat  
Completely   another bite 
empty 
 
How full do you feel? 
 
Not at all full                                                                                                                             Totally full 
 
 
How much do you think you can eat? 
 
 
Nothing at all                                                                                                                             A lot 
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How hungry do you feel? 
 
I am not                                                                                                                                   I have never              




How satisfied do you feel? 
 
I am                                                                                                                                        I cannot eat  
Completely   another bite 
empty 
 
How full do you feel? 
 
Not at all full                                                                                                                          Totally full 
 
 
How much do you think you can eat? 
 
 











How hungry do you feel? 
 
I am not                                                                                                                                   I have never              




How satisfied do you feel? 
 
I am                                                                                                                                         I cannot eat  
Completely   another bite 
empty 
 
How full do you feel? 
 
Not at all full                                                                                                                              Totally full 
 
 
How much do you think you can eat? 
 
 











How hungry do you feel? 
 
I am not                                                                                                                               I have never              




How satisfied do you feel? 
 
I am                                                                                                                                         I cannot eat  
Completely   another bite 
empty 
 
How full do you feel? 
 
Not at all full                                                                                                                              Totally full 
 
 
How much do you think you can eat? 
 
 











How hungry do you feel? 
 
I am not                                                                                                                                     I have never              




How satisfied do you feel? 
 
I am                                                                                                                                         I cannot eat  
Completely   another bite 
empty 
 
How full do you feel? 
 
Not at all full                                                                                                                               Totally full 
 
 
How much do you think you can eat? 
 
 







 Appendix 11  Participant information sheet 2  
                              
    version 3 Jan 2017  
Project Title Study to investigate factors influencing the body a weight 
IRAS number: 208879 
Principal Investigator Dr Caroline Dalton 
Biomolecular Sciences Research Centre 
Sheffield Hallam University 
Principal Investigator  
telephone/email 
0114 225 3695/c.f.dalton@shu.ac.uk 
Purpose of Study and Brief Description of Procedures 
You are being invited to take part in a research study.  Before you decide if you wish to take 
part it is important for you to understand why the research is being undertaken and what it will 
involve for you.  Please take time to read the following information carefully.  One of our team 
is available to go through this information sheet with you and answer any questions you have.  
Please ask if there is anything that is not clear or if you would like more information.  Take your 
time to decide if you would like to take part.   
The project aims to establish whether it is possible to identify the biological and psychological 
factors that are associated with success on a weight management plan.   
We think that there are differences in how people respond when they try to manage their 
weight.  These individual differences may be due to genetic or hormonal variability, or they may 
be due to psychological differences.  If we can identify factors that are associated with increase 
in body .we may be able to design better programmes to also help those people who find 
weight management more difficult.   
If you choose to participate in this study, you will be asked to fill in some questionnaires 
about your attitudes to food and exercise and your feelings.  
We also want to test your hormones and analyse your DNA, to do this we will need to take a 
DNA swab from your mouth.  
Procedures:  
Meeting 1 (after your 1st appointment at RIO, 30 minutes) 
• Read participant information sheet 
• Consider study, ask questions 
• Complete and sign consent form 
• Fill in questionnaires 
• Give a DNA sample by swabbing your mouth (this is painless and similar to using a toothbrush) 
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Meeting 2: (2 hours, at RIO, a few days after meeting 1, or during the following week) 
• Collection of blood sample. For the blood prick sample, you need to carry out a 12 hour 
overnight fast. A blood prick sample will be collected in the morning when you first arrive using 
a finger prick device (similar to that used by diabetics to test their insulin levels), this will be 
analysed for hormones.      
• Test breakfast and questionnaires.  Once you have given the blood sample you will be asked to 
fill in a questionnaire about how hungry you feel, then you will be given a breakfast of 
cornflakes, milk and orange juice.  If you are allergic to any of these items, we can offer an 
alternative e.g. rice krispies/soya milk.  You will be asked to record how hungry you feel at time 
points during the next 1 hour and 45 minutes.  During this time, you need to stay at RIO but are 
free to read or use your phone.  At the end of this time the test will finish, and you can leave.  
• You will be given £5 at the end of this session to cover your transport costs. 
 
Possible risks and discomforts:  
The blood prick sample procedure is mildly uncomfortable, no other risks or discomforts are 
anticipated.   
Benefits of the study: 
The study will provide important information regarding whether It is possible to identify what 
factors predict success for people on a weight management programme.  However, you will not 
be told your individual results.   
What will happen to my DNA and blood sample?  
Your DNA and blood samples will be stored in our laboratories which have restricted access.  
The samples will be coded with a participant number which cannot be traced back to you.  We 
will not allow access to your samples by any third party.   
What will happen to my samples and data at the end of the study? 
We would like to store your samples and data so at the end of the study so that we can use 
them in similar research projects.  If you would prefer that we did not do this, you can indicate 
this on the consent form and we will destroy your samples and remove your data from the 
database at the end of the study.  
What will happen to the results at the end of the study?  
The results will be published as academic reports in scientific journals.  There will be no 
identifying information published.  We will also write a summary report of anything we discover 
which we will send to any of the people who participated in the study who want to see it.  This 
will not contain any identifying information.  The report will be available in mid-2018.  If you 
would like to have a copy of the report, please contact RIO nearer the time on 01709 720193.  
Will my taking part in this study be kept confidential?   
Yes, no one will know you have taken part in the study except the members of the research 
team.  Your consent form will be placed by you in a sealed envelope separate from the 
questionnaires, the blood samples and the DNA sample.  You will be allocated a participant 
number, and this will not be linked to your consent form therefore the data we collect from you 
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will be completely anonymous and cannot be traced back to you.  
Has this study got ethical approval?   
Yes, this study was approved by the local Ethics Committee.  This means that experts who are 
not involved in the study have carefully considered the aims and methods of the study and 
agreed that they meet their guidelines.   
Right to Withdraw: 
Remember that you always have the right to withdraw from the study at any time. 
If you feel that these Regulations are being infringed or that your interests are otherwise being 
ignored, neglected or denied, you should inform Dr Nikki Jordan-Mahy, Chair of the Faculty of 
Health and Wellbeing Research Ethics Committee art Sheffield Hallam University (Tel: 0114 225 























  Appendix 12   Appetite Scale 2 
 
                                                       Appetite Scale 
 





How hungry do you feel? 
 
I am not                                                                                                                               I have never              
Hungry at all          been more 
hungry 
 
How satisfied do you feel? 
 
      I am                                                                                                                                   I cannot eat  
Completely   another bite 
empty 
 
How full do you feel? 
 
      Not at all full                                                                                                                          Totally full 
 
 
How much do you think you can eat? 
 
 
           Nothing at all                                                                                                                 A lot 
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              Participant number………………….                                          After breakfast         
 
 
How hungry do you feel? 
 
I am not                                                                                                                              I have never              




How satisfied do you feel? 
 
I am                                                                                                                                        I cannot eat  
Completely   another bite 
empty 
 
How full do you feel? 
 
Not at all full                                                                                                                             Totally full 
 
 
How much do you think you can eat? 
 
 









Participant number………………….                                         1 hr after breakfast         
 
 
How hungry do you feel? 
 
I am not                                                                                                                                I have never              




How satisfied do you feel? 
 
I am                                                                                                                                      I cannot eat  
Completely   another bite 
empty 
 
How full do you feel? 
 
Not at all full                                                                                                                        Totally full 
 
 
How much do you think you can eat? 
 
 









Participant number………………….                                         2 hr after breakfast         
 
 
How hungry do you feel? 
 
I am not                                                                                                                             I have never              




How satisfied do you feel? 
 
I am                                                                                                                                        I cannot eat  
Completely   another bite 
empty 
 
How full do you feel? 
 
Not at all full                                                                                                                              Totally full 
 
 
How much do you think you can eat? 
 
 













How hungry do you feel? 
 
I am not                                                                                                                                I have never              




How satisfied do you feel? 
 
I am                                                                                                                                           I cannot eat  
Completely   another bite 
empty 
 
How full do you feel? 
 
Not at all full                                                                                                                          Totally full 
 
 
How much do you think you can eat? 
 
 







  Appendix 13  Example for high protein diet 
 
Example 1 of high protein recipes for women  
Day 6   calories 1399, protein 105g  
 




2 large eggs, 30g Monterey jack cheese, 3 medium mushrooms, 1 plum tomato 
Method 
 
Spray the pan with cooking spray and place it on medium heat. Dice the tomatoes, and 
mushrooms.  Crack the eggs in a separate bowl and add the water & salt and pepper to 
it. Beat with a fork or whisk until combined. Pour the egg mixture on the vegetables. 
Cook until sides are dry gently pivoting pan to ensure evenness. Flip omelette and cook 
on other side. Add shredded cheese to half. Put the cheese side on plate. Gently flip 
other side over to have half circle. 
Egg and spinach tortilla 
Ingredients  
 
1 flour tortilla, 2 large eggs, 1 ounce cheddar cheese,2 cups fresh spinach, 1 tbsp. 
ground flaxseed 
Method 
Add each ingredient 
Snack - Tuna crunch   
Ingredients  




Dinner - Chicken dish 
Ingredients 
3 Chicken Breasts 2 tbsp. Ground Garlic (Marinade)3 tbsp. Olive Oil (Marinade)3 tbsp. 
Balsamic Vinegar (Marinade)3 tbsp. Lemon Juice (Marinade)750g Sweet Potato 
Chopped into Wedges2 tbsp. Jerk Seasoning2 tbsp. Olive Oil. 
Method 
Add the ingredients for the marinade together in a bowl. Mix and add the chicken and 
leave covered in the fridge for 2-3 hours. Chop the sweet potato and add to a roasting 
tray with a drizzle of olive oil and the jerk seasoning. Mix through. Place chicken on a 
separate roasting tray and cover with foil. Place the sweet potato and chicken into the 
oven for 40mins at 200C or until cooked. Example 2 of high protein diet recipes for 
men 
Example 2 of high protein recipes for men 
Day 7 1905 calories, protein 140 
 
Breakfast- Cottage cheese and strawberries 
Mix together: 1 c Breakstone's 2% cottage cheese 
3/4 c sliced strawberries 
With -2 boiled egg. 
Lunch- 8-Beef Sandwich 
Ingredients 
12 oz (lean beef roast) 4 sandwich thins or toast 1/4 c plain Greek yogurt 2 T soft 
cheese, 2 c green leaf lettuce 1/2 cup Onions 
Method 
Mix cheese and Greek yogurt. Layer between the bread the lettuce, beef, onions, and 
dressing. Makes 4 sandwiches 
With your lunch take1 cup of skim milk 
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Snack- Feta and grapes   
Ingredients 
60 g feta cheese, 180 g grapes 
With your snack take- ½ oz almond. 
 
Dinner- Steak & blue cheese wrap 
Ingredients 
1 tbsp. olive oil, 1 x 140g/5oz sirloin steak, trimmed of fat and cut into strips, 1 small 
red onion, thinly sliced, ½ red pepper, deseeded and sliced, squeeze balsamic glaze, 
25g Stilton or dolce latte, 1 small soft flour tortilla, handful rocket or baby spinach 
leaves 
Method 
Heat the oil in a hot frying pan, season the steak, then fry with the onion and pepper 
for 4 mins over moderate heat. Stir in the balsamic glaze, continue to cook for 1 min, 
then remove from the heat. Warm the tortilla. Slice the steak into thin strips, then tip 
back into the pan with any meat juices and mix with the veg. Spoon the mixture over 
the middle of the tortilla, crumble over the cheese, then scatter with rocket or spinach. 
Fold to make a wrap and serve straight away.  
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